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PREFACE 
Rheumatoid arthritis is the prototype of chronic joint inflammation 
(arthritis) with unknown etiology and it affects a considerable 
percentage of the adult population. Despite ample clinical and 
experimental investigations during the last decade, the reason why this 
systemic disease manifests itself mainly in the joints and why it 
displays such a chronic character is not understood. This thesis 
contains results derived from experiments which were designed to 
address the abovementioned questions. 
Our startingpoint was the idea, that chronic arthritis is a result of 
repeated exacerbations of an in itself finite inflammation. The main 
subject to be studied was therefore the way in which repeated 
exacerbations can be induced and how the expression of these reactions 
is controlled in vivo. In addition, we sought for a stimulus involved 
in both initiation and maintenance of the arthritis with such 
characteristics, that the localization of the disease could be 
explained at the same time. 
In this thesis, studies on the role of antigen-specific Τ cells 
(chapter 1 ) and mast cells (chapter 2 ) in exacerbations of antigen 
induced arthritis are described. Furthermore, the contribution of 
lymphocytes to the severity of arthritis induced by bacteria and 
exacerbations thereof is analyzed (chapter 3 ). Chapter 4 and 5 show 
evidence for the crucial role of bacterium-specific Τ lymphocytes in 
streptococcal cell wall induced arthritis in rats and, in addition, 
mechanisms regulating the expression of this Τ cell response are 
discussed. A possible reason why systemic presence of bacterial 
antigens or systemic immunity against them may induce inflammation 
especially in the joints is given in chapter 6: here it is shown that 
bacteria can induce immune responses against cartilage. Finally, 
chapter 7 is a clinical illustration which points out the possible 
relevance of abovementioned studies with respect to human joint 
inflammation. 
Thus, from various studies described in this thesis growing evidence 
is obtained, that bacteria are candidates with an excellent 
arthritogenic potential because of their phlogistic properties in 
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combination with the ability to induce "autoimmune" responses against 
joint structures in susceptible hosts. Moreover, their ubiquitous 
endogenous and exogenous presence enables them to induce repeated 
exacerbations of arthritis possibly resulting in chronic joint 
inflammation. 
CHAPTER 1 
MONOCLONAL ANTI-Ia ANTIBODIES SUPPRESS THE FLARE UP REACTION OF ANTIGEN 
INDUCED ARTHRITIS IN MICE 
Maries F. van den Broek, Wim В. van den Berg, Levinus Β.Α. van de Putte 
Clinical and experimental Immunology, 66:320-330, 1986. 
(reprinted with permission) 
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Monoclonal anti-Ia antibodies suppress the flare up 
reaction of antigen induced arthritis in mice 
MARIES F VAN DEN BROEK, W В VAN DEN BERG & L В A VAN DE 
PUTTE Department of Rheumatology, Sint Radboud Hospital. Unuersm of Nijmegen 
( Accepted for publication 26 June 1986) 
SUMMARY 
Intravenous injection of methylated bovine serum albumin (mBSA) in mice with a 
unilateral antigen-induced arthritis induced with mBSA causes a flare up of the 
inflammation in the arthritic but not in the contralateral joint To study whether this 
phenomenon is dependent on class II antigens, we treated C57B1 10 (H-2b) and C3H (H-
2k) mice with monoclonal anti-Ia1" (HB26) and anti-Iak (2-2-1) antibodies on days -3, -2,-1 
and 0 before induction of the flare up Another group was treated only once on day 0 
before antigen challenge Four injections with HB26 completely suppressed the flare up 
reaction in C57B1/10 mice, the same results were seen with 2-2-1 in C3H mice One 
injection only partly suppressed the flare up reaction in both strains, whereas four 
injections with the haplotypc-nonspecific antibodies did not affect the flare up Injections 
with HB26 appeared to be able to completely suppress a delayed type hypersensitivity 
reaction but not a reversed passive Arlhus reaction in C57B1 10 mice, indicating that anti-
la antibodies have an effect on lymphocyte-dependent but not on antigen-anlibody-
dependenl inflammatory phenomena These results demonstrate that the flare up of 
antigen induced arthritis is dependent on the presence of la antigens, suggesting that the 
interaction between antigen-presenting cells and Τ lymphocytes plays an important role in 
this process 
Keywords anti-la antibodies flare up reaction antigen induced arthritis 
INTRODUCTION 
Systemic administration of a sufficient amount of antigen into mice with an ongoing antigen 
induced arthritis results in a flare up of the joint inflammation (van de Pulleet al, 1983, Lens, van 
den Berg & van de Putte, 1984c, Lens et al, 1986) Such flare up reactions of antigen induced 
arthntis were also desenbed in the rabbit (Cooke & Maeda, 1980) Like the exacerbations in 
rheumatoid arthritis, these flare up reactions can be characterized as an acute type of inflammation 
superimposed on a smouldering chronic joint inflammation This acute type of inflammation, as can 
be seen after histological investigation of the mouse knee joints, is mainly characterized by large 
numbers of granulocytes infiltrating the synovial tissue and by an exudate of cells and fibrin in the 
joint space (Lens et al, 1984c) 
The mechanism underlying this phenomenon is not yet completely understood It was however 
Correspondence M F van den Broek Department оГ Rheumatology Si Radboud Hospital, University of 
Nijmegen, Geert Grooleplcm Zuid 8, 6525 GA Nijmegen. The Netherlands 
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shown that local hypersensitivity of the inflamed joint plays an important role in the initiation of the 
flare up reaction (Lens et at, 1984c) Recently it has been described that the flare up of antigen 
induced arthritis is dependent on lymphocytes since pretreatment with antilymphocyte serum 
suppressed the flare up reaction In the same study the flare up reaction was proven to be 
independent ofcomplement because prclrealment with cobra venom factor appeared not to be able 
to suppress this reaction (Lens et al, 1984d) 
Proliferation of and lymphokine production by Τ lymphocytes upon stimulation with antigen 
requires the presence and recognition of major histocompatibility complex (MHC) class II antigens 
on antigen presenting cells (APC) (Ber7ofsk\ 1980 Schwartz Yano & Paul 1978, Thomas, 
Yamashita & Shevach, 1977) Dendritic cells (Sunshine el al, 1983) and cells of the macrophage, 
monocyte lineage (Schwartz et al, 1978, Thomas et al, 1977, Longo & Schwanz, 1981, Hodes, 
Hathcock & Singer, 1980, Cowing et al, 1978) bear the class II antigens which are coded for by the I 
region of the MHC (la antigens) and function as APCs for protein antigens 
Using anti-la antibodies, successful studies have been performed in preventing (experimental) 
diseases in which the la-dependent immune response plays an important role, such as experimental 
autoimmune myasthenia gravis (Waldor et al, 1983), grafl-versus-host reactions (Prudhomme, 
Sohn & Delovitch, 1979), experimental allergic encephalomyelitis (Shiram & Stemman, 1983), the 
systemic lupus erythematosus-like syndrome of (NZB χ NZW)F1 mice (Adelman, Wathing & 
McDevitt, 1983) and collagen type II induced arthritis (Wooley et al, 1985) Moreover, in the 
expenmental allergic encephalomyelitis model treatment starting at the onset of paralytic signs 
results m a striking clinical improvement In addition, a clinical trial has been described in which 
patients with clinically active rheumatoid arthritis were treated with polyspecifíc anti-HLA-DR 
antibodies (Sany et al, 1982, Clot & Sany, 1984) In this trial more than 60% of the treated patients 
appeared to have a significant clinical improvement 
In this study we have investigated the effect of monoclonal anti-la antibodies on the flare up of 
an ongoing disease process Treatment with anti-la antibodies in this model differs from other 
models in the fact that we started treatment long (60 days) after immunization and thus interfered 
with a mature immune status We chose the flare up of antigen induced arthritis as a model, because 
it is a distinct phenomenon in an ongoing disease and (repeated) exacerbations may have relevance 
as a mechanism underlying the chromcity of joint inflammation 
Our results indicate that it is possible to completely suppress the flare up reaction with 
monoclonal anti-Iab antibodies m C57B1/I0 (H-2b) mice and with monoclonal anli-lal antibodies in 
C3H (H-2k) mice, while suppression with haplolype nonspecific antibodies appeared not to be 
possible This and experiments in which the effect of anti-la antibodies on delayed type 
hypersensitivity (DTH) and reversed passive Arthus (RPA) reactions was examined, point out that 
the flare up reaction is in all probability an I region linked phenomenon 
MATERIALS A N D METHODS 
Mice Male C57B1/10 (W-2b) and male C3H (H-2k) mice were used for the induction of arthritis 
and flare up Mice were 8 weeks ofage at the start of the immunization procedure Female BIOBR 
(H-21) and female Balb/c (H-2d) mice aged 12 weeks were used for the production of anti-Iab and 
anti-Iak ascites, respectively C57BI/10, BIOBR and Balb/c mice were bred in our own Central 
Animal Laboratory C3H mice were obtained from the Radiobiological Institute TNO, Rijswijk, 
The Netherlands Mice were fed a standard diet and lap water ad lib 
Immunization and induction of arthritis Mice were immunized with 100 μ% methylated bovine 
serum albumin (mBSA), Sigma Chemical Company, St Louis, Missouri, USA) emulsified in 
Freund's Complete Adjuvant (Difco Laboratories, Detroit, MI) divided into four subcutaneous 
injections into the flank and the footpads of the forelimbs As an additional adjuvant 2 x 1 0 ' heat-
killed Bordetella pertussis organisms (National Institute of Public Health, Bilthoven, The 
Netherlands) were injected inlrapentoneally After 7 days the mice were boosted with 100 μ% mBSA 
emulsified in Freund's Complete Adjuvant, divided into two subcutaneous injections into the back 
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At day 21 arlhrilis was induced by intraarticular injection of 60 /jg mBSA in 6 μ\ phosphate buffered 
saline (PBS) into the right knee joint. 
Induction of the flare up reaction. Flare up of arthnlis was induced in the chronic phase of the 
inflammation of the right knee joint (i.e 5-6 weeks after initial arthritis induction) by injection of 
300 /jg mBSA in 150 μ\ PBS into the tail vein. PBS injected i.v. in a control group appeared not to 
induce a flare up of the inflamed joint (Lens et al., 1984d). 
Measurement of the joint inflammation. Primary arthritis and flare up reaction were quantified by 
the T c uptake method as described previously (van den Berg et al., 1984; Lens et al., 1984a). This 
mclliod measures the sevcnl) ofinfljmmation b> the accumulation ofa small radioisotope al the 
site of inflammation due to a local increased blood flow and tissue swelling. In short, 10 μ& 
(3-7 χ 102 MBq) " T c was administered subculaneously and the uptake in the knee joints was 
measured by external gamma-counting 40 mm later. The severity of inflammation was expressed as 
the ratio of the T c uptake in the right (inflamed) knee joint over that in the left (control). These 
right over left (R/L) ratios correlate with histological scores (Lens et al., 1984a). Every ratio higher 
than 110 was assigned as inflammation. 
Histology of knee joints. For histological score of the inflamed knees, the right knee joints were 
removed in toto and processed for histology as previously described (van den Berg el ai, 1982). 
Standard frontal sections (6 μτη) were prepared and stained with hematoxylin and eosin. 
Monoclonal antibodies. Monoclonal antibody HB26 (25-9-17) is produced by fusion of the 
Balb/c plasmacytoma cell line Sp2/0-Agl4 with C3H anti-C3H.SW spleen cells (American Tissue 
Culture Collection, Rockville, MD). The monoclonal antibody is a cytotoxic IgG2a and recognizes 
la" and Iad (Ozato & Sachs, 1981 ). Ascites is produced by injection of 3 χ 10' hybridoma cells in PBS 
in irradiated 500 rad (5 Gy) female B10BR mice. Ten days before injection of hybridoma cells the 
mice were injected intraperitoneally with 0 5 ml pristane (2,6,10,14-lelramethylpentadecane 96%, 
Janssen Chimica, 2340 Beerse, Belgium). The ascites used in the experiments had a litre, expressed 
as 50% of the total lysis of C57BI/10 target spleen cells, of approximately 1/2500. 
Another hybridoma cell line used was 2-2-1 (Lems et al., 1983), a cytotoxic IgG2a monoclonal 
antibody reactive with Iak and definitely not with Iab. 2-2-1 is the product ofa fusion between the 
Balb/c plasmacytoma cell line Sp2/0-Agl4 and Balb/c anti-Balb/k spleen cells. Ascites of this 
hybridoma line was produced in female Balb/c mice as described above. 2-2-1 was kindly provided 
by Dr W. J. M. Tax, Department of Nephrology, St Radboudhospital, Nijmegen, The Netherlands 
The titre of the 2-2-1 ascites was adapted to be equal to the titre of HB26. 
Both ascites fluids were heat inactivated (30 min at 560C) before use. 
Treatment of mice with monoclonal antibodies. Mice received 500 μ\ ascites by an intraperitoneal 
injection on days-3,-2, -1 and Oof the induction of the flare up. The last injection was given 15-30 
mm before the i.v. administration of mBSA. The experimental group received HB26 ascites (C57BI/ 
10) or 2-2-1 ascites (C3H), the control groups received PBS, 2-2-1 (C57B1/10) or HB26 (C3H). A 
second experimental group received the anti-la ascites only once 15-30 mm before inducing flare up 
Skm tests. A delayed type hypersensitivity (DTH) reaction was induced by injection of 10 /jg 
mBSA into the right ear ОГС57ВІ/10 mice immunized with mBSA. The left ear was injected with 5 μΐ 
of PBS. The increase in ear thickness was measured after 4, 24 and 48 h with an industrial 
micrometer. The increased ear thickness in non-immune mice after injection of 10 //g mBSA was 
negligible. Modulation of the DTH reaction by the different ascites fluids was performed using the 
treatment schedule as desenbed above. 
A reversed passive Arthus (RPA) reaction was induced by injection of 10 μ\ heat inactivated 
rabbit anti-mBSA serum in the right ear and 10 μΐ heat inactivated normal rabbit serum in the left 
ear ofa virgin C57B1/10 mouse followed by an i.v. injection of 2 mg mBSA in 200 μΐ PBS. After 4 h 
thè increase in ear thickness of the right and the left ear was measured. Modulation of the RPA 
reaction was performed by one injection of 500 μ] of the ascites fluids 15 min before evoking the 
RPA reaction. 
Statistical analysis. The incidence of the flare up phenomenon in the different groups of mice 
(values obtained from the R:L ratios of the " T c uptake) was compared statistically by using the 
one-tailed Mann-Whilney t/-test. The same test was used for the statistical comparison of the 
15 
increased ear thickness (R L ratio) as measured in the different groups of mice in the DTH and RPA 
reaction 
RESULTS 
Induction of the flare up reaction As reported earlier (Lens et al, 1984a) intravenous injection of 
300 μg m BS A approximately 40 days after the induction of the primary arthritis appeared to be 
sufficient to cause a flare up reaction in the right knee joint without affecting the left This flare up 
reaction discriminated itself significantly from the background inflammation at day 40 as well by 
" T c uptake ratios as by histological score 
Influence of treatment with monoclonal anti-la antibodies on the induction of the flare up reaction 
To investigate whether the flare up reaction is an I-region linked phenomenon, we treated mice with 
a monoclonal anti-la antibody directed against the matching haplotype As a control we treated 
mice with a monoclonal anti-la antibody of the same subclass (IgG2a) and the same cytotoxic titre 
but directed against an irrelevant haplotype The studies were performed in two strains of mice. 
C57B1/10 (H-2b) and C3H (H-2k) mice Both strains were treated with HB26 (monoclonal anti-Iab) 
and 2-2-1 (monoclonal anti-Iak) Two different treatment schedules were used mice were injected 
four times once a day starting at 3 days before the induction of the flare up with the last injection IS 
mm before the intravenous challenge or mice were injected just once 15 mm before the challenge 
In C57BI/10 mice treated with four injections of HB26 the flare up reaction appeared to be 
completely suppressed (Fig 1 A), while four injections with 2-2-1 did not influence the reaction at all 
(Fig 1С) A single injection with HB26did not completely suppress the flare up reaction (Fig IB) 
In fact, the suppression mediated by one and that by four injections were significantly different from 
each other 
The same results were seen in C3H mice (Fig 2) Both suppressed reactions did not differ 
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Fig. 2 R/L ratios of " T c uptake 24 h after ι ν challenge with 300 /ig m BSA in C3H (H-2k) mice (A) treated 
with 2-2-1 (ami-la1) four times (days -3, -2 -1, and o) before ι ν challenge, (В) treated with 2-2-1 (anti-Iak) once 
(day 0) before ι ν challenge, (С) treated with HB26 (antt-lab) as in (A), (D) treated with PBS as in (A) Values 
represent the mean ±s d from groups of mice (numbers indicated in the bars) The dashed line indicates the 
background inflammation, measured before start of the treatment NS, not significant 
significantly from each other, which may probably be related to the fact that the unsuppressed 
reaction was less pronounced in this strain The suppressed reactions were however significantly 
different from the unsuppressed flare up reaction 
Figure 3 shows the histological view on this flare up phenomenon The section of the 
unsuppressed flare up reaction (Fig 3B) shows a classical pattern of a flared inflammation, ι e large 
infiltrates consisting of granulocytes invading the synovial membrane and the joint space Infiltrates 
of granulocytes can also be seen as periarticular foci in the flare up reaction In the section of the 
completely suppressed reaction (Fig ЗА) those typical features cannot be seen It only shows the 
remainder of the foregoing arthritis such as cartilage damage, a chronic mononuclear infiltrate and 
sometimes some exudate 
The results of the histological scores of C57B1/10 mouse knee joints are listed in Table 1 The 
knee joints were scored on coded slides Mice treated four times with HB26 showed no exudate or 
granulocytes infiltrating the joint space or synovium Mice treated once with HB26 showed in some 
cases exudate and few granulocytes Mice treated with PBS or 2-2-1 showed a large infiltrate of 
granulocytes and a joint space filled with exudate 
Influence of treatment with monoclonal anti-la antibodies on the induction of a delayed type 
hypersensitivity and a reversed passive Arthus reaction To investigate whether the treatment with 
anti-la antibodies had an effect on lymphocyte-dependent or on antibody- or immune complex-
dependent phenomena, we tested the influence of these antibodies on the DTH and the reversed 
passive Arthus (RPA) reaction, respectively 
The results of these expenmenis are shown in Table 2 Treatment of C57B1/10 mice with HB26, 
but not with 2-2-1 or PBS before the induction of the DTH reaction significantly (Я<0 005) 
suppressed this reaction To be sure that a delayed type of reaction had been considered, the ear 
thickness was measured after 4, 24, and 48 h 
Treatment with HB26,2-2-1 or PBS had no effect on the induction of a RPA reaction (Table 2) 
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Fig. 3. Histology of mouse knee joints 24 h after I.v. challenge (A) knee joint of C57BI/10 ( H ^ ) mouse treated 
four times (days -3. -2, -1, 0) with HB26 (anti-la1'); (B) knee joint of C57BI'10 (H-21') mouse treated four times 
(days-3,-2,-l,0)«ith 2-2-1 (anti-Iak). (C) detail of periarticular focus with granulocytes in the joint section of 
C57B1/I0 (H^11) mouse treated as in (B), (D) detail of figure 3B. Staining; hematoxylin & eosin Magnification: 
A&B χ 100, C&D χ 250 F, femur, JS, joint space. P, patella, PF, periarticular focus. 
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Table 1. Histological score of mouse knee joints (C57B1/10, H-2b) at day 1 after flare up induction 
Treatment Granulocytes' Exudate! 
4xHB26(anli lav ' ) 
lxHB26(anli-Iab) 
4x2-2-1 (anli-Iak) 
4xPBS 
0 2 
0 9 
2 1 
2 2 
01 
0 4 
1 1 
12 
• Mean of values scored on a scale from 0-3 
0, no granulocytes in infiltrate, exudate or in 
periarticular foci, 1, granulocytes in mfillrate, 
exudate and in periarticular foci, 2, many 
granulocytes in infíltrate exudate and periarti-
cular foci, 3, infiltrate and exudate consisting 
mainly of granulocytes 
t Mean of values scored on a scale from 0-2 
0, no exudate, 1, 1/4 or less of joint space filled 
with exudate, 2, more than 1/4 of joint space 
filled with exudate 
Table 2. Influence of HB26 (anti-Iab) and 2-2-1 (anti-Iak) on the induction ofDTH and RPA reactions in the ear 
ofC57Bl/10(H-2b)mice 
R/L ratios of ear thickness· 
DTHf RPAt 
Treatment 4 h 24 h 48 h 4 h 
HB26(anti-Iab) 112±O08 1 2 8 ± 0 0 2 1 3 0 ± 0 0 3 1 6 8 ± 0 0 4 
2-2-1 (anti-Iak) 174 + 005 2 4 4 ± 0 0 3 2 4 6 ± 0 0 4 1 6 5 ± 0 0 7 
PBS 176 + 006 2 4 6 ± 0 0 6 2 4 7 ± 0 0 3 1 6 8 ± 0 0 3 
The values represent the mean + s d from groups of five mice 
The values of the DTH reaction in HB26 treated mice differed 
significantly (P<0 005) from that in 2-2-1 and PBS treated mice 
The values in the RPA reaction did not differ significantly 
* Values are obtained by dividing the measured ear thickness of 
the nghl (experimental) by the left (control) ear 
t A DTH reaction was elicited by injection of 10 pg mBSA in the 
nght ear of immunized mice The left ear was injected with PBS 
X A RPA reaction was elicited by injection of 2 mg mBSA ι ν 
and 10 μ\ rabbil-anti-mBSA serum in<he nght ear of virgin mice 
The left ear Aas injected with the same amount of normal rabbit 
serum 
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These results indicate, that anti-Ia antibodies modulate lymphocyte-dependent, but not 
antibody- or immune complex-dependent inflammatory phenomena 
DISCUSSION 
In this study we have shown that treatment with haplotype-specific monoclonal anti-la antibodies 
completely suppressed the induction of the flare up reaction of antigen induced arthnlis in mice, 
whereas treatment with haploiypc nonspecific monoclonal anli-Ia antibodies did not Administra­
tion of haplotype-specific antibodies resulted also in a significant suppression of a DTH rcattion 
but did not affect a RPA reaction The latter results indicate that the flare up reaction is dependent 
on lymphocytes and that antigen-antibody interactions alone are not sufficient to induce a flare up 
of inflammation 
In the experiments performed in this study, mice were treated with anti-la antibodies 40 days 
after induction of the primary arthritis At that time the active inflammation, but not the immune 
status against mBSA had faded (data not shown) In this model we interfered with an exacerbation 
of an ongoing smouldering disease process relatively long after immunization This discriminates 
our study from studies in other models The treatment studies with anti-la antibodies in 
experimental autoimmune myasthenia gravis (Waldor el al, 1983), in collagen type II induced 
arthntis (Wooley et al, 1985) and in the SLE-like model (Adelman et al, 1983) describe a mere 
prevention of the disease and not an interference with it In the former two models treatment with 
anti-la antibodies only was successful when it was performed before the immunization with 
acetylcholine receptor or collagen type II, respectively In the SLE-model treatment started when 
the mice were approximately 4 months of age, a time way before the clinical onset of the disease (e g 
at 8 months (Berden el al, 1983)) Treatment of animals before immunization and amply before the 
onset of the disease may be considered to have some similarity, namely that the afferent phase of the 
immune response has not been reached yet On the other hand, in experimental allergic 
encephalomyelitis (Shiram & Stemman, 1983), anli-Ia antibodies administered after immunization 
with myelin basic protein had a suppressive effect on both the acute and the chronic relapsing form 
of encephalomyelitis The treatment was started at the first clinical sign of the disease Besides the 
known ability to suppress systemic autoimmune features with anti-la antibodies at the lime of 
immunization (Waldor el al, 1983, Adelman et al, 1983, Wooley et al, 1985) or at the clinical onset 
of the disease (Shiram & Stemman, 1983), we show that it is also possible to suppress local 
exacerbations of an immune reaction with anti-la antibodies 
Anti-la antibodies are well known to suppress the Τ cell immune response to a variety of 
antigens іиічі о (Prudhomme et al, 1979, Shiram & Stemman, 1983, Adelman el al, 1983, Wooley et 
al, 1985, Sprenl, 1980, Rosenbaum, Adelman & McDeilt, 1981, Perry & Greene, 1982) and in ι uro 
(Longo & Schwartz, 1981, Hodese/α/, 1980) The precise mode of action of these antibodies is not 
completely understood, it is however proven that the immunosuppressive effect is not directed 
against the Τ cell itself, but is probably an effect mediated through the inhibition of proper antigen 
presentation to helper Τ cells by la-positi ve APCs such as dendritic cells (Sunshine e ι al, 1983) and 
cells of the macrophage/monocyte lineage (Schwartz et al, 1978, Thomas et al, 1977, Longo & 
Schwanz, 1981, Modes et al, 1980, Cowing et al, 1978, Kruisbeek et al, 1985) Another possible 
effect of anti-Ia antibodies is the induction of suppressor Τ cells as has been shown in vn о (Perry & 
Greene, 1982) and m vitro (Lamb e ι al, 1982) This may fit our observation that one treatment with 
anti-la antibodies just before antigen challenge was not sufficient to cause a complete suppression of 
the flare up reaction It is possible that the induction of suppressor cells requires more than the given 
time The fact that with one treatment very shortly before the challenge the flare up could at least be 
partly suppressed, indicates that there must be a direct mechanism of action for the anti-la 
antibodies besides the possible induction of suppressor Τ cells These direct effects can consist of 
cytolytic activity towards la-positive cells, inhibition of antigen presentation by covering the la 
molecules on APCs or through stenc hindrance However the latter two are not very plausible 
explanations, because it has been shown that only intact, but not F(ab); fragments of anti-la 
antibodies are capable of inhibiting the immune response (M uchmore el al, 1983) A cell type that is 
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very potent as antigen-specific ARC and could be an important target for the anti-la antibodies is 
the antigen-specific В cell (Abbas, Harber & Rock, 1985, Lanzavecchia, 1985) This cell can present 
minute amounts of antigen to Τ cells, so elimination could have important consequences for 
reactions in which small amounts of antigen form the trigger (as is the case m our flare up reaction 
(Lens et al, 1984c, 1986)) It has been described that splenic В cells have almost completely 
disappeared 5 days after treatment of mice with anti-la antibodies (Waldor el a/, 1984) 
Previous studies from our laboratory have shown that local hypersensitivity of the inflamed 
joint is an important principle in the initiation of the flare up reaction Intraarticular injection of 
sc\ eral nanograms man inflamed joint causes exacerbation of the inflammation w hile this docs not 
induce an acute inflammation in the control (non-arthritic) joint of the same mouse (Lens el al, 
1984c) Recently it has been shown that pretrealmenl of mice with antilymphocyte serum 
completely suppressed the flare up reaction, while pretreatment with cobra venom factor did not 
(Lens et al, 1984d) These data support the view that locally retained antigen-specific Τ cells are 
important mediators of the initiation of the flare up reaction of antigen induced arthritis The role of 
locally retained Τ cells in flare up-like phenomena such as allergic skin reactions has been reported 
formerly ( Jansen & Bleumink 1970, Scheper et al, 1983) Further supporting evidence for a role for 
specific Τ cells that are retained in the joint in the initiation of the flare up can be found in the fact 
that the flare up reaction is very fast il is measurable as short as 6 h after induction, a time that is loo 
short to allow sufficient recruitment of Τ cells from the circulation Treatment with anti-la 
antibodies did not decrease the titre of circulating anti-mBSA antibodies at the time of the flare up 
reaction as is measured by an enzyme linked immunosorbent assay (ELISA) (data not shown) It 
can not be excluded that a local enhancement of antibody levels may contribute to some extent to 
the flare up reaction of the inflamed joint It has been shown that local production of specific 
antibodies by retained В cells could play a role in skin flare up reactions (Polak, Turk & Frey, 1973) 
The contribution of В cells in the flare up of antigen induced arthritis, if there is any, has to be 
independent of complement (Lens et al, 1984d) Treatment with anti-la which does inhibit the flare 
up reaction, does not inhibit an antibody mediated inflammatory reaction (RPA), so the flare up 
reaction is in all probability an immune complex independent reaction The fact that an anti-la 
treatment does also inhibit lymphocyte dependent reaction (DTH) and the probability that antigen 
presentation is involved is a strong pointer 4n the direction of the Τ cell as the most important 
mediator of the flare up reaction 
Anti-la treatment has been postulated as a possible therapy for the МНС-associated diseases 
mentioned above In a human clinical trial it has been shown that anli-HLA-DR antibodies can 
suppress a clinically active rheumatoid arthritis in 60% of the patients (Sany et al, 1982, Clot & 
Sany, 1984) In rheumatoid arthritis the action of anti-la (anti-HLA-DR) can be hypothesized as 
follows (Pincus, Clegg & Ward, 1985, Klareskog et al, 1982, Janossy et al, 1981) eliminating the 
la-positive APCs could be a method for interrupting the proposed perpetuating process of 
rheumatoid arthritis That la-positive APCs play a role can be shored up by the fact that on frozen 
sections of human rheumatoid synovium many activated Τ cells (OKT4-posilivc) were found in 
close contact with HLA-DR-positive interdigitating cells and macrophages This could imply the 
existence of a vicious circle in the pathogenesis of rheumatoid arthritis the HLA-DR-positive cells 
are excellent APCs to Τ cells and effective Τ cell activators as is proven m vitro (Klareskog et al, 
1982) The activated Τ cells on their turn can induce arrival and local expansion of HLA-DR-
positive cells and can stimulate the expression of HLA-DR on (cultured) macrophages (Janossy et 
al, 1981 .Steeg, Moore & Oppenheim, 1980) Breaking through this circle by eliminating the HLA-
DR positive (or in the mouse the la positive) cells could be a possibility for stopping this progressive 
disease However as long as the precise mechanisms of action of these potent immunomodulating 
antibodies are not understood, one should be careful in using them and be aware of unknown side-
effects 
The authors wish to thank G J F GrultersandP В Spaan for the animal care This work was supported by a 
grant from the Dutch League Against Rheumatism 
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The Role of Mast Cells in Antigen 
Induced Arthritis in Mice 
MARIES F van den BROEK, WIM В van den BERG, and LEVINUS В A van de PUTTE 
Abstract Our study was designed to investigate the role of mast cells in an experimental arthritis. 
We used antigen induced arthritis in mast cell deficient mice and their normal littermates for 
this purpose. Both the severity and chromcitv of infiltrate, exudate and tissue swelling appeared 
to be similar when the primary arthntis was examined. Cartilage damage as a result of chronic 
inflammation occurred to a lesser extent in masi cell deficient mice. The flare reaction of anti­
gen induced arthntis was significantly less vehement in mast cell deficient mice considering 
tissue swelling, but only tendentiously different when the exudate was scored. Our results indi­
cate that mast cells contribute to cartilage damage and may play an enhancing role in the flare 
reaction of arthritis in mice. (J Rheumatol 1988,15:544-551) 
Key Indexing Terms 
MAST CELLS ANTIGEN INDUCED ARTHRITIS MURINE MODEL 
In rheumatoid synovia, mast cells can be demonstrated in 
enlarged quantities as can one of its products, histamine1 ' 
This finding points to an activation and thus function of mast 
cells in rheumatoid arthritis (RA) It has been suggested that 
mast cells contribute to joint inflammation by releasing pro­
teases, exoglycosidases, sulfatases, chemotactic factors and 
vasoactive amines upon triggeringM The latter two might 
enhance the influx of effector cells at the site of inflammation 
during an exacerbation Mast cells also have been impli­
cated in joint destruction at the pannus-cartilage junction4 
The real impact of mast cells in RA is very difficult to study 
in humans, so we designed our investigation to explore the 
role of mast cells in different features of an experimental 
arthritis 
For this purpose we used antigen induced arthritis as a 
model for RA and mast cell deficient mice (WBB6F1-W/W1) 
and their normal littermates (WBB6FI- + / + ) Antigen 
induced arthritis is a model widely used for studying RA5 ' 
It can be induced in antigen primed animals by an injection 
of antigen into the knee joint In mice, for arthritis to be 
chronic, it is necessary to use a catrame antigen like methy­
lated or amidated bovine serum albumin (mBSA and aBSA, 
respectively, isoelectric point greater than 8 5) These 
catrame antigens display good retention in negatively charged 
cartilage'l0 The importance of retention may be the fact 
that small amounts of antigen continuously leak into the joint 
space where it acts as an inflammatory stimulus 
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Flare reactions of chronic arthritis can be induced by sys­
temic administration of antigen" " These exacerbations 
can be best characterized as an acute type of inflammation 
superimposed on the foregoing chronic one Histologically, 
these reactions are marked by a massive infiltrate of granulo­
cytes in the joint space and synovial tissue and by tissue swell­
ing From former studies it became evident that local 
hyperreactivity of the inflamed joint plays an important role 
in the flare reaction13 This local hyperreactivity is likely 
due to retained antigen specific helper Τ cells, for it has been 
proved that Τ lymphocytes play a critical role in at least the 
initiation of the flare reaction14 l7 
Our results indicate that the induction and the chronicity 
of the mBSA arthritis in mast cell deficient mice 
(WBB6F1-W/Wv) showed the same characteristics as that 
in their control littermates (WBB6F1-+/-I-) Chondrocyte 
death and cartilage matrix depletion as a variable for car­
tilage damage were of a higher degree in WBB6F1-+/ + 
mice Thus mast cells probably play a role in cartilage des­
truction, The flare reaction appeared to be significantly 
diminished in mast cell deficient mice compared with nor­
mal mice, implicating not an obligatory but an enhancing 
role for mast cells in the flare reaction 
MATERIALS AND METHODS 
Мне Маы tell deficient mice and their normal littermates were purchased 
from the Jackson Laboratory (Bar Harbor, ME) Mast cell deficient mice 
(WBB6FI W/W) and the normal controls (WBB6F1 +/ + ) were obtained 
by crosses between WB/ReJ W/+ and C57BI/6J Wv/+ mice At the time 
of the first immunization the mice were 8-10 weeks of age Mice were 
fed a standard diet and tap water ad libitum 
Immunization and induction of arthritis Mice were immunized with 100 
/ig mBSA (Sigma Chemical Company, Si Louis, MO USA) emulsified 
in Freund s complete adjuvant (FCA) (Difco Laboratones, Detroit Ml) 
divided into 4 subcutaneous injections into the flank and the footpads 
of the forehmbs As an additional adjuvant 2 χ IO9 heal killed Bordetella 
pertussis organisms (National Institute of Public Health and Environmental 
Hygiene Bilthoven, The Netherlands) were injected intrapcntoneally After 
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7 days, the mice were boosted with 100 μg mBSA emulsified in FCA and 
divided into 2 subcutaneous injections in the back 
At Day 21 arthritis was induced by an intraarticular injection of 60 jig 
mBSA in phosphate buffered saline (PBS) into (he right knee joint An irrele 
vant antigen (ovalbumin) injected into the left joint did not cause inflam 
mation 
Induction of the fiare reaction In the chronic phase of the arthritis of the 
right knee joint (ι e , 5-6 weeks after arthnds induction) a flare reaction 
was induced by injection of 300 μg mBSA in 150 μΙ PBS in the tail vein 
In a control group 130 μΙ PBS was injected 
Measurement of the joint inflammation Primary arthritis and the flare 
reaction were quantitated by the " " T c uptake method as described1819 
This method measures tissue swelling and local increased blood flow by 
the accumulation of a small radioisotope at the site of inflammation In short, 
10 μΟ (3 7 χ IO2 mBq) " " T c was administered subcutaneously and the 
uptake in the right inflamed and in the left control joint was measured 40 
mm thereafter by external gamma counting The seventy of inflammation 
was expressed as the nght over left ratio of these values This ratio has 
been shown to correlate well with histological scores19 Every ratio exceed­
ing 1 10 was considered inflammation 
Histology of murine knee joints To score the degree of inflammation, the 
nght knee joints were removed in toto and processed for histology as 
described7 Standard frontal sections of 6 μ were prepared and stained with 
hematoxylin and eosm (H&E) To determine the measure of cartilage deple­
tion of proteoglycans, sections were stained with safranm О a dye that selec­
tively binds to negatively charged residues Depletion of mamx proteoglycans 
was scored semiquantitativcly on a scale from 0-3 The sections were blindly 
scored by 2 independent observen 
Delayed type hypersensitivity (DTH) reaction A DTH reaction was induced 
by injection of 10 μ^ mBSA in 5 μΙ PBS into the right ear of W/W* and 
+ /+ mice that were previously immunized with mBSA The ear thickness 
was measured after 24 h with an industrial micrometer, and expressed as 
nght over left ratios Injection of (he same amount of mBSA in the ear of 
a ntHiimmunized mouse did not give rise to ал ear swelling after 24 h (data 
not shown) 
Antigen induced Τ cell proUferanon assay Mice were immunized and boosted 
as desenbed above At Day 21 after immunization, they received an intra 
venous (Г ) booster injection of 30 μg mBSA in 150 μΙ PBS Four days 
after the IV injection, spleens were removed aséptica!ly A single cell sus-
pension was made by gently teasing the spleen in RPM1 1640 dutch modifi-
cation (dm) (Row Laboratones) in a stenle infusion administration system 
(Nederlands Produkticlaboratonum voor Bloedtransfusieapparatuur en 
Inftisievloeistoffen BV, Emmer-Compascuum, The Netherlands) The spleen 
cells were washed once with RPMI 1640 dm and erythrocytes were lysed 
with 0 16 M NH4C1 0 17 M Tns HCl, pH 7 2 dunng 5 min at room tem-
perature The cells were washed twice with RPMI 1640 dm and were incu 
bated for adherence in RPMI 1640 dm + 5 % heat inactivated human AB + 
serum with a density of 3 x 106 ml during 60 mm in a C 0 2 incubator at 
370C Nonadherent cells were removed by aspiration and spun down The 
cells were suspended in 1 ml RPMI 1640 dm + 5% heat inactivated human 
AB+ serum + 10 mM pyruvate + 20 mM L-glutamine and incubated on 
a nylon wool column for 45 mm at 370C in a C 0 2 incubator 
The nylon wool column was prepared as follows 2 5 ml synnges without 
plug were filled with about 1 5 g nylon wool (LP-1 Leukopak leukocyte 
filler Fenwal Laboratones, Div of Travenol Laboratories Ine Morton 
Grove IL) and rinsed before use with 30 ml stenle PBS and 10 ml RPMI 
1640 dm + 5% heat inactivated human AB+ serum and was incubated with 
RPMI 1640 dm + 5% serum during 45-60 mm in a CO, incubator 
After incubation on the column the nonadherent cells were eluted with 
30 ml RPMI 1640 dm The cell population obtained consisted of 95-98% 
of thy I 2 positive cells (hat had been routinely checked by immunofluores-
cence (mouse IgM anti thyl 2 purchased from NEN UK) The cells were 
resuspended in RPMI 1640 dm + 5 % heat inactivated human AB + serum 
+ 10 mM pyruvate + 20 mM L glutaminc + 50 μg/ml gentamycin (Flow 
Laboratories) in a density of 10* cells/ml This suspension (100 μΙ) was 
placed in the well of a stenle round bonom 96-we)l microuter plate (Costar, 
Cambridge MA USA) To induce antigen specific proliferation, the wells 
received variable amounts of antigen (mBSA) as desenbed in Results or 
concanavalin A (Con A, Flow Laboratories) added in a volume of 100 μΙ 
The plates were then placed in a COj incubator for 3 days After (hai time 
37 mBq (Ι μΟ) 3H thymidine (Amersham Nederland BV TRK 61 
spec act 20-30 Ci/mmol) was added/well After 24 h the cells were har 
vested with a cell harvester (Titertek Cell Harvester 550, Flow Labora 
tones) onto glass fiber filters (Titertek Row Laboratories) The filters were 
placed in Aqualuma (Lumac BV The Netherlands) and counted in a liquid 
scintillation analyzer (LKB Wal lac 1214 rackbeta) All antigen concentra 
tions were tested in quadruplicate 
Determination ofanti mBSA levels Two pools of blood were collected from 
+ /+ as well as W/Wv mice, each pool consisting of 5 mice Pool 1 was 
collected 7 days after arthritis induction, Pool 2 24 h after flare induction 
(obtained from the PBS injected group), 28 and 56 days after first immuni­
zation, respectively Blood was obtained by bleeding from the retroorbital 
venous plexus and was allowed to clot at room temperature for 3 h and 
subsequently centrifugea for 5 mm at 2000 g Sera were stored at - 2 0 ' С 
The level of antibodies against mBSA was determined by an eznyme linked 
immunosorbent assay (ELISA) Polystyrene flat bottom microliter plates 
(Costar, Cambndge, MA, USA) were coated with 150 μΙ 100 Mg/ml mBSA 
in PBS /well overnight To avoid nonspecific binding, the plates were sub­
sequently coated with 1 % (w/v) gelatine in PBS, 150 μΙ /well for 2 h After 
3 washes with wash-buffer [PBS + 0 05% (v/v) Tween 20] the sera were 
diluted in 1 % (w/v) gelatine in PBS m 2 fold dilutions with a final volume 
of 100 μΙ/well After I h of incubation the plates were washed 5 times with 
wash buffer and were incubated with 100 μ) peroxidase conjugated rabbit 
antimouse Ig (Miles, Elkhart, IN. USA) diluted 1/500 in 0 5% (w/v) gela­
tine in PBS for I h After 5 washes with wash-buffer, 100 μΙ freshly pre­
pared substrate solution, 0 8 mg/ml 5 aminosalicylic acid, 0 8 μΙ/ml 30% 
H 2 0 2 in 50 mM sodium phosphate buffer, pH 6 0, were added /well After 
30 mm, the extinction was read at 450 nm in a Titertek Multiskan (Row 
Laboratones) All incubations were earned out at room temperature 
Mast cell staining To localize mast cells in + / + mice and to determine 
whether the W/Wv mice were indeed mast cell deficient compared to their 
control 1 mérmales joint sections and cell suspensions obtained by peritoneal 
lavage were stained for the presence of mast cells We used the Alcian blue 
safranm method20 and the thiomn method21 
Statistical analysis The seventy of the DTH reaction, primary arthntis and 
flare reaction in WBB6F1 W/Wv and WBB6F1 + / + mice were compared 
statistically using the 2 tailed Mann-Whilney U test 
RESULTS 
Comparison of arthntis and flare reaction in mast cell defi-
cient (WBB6F1-W/W" and normal (WBB6F1-+/+) mice A 
chronic unilateral arthritis was induced in mBSA primed 
W/W" and + / + mice by injection of 60 μξ mBSA into the 
right knee joint At set times after arthritis induction, Day 
3, 7, 14 and 28, the seventy of the joint inflammation was 
determined by the ""Tc uptake method" " Subsequently, 
the inflamed knee joints were removed in toto and processed 
for histology As can be seen in Table 1, the «"Tc uptake 
ratios show a chronic course of the arthritis in both the 
W/W· and +/+ mice The ""Tc uptake ratios of W/W" 
and +/+ mice did not differ significantly (p>0 05) 
Histological analysis confirmed the fact that the acute as 
well as the chronic phase of antigen induced arthritis in 
W/Wv and +/+ mice were indistinguishable, implicating 
an independence of mast cells in this inflammatory event 
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Table 1 Anngen induced arthnns in mast cell deficient 
(WBB6F1-W/W· and normal ÌWBB6F1-+/+) mice 
Days after IA 
Injection 
3 
7 
14 
28 
R/L Rallos of ""Tc 
+ / + 
1 75 ± 0 15 
1 55 ± 0 12 
1 20 ± 0 09 
1 18 ± 0 0 4 
Uptake· 
w/w» 
1 86 ± 0 19 
1 67 ± 0 09 
1 22 ± 0 10 
1 17 ± 0 04 
* Values represent the mean ± SD from groups of 6 mice 
A salient phenomenon of chronic arthritis is the destruc-
tion of the joint in which cartilage damage is one of the first 
features Wc scored cartilage damage in both strains at 3, 
7, 14, and 35 days after arthritis induction using matrix deple-
tion (saframn О staining) and numbers of dead chondrocytes 
(empty lacunae) as variables Table 2 shows the measure­
ments of these Both features were detectable at Day 7 and 
became more pronounced with the progression of the arthri­
tis As well, chondrocyte death as matrix depletion displayed 
a tendency to be more marked in normal than in mast cell 
deficient mice At Day 7, in 4 of 6 normal and only 1 of 
6 mast cell deficient mice, the matrix was depleted by more 
than 50% At Day 14 and 35, a depletion of more than 75 % 
occurred only in +/+ mice (with one exception at Day 14) 
Considering chondrocyte death, and thus the restoring 
capacity of the matrix, the differences were more clear death 
of more than 50% of the chondrocytes for +/+ and W/Wv 
mice, respectively, was seen at Day 7 in 2 of 6 vs 0 of 6 
mice, at Day 14 in 4 of 5 vs 2 of 6 mice and at Day 35 in 
Table 2 Cartilage damage as a result of arthritis in mast 
cell deficient (WBB6F1-W/W') and normal (WBB6FI-+/+) 
mice 
Days 
afier AI 
3 
7 
14 
35 
Strain 
+ / + 
W/W' 
+/+ 
W/W' 
+/+ 
W/Wv 
+/+ 
W/W' 
Nun 
Chondrot 
0 
6 
6 
4 
3 
1 
3 
0 
2 
1 
0 
0 
0 
3 
0 
1 
1 
3 
2 
0 
0 
2 
0 
2 
2 
5 
7 
iber of Mice wr 
:yte 
3 
0 
0 
0 
0 
2 
0 
6 
1 
Death· 
p..» 
NS 
NS 
< 0 14 
< 0 02 
Ih a Certain Sec 
Matrix Depli 
0 
6 
6 
0 
0 
0 
0 
0 
0 
1 
0 
0 
2 
5 
1 
2 
1 
2 
2 
0 
0 
4 
1 
1 
3 
3 
6 
3 
0 
0 
0 
0 
3 
1 
3 
0 
ire 
tlion·· 
p»·» 
NS 
< 0 2 
< 0 2 
< 0 08 
* Scored on a scale from 0-3 by counting empty lacunae in the 
cartilage 
0 = 0 % of the lacunae are empty, 1 = < 2 5 % , 2 = 2 5 - 7 5 % , 
3 = > 7 5 % 
> Scored on a scale from 0-3 by determining the amount of retained 
saframn О m the cartilage matrix as a measure for the presence of 
negatively charged proteoglycans 
> As determined by the 2 tailed Mann Whitney U test 
NS=not significant 
11 of 12 vs 8 of 13 mice More than 75% death of chondro­
cytes was seen at Day 35 in 6 of 12 for +/+ and 1 of 13 
in W/W* mice These data show a shift towards more 
severe cartilage damage in normal mice compared to mast 
cell deficient ones and imply a contribution of mast cells to 
cartilage damage as a result of chronic inflammation Figure 
1 displays a histological illustration of these data To illus­
trate cartilage damage, sections of an arthritic knee joint 14 
days after arthritis induction are shown Similar results were 
seen when other times after arthritis induction were con­
sidered When Figures 1A and В are compared, it is clear 
that the amount of dead chondrocytes was greater in Grade 
3 (A) cartilage than that in Grade 1 (B) sections 
As reported earlier12 IV injection of 300 μg mBSA about 
5-6 weeks after induction of primary arthritis appeared to 
be sufficient to cause an antigen specific flare reaction in the 
inflamed knee joint without affecting the left In either strain 
of mice, the flare reaction, measured by w"iTc uptake 24 h 
after IV challenge, differed significantly (p=0 002) from 
the background arthritis at that time (Table 3) The latter was 
determined by scoring joints after Г injection of PBS instead 
of mBSA Also histologically, W/Wv as well as +/+ flared 
joints were clearly distinguishable from their background 
joints In both strains the flare reaction was characterized 
by a cellular infiltrate in the synovium and an exudate in the 
joint space consisting mainly of granulocytes and sometimes 
fibrin Granulocytes were not seen in great amounts in the 
chronic phase of arthritis, so their abundant presence was 
a reliable variable for the incidence of a flare reaction, which 
in fact is an acute type of inflammation superimposed on 
chronic joint inflammation When the magnitude of the flare 
reaction in both strains was compared, it became clear that 
the reaction in +/+ mice was significantly higher than in 
W/W* mice, considering ""Tc uptake ratios (Table 2) 
Histologically, however, only a slight difference could be 
seen in the quality and quantity of the infiltrate and exudate 
Our results indicate that for a Лаге reaction to occur, mast 
cells are not obligatory, but that the presence of such cells 
contributes to a more vehement flare reaction in tissue swell­
ing and blood flow 
Comparison of immunologic variables in mast cell deficient 
(WBB6F1-W/W') and normal (WBB6FI- + /+) mice 
Because antigen induced arthritis is an immunologic model, 
it is of utmost importance that crucial immunologic variables 
are similar in both strains If not, it would be impossible to 
ascribe the observed differences like the vehemence of flare 
reaction and the amount of cartilage damage to the presence 
or absence of mast cells A variable which is of proven 
importance in at least the flare reaction is the Τ cellM " We 
used the antigen induced proliferative response of isolated 
Τ cells in vitro as a measure for Τ helper function The 
amount of 'H-thymidine incorporated by a pool of Τ cells 
obtained from 7 W/W' and 7 +/+ mice after stimulation 
with antigen is shown (Table 4) The results are clearcut 
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Fí^. /. Joint sections of mast cell deficient 
(WBB6F1-W/WV) and normal 
(WBB6F1 +/ + ) mice 14 days after 
arthritis induction. A — +/ + , Η & E 
• staining; В — W/Wv, Η & E staining; 
magnification — 250 x ; js = joint space; 
ρ = patella; 1 = empty lacuna; с = live 
chondrocyte. These sections show 
cartilage damage scored by the measure of 
r chondrocyte death. Live chondrocytes are 
visible as stained nuclei in the cartilage 
(indicated by an arrow and "C") . Dead 
chondrocytes rapidly disintegrate, so no 
nuclei are seen in the lacunae: the latter 
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 i" the cartilage 
matrix (indicated by an arrow and "L") . 
Table 3. Flare reaction of antigen induced arthritis in mast cell deficient 
(WBB6FJ-W/W>) and normal (WBB6FJ- + /+) mice 
IV Injection 
300 μg mBSA 
PBS 
R/L Ratios of T c Uptake* 
+ /+ w/w> 
1.48 ± 0 16 1.36 ±0.19 
1.13 ±0.09 1 12 ± 0.08 
P " 
0.05 
NS 
No. of Granulocytes 
in 
Infiltrate/Exudate··· 
+/+ W/W1 
1.8 IS 
0.8 0.8 
* Values represent the mean ± SD from groups of 8 ( + / + ) or 10 (W/Wv) mice. 
** Determined by the 2 tailed Mann Whitney U test to compare the reaction in both strains. 
••* Scored on a scale from 0-3. 0=0% granulocytes in infiltrate and exudate, I • <25%, 2=25-75%, 
3=>75%. 
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Table 4 Antigen induced Τ cell proliferation in vitro m 
mast cell deficient (WBB6F1-W/Wy) and in normal 
(WBB6FÌ-+/+) mice 
fig/ml mBSA 
in Culture 
0 
0 1 
0 3 
10 
3 0 
10 0 
300 
100 0 
300 0 
No CPM 
+ / + Cells 
615 
495 
2811 
2908 
8024 
2884 
634 
594 
737 
Э
Н thymidine Incorporated* 
W/Wy Cells 
574 
703 
1849 
2849 
7987 
3558 
435 
313 
359 
* Mean value of quadruplicate expenments, standard error was always 
less than 10% 
mBSA primed Τ cells were incubated with various concentrations of anti­
gen The Τ cells were obtained from 7 pooled spleens of mast cell deficient 
(W/Wv) and normal ( + / + ) mice After incubation for 3 days, 1 μC\ 3H 
thymidine was added and 24 h thereafter the cells were harvested and the 
amount of 3H thymidine incorporated was counted 
Table 5 DTH reaction in mast cell deficient 
(WBB6F1-W/W') and normal (WBB6F1-+/+) mice 
R/L Ratio of Ear Thickness* 
+/ + W/W» 
206 
1 92 
200 
I 92 
1 98 ± 0 07 
I 86 
1 75 
1 72 
I 72 
1 76 ± 0 07 mean ± SD 
' Determined by measuring the ear thickneu (0 01 mm) 24 h after 
injection of 10 pg mBSA in the right and 5 μ\ PBS in the left ear 
the Τ cell responses to antigen and mitogen (data not shown) 
were similar in both strains Cells derived from 
WBB6F1-W/W« or WBB6F1- + /+ mice showed the same 
optimal concentration of antigen (3 /ig/ml) and the same 
degree of proliferation at this optimal and also at suboptimal 
doses of antigen 
Although a role for antibodies in the arthritis and the flare 
reaction has not been established yet, we wanted to know 
whether a difference in the level of antibodies directed against 
mBSA in the sera of W/Wv and +/+ mice existed When 
collected at the same time, the sera of W/W' and +/ + 
mice showed no different antibody titer against mBSA Sera 
of both W/W» and +/+ mice collected 28 days after 
immunization (Figure 2A) had a somewhat higher titer than 
those collected 56 days after immunization (Figure 2B) 
Our data show that in either strain of mice the cellular and 
humoral anti-mBSA responses were similar, so observed 
differences between +/+ and W/W" mice in the flare 
reaction or cartilage damage cannot be due to a difference 
in Τ cell or antibody response 
Additionally, we investigated the effect of mast cell defi­
ciency on an immune response in vivo, the DTH reaction 
A rationale for this experiment was the belief that the induc­
tion of arthritis and to a lesser extent the flare reaction exhibit 
some similarities to a DTH reaction310-132122 The DTH 
reaction in normal mice is significantly higher when com­
pared to mast cell deficient httermates (p = 0 015) (Table 5) 
Mast cell staining Mast cell staining was performed accord­
ing to the Alcian blue-safranin method20 and the thiomn 
method21 Both methods gave a convincing staining of mast 
cells in cytospin preparations of peritoneal cells of 
WBB6F1- + /+ mice, while no mast cells could be detected 
in the same preparations of mast cell deficient mice, 
WBBóFl-W/W" Safranin O alcian blue staining of the 
joint sections revealed that the majority of the mast cells 
(85%) were situated subcutaneously and only a few (15%) 
in the deep synovial infiltrate, but always remote from the 
scene of calamity, the cartilage Table 6 shows the mean 
amount of mast cells detected /joint section at different stages 
of arthritis It is obvious that the amount of mast cells 
increased with the duration of the arthritis, however, the 
localization remained as described above No difference in 
mast cell number could be seen if a flared joint was com-
pared with a background arthritic joint This suggests that 
degranulation of mast cells did not occur in this process, 
although the flare reaction was slightly, though significantly, 
more severe in + / + mice 
The above mentioned data only relate to connective tissue 
type mast cells, because the method used for fixation and 
staining was suitable for this type of mast cell only and not 
for the mucosal type mast cell 
DISCUSSION 
We investigated the role of mast cells in antigen induced 
arthritis in mice As this experimental model shows some 
similarities with human RA9 » and 2 murine strains, which 
differ from each other only by the presence or absence of 
Table 6 Numbers of mast cells detected/joint section in 
mast cell deficient (WBB6F1-W/W") and normal 
(WBB6FJ-+/+) mice at different times after arthritis 
induction 
Days after IV Injection 
3 
7 
14 
28, 24 h after PBS IV 
28 24 h after mBSA IV 
Control joint 
No Mast Cells/Joint Section' 
W/Wv 
0 ± 0 
0 ± 0 
0 ± 0 
0 ± 0 
0 ± 0 
0 ± 0 
+/ + 
19 ± 4 
24 ± 5 
47 ± 5 
118 ± 14 
116 ± 9 
20 ± 3 
* Each value represents the mean ± SD of 9 joint sections 
Staining safranin O/Alcian blue 
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U 
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α β 
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ΟΑ 
02 
U 
10 
αβ 
αβ 
α* 
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β 9 10 11 7 8 9 10 11 
dilution of serum 2 •к 
Fig 2 Humoral anti mBSA response 
in masi cell deficient (WBBF1 W/W) 
and noimal (WBB6F1 + / - ) nuce A 
» serum pool (n = 5) collected 7 days 
after arthritis induction (28 days after 
immunization) В = serum pool (n=S) 
collected 24 h after IV PBS injection 
(5ύ days after immunization) 
· — · = WBB6FI +/ + 
A — A - WBB6FI W/W" 
mast cells, it is possible to consider the contribution 
of mast cells to different features of chronic joint inflam­
mation 
RA is characterized by a continuous influx in the syno­
vium of various cell types with various capacities Among 
these capacities are the secretion of cartilage degrading 
enzymes, chemotactic factors and other stimuli that contribute 
to the inflammatory process A cell type that has received 
relatively little attention in RA is the tissue mast cell Recently 
it has been shown11421 that functional mast cells are present 
in rheumatoid synovia and synovial fluids in greater amounts 
than m healthy synovia The suggestion that mast cells may 
play a role in chronic inflammations is supported by studies 
in animals with respect to DTH reactions22 M, in DTH reac­
tions mast cells were shown to enhance the influx of lypho-
cytes by release of vasoactive amines 
In our study we demonstrate that both the acute (3 days 
after arthritis induction) and the chronic phase (7, 14, 28 
and 35 days after arthritis induction) of the antigen induced 
arthritis displayed the same course in normal mice 
(WBB6F1 +/ + ) and in mice lacking mast cells 
(WBB6FI W/W») Another feature of this joint mflam 
mation, the destruction of cartilage, showed a difference 
when both strains of mice were compared destruction in 
+ /+ mice was more vehement than in W/W" mice 
A phenomenon which likely plays an important role in the 
propagation of chronic inflammation and also in the destruc 
tion of cartilage is the (repeated) exacerbation of the arthri­
tis From our data it is obvious that in normal as well as in 
mast cell deficient mice a flare reaction can be induced 
Although the presence of mast cells is clearly not obligatory 
for the induction of an exacerbation, the presence of these 
cells certainly is enhancing The flare reaction, measured 
by the ""Tc uptake method, is significantly more vehement 
in +/+ mice than in their mast cell deficient littermates 
However, when the cellular infiltrate and exudate were 
analyzed quantitatively and qualitatively 24 h after IV 
challenge with antigen, only a slight but absolutely not sig­
nificant difference in the amount of granulocytes could be 
demonstrated between both strains of mice 
To exclude the possibility that the reported differences 
between mast cell deficient mice and their normal littermates 
in flare reaction and the damage to the cartilage were due 
to other immunological abnormalities, we compared 3 vari­
ables of immunologic function in each strain of mice First, 
we compared the humoral response at 2 intervals after 
immunization the anti mBSA titer (ELISA, Figure 2) was 
identical in both strains A 2nd and far more important vari­
able was the cellular response, as it has been shown14 " that 
always the flare reaction is totally dependent on antigen 
specific Τ lymphocytes The comparison of the Τ cell 
response in vitro (antigen induced Τ cell proliferation assay, 
Table 4) provides clear evidence for the fact that this 
immunological function is also similar in +/+ and W/W" 
32 
mice. The last variable tested was the DTH reaction. Evi­
dence has been presented by others22 24 that the DTH 
reaction is completely dependent on mast cells, however, 
ample contradictory findings have been reported25 x In the 
latter studies, it has been shown that in mast cell deficient 
mice a DTH reaction can be induced, albeit in some reports 
less severe than in normal mice. Our data are in agreement 
with the latter: a DTH reaction could be induced in either 
strain of mice, the mast cell deficient strain, however, dis­
played a significantly lower response than their normal 
littermates 
The reason for the controversy with respect to the role of 
mast cells in the DTH reaction may be the following· in 
studies that demonstrate a total dependence of the DTH 
reaction on mast cells22 24 always drugs that antagonize the 
vasoactive amine serotonin (5-HT) were used, also, in our 
hands these drugs, such as rcserpine (depletes mast cells of 
5-HT without biological effect), cromoglycatc (prevents 
5-HT release), methysergidc and ketansenn (5-HT receptor 
antagonists) completely suppressed the DTH reaction. When 
reserpine and kctanserin were tested for their ability to sup­
press the flare reaction, both appeared to be active (unpub­
lished observations). Results obtained by using these drugs 
in Τ cell dependent reactions, however, are not as clearcut 
as they seem to be. It has been reported that reserpine sup­
presses Τ cell responses in vivo and in vitro without the 
involvement of mast cells10. We examined the effect of 
methysergide and ketanserin on an in vitro antigen induced 
Τ cell proliferation assay and our findings (unpublished 
observations) were in agreement with those published about 
reserpine30. As it is obvious that the DTH as well as the 
flare reaction are Τ cell dependent phenomena14 ">l7, the use 
of 5-HT antagonizing drags, which also influence the obliga­
tory component of those reactions, does not provide evidence 
for the dependence on or even involvement of the mast cell 
in the above mentioned reactions. 
From our studies it becomes clear that the mast cell con­
tributes in several ways to different features of an experi­
mental arthritis in mice. When the primary arthritis is 
considered, no differences due to mast cells were observed 
with respect to quantity and quality of infiltrate and exudate 
or to tissue swelling at the times after induction studied Thus, 
it appears to be that the mast cell does not play a role of any 
importance in the acute (3 days) or chronic (7-35 days) phase 
of joint inflammation, regarding the variables mentioned 
above. It could be possible, however, that mast cells play 
a role in the inductory phase of the joint inflammation (i.e., 
the first 24 h) analogous to their described role ill the DTH 
reaction22 24. 
The ultimate result of chronic inflammation, cartilage 
damage, is influenced by the presence of mast cells. We can 
only speculate about the contribution to cartilage damage by 
mast cells. It could be a direct injurious effect by destruc­
tive enzymes released from the activated mast cells3 or an 
indirect effect accomplished by other inflammatory cells and 
mediators whose influx at the inflamed site is enhanced by 
products of the triggered mast cell. A possible explanation 
for the unexpected finding that virtually no mast cells were 
detected in the vicinity of the cartilage could be the fact that 
the staining method used predominantly demonstrates gran­
ules, which could be absent in previously activated mast cells. 
If, however, our staining method gives a real view of the 
amount of mast cells present in the inflamed joint, cartilage 
damage due to a direct effect is not a plausible explanation 
for the observed difference between each strain. If an 
indirect effect lies at the basis of the enhanced cartilage 
damage due to mast cells, one would expect a quantitatively 
or a qualitatively different infiltrate; however, this could not 
be detected by the methods used It is still possible that the 
differences are too small to detect or that they reside in a 
component that is invisible 
The flare reaction of antigen induced arthritis was signifi­
cantly less severe in mast cell deficient mice when tissue 
swelling was considered but the difference was only margi­
nal regarding cellular infiltrate and exudate The number of 
mast cells in the joint was not affected by flare reactions 
(Table 5), suggesting that the role of mast cells in this 
phenomenon is a minor one, at least not one which demands 
massive degranulation of mast cells. The fact that we did 
sec a (statistically significant) difference between both strains 
regarding the flare reaction points to an enhancing function 
of the mast cell in exacerbations, which might be of impor­
tance for the propagation of chronic arthritis. By which mode 
mast cells influence flare reactions is not clear. There are 
several mechanisms (or combinations thereof) of action pos­
sible in this model. Unlike the primary arthritis and the DTH 
reaction, the flare phenomenon is dependent on local hyper­
reactivity, which is possibly due to locally retained antigen 
specific helper Τ cells1 3 1 7. It is a plausible hypothesis that 
the flare reaction is started by the activation of those retained 
Τ cells upon challenge with antigen. Once activated, these 
Τ cells produce soluble factors that could be chemotactic and 
thus attract inflammatory cells to the joint. As our data show, 
there is an enhancing role for the mast cell in this reaction. 
That enhancement could consist of increased influx of 
effector cells due to leaking degranulation products of trig­
gered mast cells. A higher amount of antigen into the joint 
is another possibility that could aggravate the flare reaction. 
In the hyperreactive joint, certain numbers of plasma cells 
can be detected of which a large part is probably directed 
against the homologous antigen31. If mast cells become 
enriched with homocytotropic antibodies produced by these 
local plasma cells, an increased type I hypersensitivity reac­
tion will occur after challenge with antigen. 
How and in which order cellular events take place in the 
inflamed joint is not clear yet, our results, however, pro­
vide direct evidence for an enhancing role of mast cells in 
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the progression of this model for rheumatic disease and the 
resulting destruction of cartilage. 
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SUMMARY 
Intraarticular injection of cell walls from the grampositive bacterium 
Streptococcus pyogenes induces an arthritis in both Streptococcal cell 
wall (SCW)-primed and naive mice. This joint inflammation subsides 
after two weeks but it could be reactivated by systemic injection of 
SCW in a dose dependent way. The primary arthritis as well as the flare 
up reaction were more vehement in immunized than in naive mice. 
Pretreatment with antilymphocyte serum of nonimmunized arthritic mice 
before systemic challenge completely inhibits the flare up reaction, 
suggesting the involvement of lymphocytes in the reactivation. 
Dose/response studies showed that intravenous challenge with SCW 
amounts too small to induce a primary arthritis were able to reactivate 
a chronic arthritis, implying that an inflamed joint is in a 
hyperreactive state, probably due to locally retained lymphocytes. 
Furthermore we demonstrate that arthritis as a result of injection with 
SCW can be reactivated by fragments of a nonrelated, gramnegative 
endogenous bacterium; Escherichia coli. The latter finding might be of 
importance for the understanding of the pathogenesis of chronic 
arthritis: once an arthritis is induced by one bacterium, other 
(unrelated) bacteria, probably derived from an endogenous source, may 
be able to reactivate the inflammatory process, thus contributing to 
chronicity. 
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INTRODÖCTION 
Despite a wide array of animal studies, the mechanism by which a joint 
inflammation becomes chronic is not completely understood. For this 
purpose several models are used, among which antigen induced arthritis 
(1-6) and streptococcal cell wall (SCW) induced arthritis (7-10). 
In antigen induced arthritis, joint inflammation occurs after 
intraarticular (i.a.) injection of antigen in a primed animal. 
Chronicity has been proven to be dependent on the retention of antigen 
in the knee joint and on the local presence of Τ cells (3,5,11). The 
importance of antigen retention may reside in the fact that small 
quantities of antigen continuously leak into the joint space where they 
act as an inflammtory stimulus. 
In SCW induced arthritis, a chronic polyarthritis is induced by 
systemic administration of SCW to susceptible rats (7-10). In this 
model, chronicity is in all probability dependent on a depot of 
antigenic material persisting in the body, as i.a. injection of the 
same material in the same rats has been shown to induce only a 
transient arthritis (12,13). SCW, being very resistant to degradation, 
form a depot from which a perpetuous flow of antigen can enter the 
joint and reactivate the inflammation, thus leading to chronicity. 
That a subsiding arthritis can be reactivated by new antigen entering 
the joint has been extensively demonstrated in the antigen induced 
arthritis model (14-16): intravenous or oral challenge with antigen 
after induction of arthritis leads to an acute arthritis superimposed 
on the waning one. This so called flare up phenomenon has been proven 
to be dependent on antigen specific helper Τ cells which persist in the 
inflamed joint (17-19). 
An important source of antigen is the gastrointestinal tract, being the 
organ through which most foreign material enters the body. The 
gastrointestinal tract is also very rich in endogenous bacteria which 
might also function as antigen under certain circumstances, like during 
an inflammation. To study the flare up as a possible mechanism of 
chronicity with more relevant antigen, we used the bacterial antigen 
S.pyogenes. When injected into the knee joint of a SCW-primed or a 
naive mouse, a quantitiy as small as 5 цд induced a severe or moderate 
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arthritis respectively. This indicates that systemic priming is not 
obligatory for the induction of arthritis. In primed as well as in 
naive mice the arthritis could be reactivated by systemic injection of 
SCW in a dose dependent way. The fact that pretreatment with 
antilymhocyte serum completely inhibited the flare up reaction is a 
strong pointer to a role for lymphocytes in this phenomenon. 
A very intrigueing observation is, however, the fact that a SCW induced 
arthritis can be reactivated by systemic injection of fragments of a 
nonrelated endogenous bacterium: Escherichia coli. The latter finding 
supports the often suggested relationship between bacterial infections 
of the gastrointestinal or urinary tract and arthritis (20). 
MATERIALS S METHODS 
MICE 
Female C57B1/10 mice were used for the induction of arthritis and flare 
up reaction. Mice were 8-10 weeks at the start of the immunization 
procedure (protocol 1) or at the time of intraarticular (i.a.) 
injection of antigen (protocol 2). Animals were bred in our own Central 
Animal Laboratory and were fed a standard diet and tap water. 
STREPTOCOCCAL CELL WALLS (SCW) 
Streptococcus pyogenes TI2 organisms were cultured in Todd-Hewitt broth 
and after 24 hours the cells were harvested. Cells were disrupted with 
glass beads and sonication and the material was subsequently treated 
with various degrading enzymes as described previously (7). Further 
isolation was carried out by differential ultracentrifugation steps as 
has been described (10) and the resulting 100,000 g pellet was used 
throughout the experiments. This preparation contained 12.8% muramic 
acid (21). The used preparation was arthritogenic in female Lewis rats 
(data not shown). 
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ESCHBRICHIA COL·! CKLL WALLS (ECW) 
Escherichia coli RR1 organisms were cultured in yeast extract/trypton 
broth for 24 hours at 370C and were harvested. Cells were disrupted as 
follows: the cell pellet was transferred to a mortar on ice and Alcoa 
powder (Alcoa Chemicals, the Alumunium Company of America) was added in 
portions to a total of twice the weight of the pellet. After each 
portion, the mixture was thoroughly pounded. Subsequently, portions of 
PBS were added to twice the volume. Alcoa and non-disrupted cells were 
removed by 
centrifugation. The disrupted cells were centrifuged (15 minutes, 
25,000 g) and the supernatant was treated with enzymes as described 
(7,10) 
IMMUNIZATION 
For protocol 1 the mice were immunized with 100 pg of SCW emulsified in 
100 μΐ Incomplete Freund's Adjuvant (IFA) (Difco Laboratories, Detroit, 
MI) divided into four subcutaneous injections into the flanks. After 7 
days the mice were boosted with 100 pg SCW/100 μΐ IFA divided into two 
subcuteneous injections into the back. 
ARTHRITIS AND FIABE DP INDOCTION 
Arthritis was induced by intraarticular injection of 5 or 25 цд SCW 
(dryweight) in 5 μΐ phosphate buffered saline (PBS) into the right knee 
joint 21 days after the first immunization (protocol 1) or in naive 
mice (protocol 2). As a control, PBS was injected into the left knee 
joint. 
The flare up reaction was induced 21 days after i.a. injection by 
intravenous (i.v.) administration of 0, 30, 100 or 300 pg (dryweight) 
SCW or 300 yiq ECW. 
MEASdBEMENT OF JOINT INFLAMMATION 
Primary arthritis and flare up reaction were quantified by the ggnu, 
uptake method (5,22). This method measures by external gamma counting 
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the accumulation of a small radioisotope at the site of inflammation 
due to a local increased blood flow and tissue swelling. The severity 
of inflammation is expressed as the ratio of the 99mTc uptake in the 
right (inflamed) over the left (control) knee joint. All values 
exceeding 1.10 were assigned as inflammation. 
HISTOLOGY OF KNEE JOINTS 
For histological score of the inflamed knees, the right and left knee 
joints were removed in toto and processed for histology as previously 
described (4). Standard frontal sections (бцт) were prepared and 
stained with hematoxilin and eosin (H&E). Scoring of inflammation was 
done by two independent observers on coded sections. The parameters 
used were: # of granulocytes in infiltrate and exudate (0-3), # of 
infiltrate (0-3) and # of exudate (0-3). 
TREATMENT WITH ANTILYMPHOCYTE SEBUM (ALS) 
ALS was produced in rabbits by injection of C57Bl/Rij thymus and lymph 
node cells emulsified in Complete Freund's Adjuvant (CFA) (Difco 
Laboratories Inc., Detroit, MI). The rabbit received 0.2 ml of the 
emulsion subcutaneously at multiple sites to a total of 10^ cells. Two 
i.v. boost injections were given with 108 cells in PBS at 3 and 4 weeks 
after iimunization. The rabbit was bled 7 days after the last injection 
and the serum was heated at 560C for 30 minutes to inactivate 
complement. The serum showed a 100% lysis of murine splenic lymphocytes 
with a titer of 1/1000 (titer = dilution that lyses 50% of the 
lymphocytes). Mice were treated with ALS in protocol 2 as follows: 0.3 
ml ALS was injected intraperitoneally (i.p.) 48, 24 and 1 hour before 
flare up induction. The control group received 3 χ 0.3 ml heat 
inactivated normal rabbit serum (NRS) i.p. 
STATISTICAL ANALYSIS 
The R/L ratio's of the ggnu, ^ , j *. ^ • *. • •,-, 
"""Tc uptake were compared statistically using 
the two-tailed Mann-Whitney U test. 
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RESULTS 
ARTHRITIS AND FLARE DP IN IMMUNIZED MICE (protocol 1) 
I ARTHRITIS 
An unilateral arthritis of moderate chronicity was induced in SCW 
primed mice by injection of 5 or 25 yiq SCW into the right knee joint. 
At set times after arthritis induction, day 1, 7 and 21, the severity 
of the joint inflammation was determined by the· 99ттс uptake method 
(5,19). As can be seen in table 1, the arthritis occurs when either 5 
or 25 iig SCW were injected i.a. albeit not with the same severity. 
Histologically, 7 days after i.a. injection of both 5 and 25 pg the 
population of cells infiltrating the joint and joint space consisted 
mainly of granulocytes (figure 1A-B). The infiltrate and exudate at 
later stages gradually changed to mononuclear, implying a more chronic 
type of inflammation (figure 1 C-D). The same difference in vehemence 
between 5 and 25 pg as was detected by 99mip
c Uptake was also seen after 
histological analysis. 
Table 1: P/L ratio's of 99mTc uptake measured at day 1, 7 and 21 after 
injection of 5 or 25 pg SCW into the right knee joints of 
previously immunized mice. 
R/L ratio 
days after i.a. 
injection 5 pg 25 pg P* 
1 2.12 ± 0.29 (7) 2.60 ± 0.21 (7) 0.003 
7 1.53 ± 0.15 (7) 1.72 ± 0.14 (7) 0.03 
21 1.05 ± 0.07 (8) 1.09 ± 0.04 (8) NS 
The values represent the mean * s- d· o f groups of 7-8 mice (numbers in 
brackets) and were obtained by dividing the measured radioactivity in 
the right (inflamed) by that in the left (control) joint. *determined 
by the Mann Whitney U test. 
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II ПАНЕ OP WITH SCW 
In analogy with the antigen induced arthritis model in mice (14-16), a 
flare up reaction was induced by intravenous injection of SCW in the 
chronic phase of a SCW-arthritis. Systemic antigen leads to an 
exacerbation in the inflamed joint without affecting the control one. 
As well in mice which received 5 ug as in mice which received 25 jig 
i.a. a distinct flare up reaction was measurable 24 hours after i.v. 
challenge with SCW. The flare up reaction differed in both cases 
significantly from the background inflammation at day 21 when Э пурс 
uptake was considered (figure 2). Also histologically, flared joints 
were clearly distinguishable from the background ones : the former 
joints contained high amounts of granulocytes in the infiltrate and 
exudate as contrasted with the latter ones, indicating that in the 
flared joints an acute inflammation was superimposed on the foregoing 
chronic one (figure 1 C-F). The observed exacerbation is not a 
nonspecific reaction of a previously inflamed joint to a systemic load 
of SCW because i.v. injection of 300 y¡g SCW in mice with a subsided 
mBSA-arthritis does not result in a flare up reaction (data not shown). 
Figure 1: Joint sections of previously immunized mice after induction 
of arthritis . 
λ = 7 days after i.a. injection of 5 цд SCW; В = idem A, 25 }ig i.a. 
Note the large amount of cells (mainly PMNs) infiltrating (i) the 
synovium and forming an exudate (e) in the joint space. 
С = 21 days after i.a. injection of 25 pg SCW, 1 day after i.v. 
injection of PBS (flare up background); D = idem C, detail. The 
inflammation has waned after 21 days, only a small infiltrate is left 
which contains almost no PMNs. 
E = idem C, 300 pg SCW i.V.; F = idem E, detail.The same time after 
arthritis induction as in fig.1C+D, but in this case 24 hours after 
i.v. challenge with SCW. Note the resulting acute inflammation (exudate 
of PMNs) (e). 
Staining: НЬЕ; Magnification: 25 χ (A-B-C-E) or 250 χ (D-F); js=joint 
space, p=patella, f=femur 
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Figure 2: R/L ratio's of ЗЭт^
 Uptake 24 h after i.V. challenge with 
300 цд SCW or PBS in previously immunized mice. 
A = 5 цд SCW i.a. & 300 pg SCW i.v. 
В = 5 дд SCW i.a. S PBS i.V. 
С = idem A, 25 дд i.a. 
D = idem B, 25 цд i.a. 
Values represent the mean ± s.d. from groups of 8 mice. Statistical 
analysis was carried out using the two-tailed Mann-Whitney U test. 
NS=not sinificant. 
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ARTHRITIS AND FLARE DP IN HON IMMUNIZED MICE (protocol 2) 
I ARTHRITIS 
To investigate whether systemic priming is a prerequisite for arthritis 
induction and the flare up phenomenon, naive mice were injected withS 
or 25 pg SCW. This resulted in an unilateral inflammation measurable as 
well by 9 9 mTc uptake as by histology. Injection of 5 yg SCW induced an 
arthritis which was less severe than that induced by 25 pg both on the 
level of Э пърс
 Uptake (table 2) and on the level of inflammatory 
Table 2: R/L ratio's of ЭЭпьрс ц р ^ ^
 a t d a y ^ η ^d 21 after injection 
of 5 or 25 pg into the right knee joints of naive mice. 
R/L ratio 
days after i.a. 
injection 5 pg 25 pg P* 
1 1.60 ± 0.15 (7) 1.96 ± 0.20 (7) 0.002 
7 1.27 ± 0.06 (7) 1.29 ± 0.05 (7) 0.1 
21 1.06 ± 0.03 (8) 1.09 ± 0.05 (9) NS 
The values represent the mean t s.d. of groups of 7-9 mice (numbers in 
brackets) and were obtained by dividing the measured radioactivity in 
the right (inflamed) by that in the left (control) joint. * determined 
by the two-tailed Mann Whitney U test. 
infiltrate and exudate (figure 3). The degree of chronicity was 
comparable in both cases when scored on day 7 and 21. When the 
arthritis was compared to that in iimunized mice, the latter was far 
more vehement (compare tables 1/2 and figures 1B/3) at both antigen 
doses, indicating that systemic immunity to SCW contributes to the 
development of joint inflammation after i.a. challenge with SCW. The 
fact that previous priming is not obligatory, one can conclude that 
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Figure 3: Joint sections of non immunized mice 7 days after induction 
of arthritis by i.a. injection of 25 txg SCW. 
Note the exudate in the joint space (arrow + e) and infiltrated 
synovium (arrow + i)· The inflammation consists mainly of PMNs. 
Staining: H S E; Magnification: 25 χ; p=patella, f=femur· 
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systemic immunity is enhancing rather than prerequisite, in contrast 
with using protein antigens. The presence of systemic anti-SCW immunity 
in naive mice could be excluded by a lymphocyte transformation test and 
by enzyme-linked immunosorbent assay (data not shown). 
II FIABE UP WITH SCW 
To induce a flare up, we administered 300 pg SCW i.v. 21 days after 
i.a. injection. Figure 4 shows the Э піірд
 Uptake ratio's measured 24 
hours after i.v. challenge. The ratio was significantly higher than 
that measured in joints after i.v. PBS administration. Also 
histologically, a flare up reaction was obviously present 
(figure 5 Α-B): the infiltrate and exudate consists of granulocytes 
(acute inflammation), which are lacking in the PBS control group. For a 
flare up to occur, a local hyperreactive joint is necessary (16) and it 
results from our data, that local priming is sufficient to induce this 
hyperreactive state. 
III IMPORTANCE OF LOCAL HYPERBBACTIVITY; TREATMENT WITH ALS 
Table 3: R/L ratios of 9 9 mTc uptake 24 hours after i.v. challenge with 
various doses of SCW. Mice were pretreated 48, 24 and 1 hour 
before challenge with ALS or NRS. 
preatreatment 
i.V. injected NRS ALS Ρ* 
PBS 1.08 ± 0.06 (9) 1.10 ± 0.06 (7) NS 
30 pg SCW 1.27 ± 0.09 (8) 1.10 ± 0.08 (8) 0.001 
100 »g SCW 1.26 ± 0.08 (8) 1.10 ± 0.06 (8) 0.001 
300 m SCW 1.42 ± 0.09 (8) 1.10 ± 0.05 (8) 0 
Arthritis was induced 21 days before i.v. challenge by injecting 25 цд 
SCW into the right knee joint of naive mice. 
j. s.d. from groups of raice (number in 
Values represent the mean -
brackets). * Statistical comparison of ALS and NRS pretreated groups: 
two-tailed Mann-Whitney U test. 
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Figure 4: R/L ratio's of 99i№j
c
 uptake 24 after i.V. challenge with 300 
μg SCW or PBS in non immunized mice. 
A = 5 цд SCW i.a. & 300 цд SCW i.v. 
В = 5 дд SCW i.a. & PBS i.v. 
С = 25 pg SCW i.a. & 300 цд SCW i.v. 
D = 25 pg SCW i.a. & PBS i.v. 
Values represent the mean ± s.d. from groups of 8 mice. Statistical 
analysis was carried out using the two-tailed Mann-Whitney и test. 
NS=not significant. 
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Figure 5: Joint sections of arthritic, non immunized miced after i.V. 
challenge with PBS or SCW. 
A = 25 ug SCW i.a. & 300 pg SCW i.v. 
В = 25 yg SCW i.a. & PBS i.v. 
Figure 5A shows the result of reactivation of a subsided arthritis by 
i.v. challenge with SCW. An acute inflammation characterized by a 
PMN-rich exudate (arrow + e) and infiltrate (arrow + i) is seen. In the 
subsided arthritis (5B) these features are lacking. 
Staining; H & E; Magnification 25 χ; p=patella/ f=femur 
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To exclude the possibility that the acute inflammation measured after 
i.V. SCW administration was not a flare up reaction dependent on 
hyperreactivity of the previously inflamed joint, but more like a 
primary arthritis induced by the influx of a sufficient amount of SCW 
(i.e. 0.5 pg or more, data not shown), we administered three different 
doses (30-100-300 pg) i.v. 
All doses used induced a clear flare up reaction which was 
dose-dependent (table 3) in the previously injured joint. The fact that 
after any of the antigen doses given i.v. absolutely no abnormalities 
could be detected in the contralateral control joint is a strong 
argument against the measured inflammation after i.v. challenge being 
just a primary arthritis and points to the importance of local 
hyperreactivity. 
To investigate whether the flare up reaction - and thus the local 
hyperreactivity- was dependent on lymphocytes, we pretreated mice with 
0,3 ml ALS at 48, 24 and 1 hour before i.v. SCW injection. ALS 
preptreated mice displayed no flare up reaction after i.v. challenge 
with 30, 100 or 300 pg SCW as was measured histologically (data not 
shown) or by ЗЭпьрд
 Uptake (table 3). In mice pretreated with NRS a dose 
dependent exacerbation of the arthritis was detectable after i.v. SCW 
challenge. 
IV FLAKE DP OF SCW INDOCED ARTHRITIS BY I.V. INJECTION OF HETEROLOGOOS 
ECW 
Because unrelated bacteria share some common determinants, such as 
muramyl dipeptide, we investigated the possibility that a SCW induced 
arthritis could be reactivated by cell walls of nonrelated bacteria. If 
nonrelated endogenous bacteria would be able to induce a flare up 
reaction of a SCW-arthritis, this could be of great physiological 
importance for the pathogenesis of chronic arthritis. For this purpose 
we used cell walls of the gut bacterium, E.coli. 
200 pg SCW or ECW were administered i.v. 21 days after i.a. injection 
of 25 pg SCW into the right knee joint of naive mice. Table 4 shows the 
R/L ratio's of ЭЭпьр,; uptake measured 24 hours after i.v. challenge: 
the ratio's as a result of systemic bacteria were significantly 
different (P<0.001) from that of the PBS injected group. Both cell wall 
injected groups however were similar with respect to 99mTc uptake 
ratio's, indicating, that a SCW induced arthritis can be reactivated to 
the same extent by homologous as well as by nonrelated endogenous 
bacteria. Histological analysis confirmed our observations (data not 
shown). 
As was also the case with SCW, 200 tig ECW injected i.v. in naive mice 
caused no abnormalities in the contralateral joint (data not shown), 
implying that the described reaction to ECW i.v. is an exacerbation and 
not a primary arthritis. 
Table 4: R/L ratio's of Э тр,, uptake 24 hours after i.v. challenge with 
homologous (SCW) or non related heterologous (ECW) cell walls. 
i.v. injected R/L ratio 
PBS 1.08 ± 0.04 (8) 
200 цд SCW 1.21 ± 0.07 (8) 
200 pg ECW 1.24 ± 0.06 (7) 
Arthritis was induced 21 days before i.v. challenge by injection of 25 
pg SCW into the right knee joint of naive mive. 
Values represent the mean ratio of ЭЭтір
 Uptake ± s.d. from groups of 
mice (number in brackets). 
Both cell wall injected groups did not differ significantly from each 
other but were statistically different (P<0.001) from the PBS injected 
group (two-tailed Mann-Whitney U test) 
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DISCUSSION 
In this study we show that i.a. injection of SCW induces an arthritis 
in both naive and previously immunized mice, indicating that systemic 
immunity to SCW is not obligatory for this process. An exacerbation of 
the arthritis can be induced by systemic challenge with SCW.The notion 
that the left knee joint remains unaffected after i.v. administration 
stresses the importance of local hyperreactivity of the previously 
inflamed joint in the flare up reaction in as well naive as immunized 
mice. That this hyperreactivity has to be a bacteria-specific one 
becomes clear from our finding, that i.v. injection of SCW does not 
reactivate a non-bacterial (f.i. mBSA) arthritis (data not shown). The 
fact that pretreatment with ALS completely abolishes the flare up 
reaction suggests a role for lymphocytes in this phenemenon. 
In addition, we show that a SCW-induced arthritis can be reactivated by 
nonrelated ECW, probably because of the existence of common bacterial 
determinants on both bacteria. The latter observation might be of great 
importance for the pathogenetic process of arthritis. 
Systemic or intraarticular (i.a.) injection of streptococcal cell walls 
(SCW) induces an arthritis in rats (7,12,13). For arthritis to occur 
after systemic administration, the use of a susceptible strain of rats 
(female Lewis) (7,8) or mice (Balb/c) (26) is obligatory, while the 
arthritis after i.a. injection is present in as well susceptible (12) 
as resistant rats (13). Chronic arthritis however, only occurs after 
systemic injection of cell walls. A reason for this can be the 
continuous flow of cell walls into the joint from a depot in the body, 
causing a perpetuous stimulation in the joint and thus chronicity of 
the inflammation. That renewed antigen challenge indeed can reactivate 
an arthritis has been demonstrated in rats in the i.a. streptococcal 
cell wall model (12,13) and in mice in the antigen induced arthritis 
model (14-19). In previous studies we have demonstrated that the flare 
up reaction of antigen induced arthritis in mice is dependent on 
hyperreactivity of the inflamed joint mediated by antigen specific 
helper Τ lymphocytes (18-19) and independent of complement (18). 
To investigate whether mice were susceptible for arthritis induced by 
i.a. injected SCW, whether the flare up reactions were dependent on a 
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hyperreactive joint and whether systemic immunity to SCW contributed in 
a way to the vehemence of these reactions, we designed the experiments 
described in this study. In addition, we studied the role of 
lymphocytes in the exacerbation of the arthritis and the possibility to 
reactivate SCW arthritis with non-related endogenous bacteria. 
From our experiments it became clear, that an arthritis occurred as a 
result of i.a. injection of SCW both in immunized (table 1, figure 1) 
and in naive (table 2, figure 3) С57ВІ/10 female or male (data not 
shown) mice. The arthritis was dose dependent both in vehemence and 
chronicity. When we compared the arthritis at different times after 
induction in previously immunized mice to that in naive mice, it was 
obvious that the arthritis was significantly more severe in the former 
than in the latter group, indicating that specific systemic immunity 
contributes to the measure of SCW induced arthritis. This is in strong 
contrast with mBSA induced arthritis in mice (3-5): in the latter 
model, both retention of cationic mBSA in the joint and (systemic) 
immunity are prerequisite for inflammation to occur (11). That i.a. 
injection of (anionic) SCW can cause arthritis in naive mice is 
probably due to the nonspecific inflammatory properties of SCW (23). 
Considering the exacerbation, which might be of great importance for 
maintainance of arthritis and thus for chronicity, this reaction was 
clear\y present both in naive (figure 3 and 5) and in immunized (figure 
1 and 2) mice and was, like the primary arthritis, more pronounced in 
the latter group of mice. 
The next thing to do was to exclude the possibility that the 
exacerbation we were studying was not a flare up reaction of a 
formerly injured joint but more like another primary arthritis due to a 
sufficient amount of SCW reaching the joint. A strong argument against 
this possibility is the fact that the contralateral knee joint is not 
affected at all after intravenous antigen challenge regardless of the 
immunological background of the mouse. In spite of this there was still 
a chance we were looking at a primary arthritis instead of a flare up 
reaction, because the foregoing inflammation might have altered the 
joint in a way that it becomes more permeable to antigenic material. 
Studies from others (12) in rats however have demonstrated that after 
i.v. challenge with 300 цд SCW in the case of a former inflammation as 
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little as 70 ng (0.02%) reaches the joint and in case of a naive joint 
two times less (30 ng, 0.008%). The amount of SCW that has to be 
injected for causing a primary arthritis in our mice was at the least 
0,5 yxg (data not shown): this is seven times more than the amount that 
can reach an inflamed joint. Thus, we are quite sure that we are indeed 
studying a real exacerbation of a previously inflamed joint. Additional 
support emerges from our dose-response experiment (table 3). Even as 
little as 30 iiq SCW given i.v. appeared to be sufficient to induce a 
reactivation of the subsided arthritis. 
From the above mentioned data it becomes clear, that it is possible to 
induce an arthritis by i.a. injection of SCW in mice and that this 
arthritis can be reactivated by an i.v. antigen challenge. We have 
amply shown in former studies (16-19), that reactivation of arthritis 
is dependent on a hyperreactivity in the joint due to the foregoing 
inflammation and that this hyperreactivity is dependent on antigen 
specific helper Τ cells. 
Results from early studies on the arthritis model induced by i.p. 
injection of SCW (7-10) suggested that Τ cells play a minor, if any, 
role in this disease, and that the main features of the disease are 
mediated by macrophages, which try to degrade the very resistant SCW 
in vain. More recent studies, however, showed a clear involvement of Τ 
lyumphocytes in the chronic phase of the arthritis: it was demonstrated 
that the chronic phase of the arthritis was inducible in euthymic rats 
only (24,27), while athymic rats only suffer from the acute, and thus Τ 
cell independent, phase. The expression of la antigens in the chronic 
disease correlated well with disease expression and presence of Τ 
cells, providing strong evidence for the crucial role of Τ cells (27). 
Moreover, recent studies from our department obviously showed that 
susceptible Lewis rats mounted a clear SCW-specific Τ cell response 
after various ways of SCW priming, while the same response was 
absolutely absent in resistant F344 rats (28). Besides specific Τ cell 
responses, also the continuous presence of the degradation-resistant 
material in the animal is obligatory, as it has been demonstrated, that 
injection of mutanolysin had important beneficial effects on the 
arthritis (25). The SCW throughout the body might form a reservoir, 
from which antigenic material can enter the joint and induce (T cell 
55 
dependent) flare up reactions, thus maintaining the arthritis. 
To study the involvement of lymphocytes in the flare up reaction, we 
used pretreatment with rabbit-anti-mouse-lymphocyte serum (ALS). Table 
3 shows that pretreatment with ALS completely inhibited the 
exacerbation of the arthritis independent of the antigen dose used for 
challenge. This experiment was performed in mice which were not 
immunized before induction of the arthritis, because we least expected 
SCW specific lymphocytes to be present in mice without a SCW insnune 
background. If ALS had any effect in this system, the effect in immune 
mice was expected to be even more clear. 
The fact that (T) lymphocytes apparently are crucial in the flare up 
reaction of these mice, implicates that after local priming (specific) 
lymphocytes are present at the site of inflammation and that these 
cells play a key role in the hyperreactive state of the inflamed joint 
and thus, together with invading antigen, in chronicity of arthritis. 
Our experiments with ALS are not a complete proof of the involvement of 
specific lymphocytes as main effector cells in the flare up reaction in 
this model: the possibility that the ultimate effector cell is the 
macrophage, whose function is regulated somehow by (specific) 
lymphocytes, remains still valid. Which cells and which conditions of 
the mouse are obligatory for a flare up reaction or a chronic SCW 
arthritis are currently under study in our laboratory. 
A recent study in rats showed that an arthritis induced by i.a. 
injection of SCW could be reactivated by i.v. administration of SCW of 
the same or of another species (12) or by LPS derived from several 
gramnegative bacteria (12,13). Reactivation of the arthritis with LPS 
was also possible to almost the same extent when nude rats were used, 
implying that Τ lymphocytes were not involved in this process. These 
results indicate that other mechanisms not related to Τ cells may play 
a role in exacerbations. If a flare up reaction is induced with LPS,it 
is thinkable that the latter flare up reaction is based on a 
nonspecific mechanism, because of the properties of LPS, being a 
polyclonal activator of a wide array of cell types (29) among which the 
В cell (30) and the macrophage (31). In response to this activation, 
the latter might start producing IL-1 among other things; this IL-1 is 
known to induce for example arthritis and synovitis when injected into 
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joints (13,31). When the challengeing agens is a gramnegative bacterium 
however, the specific (bacterial antigenic determinants) and 
nonspecific (LPS) might be combined, thus leading to a more pronounced 
reaction. 
Experiments which might have a great impact for the pathogenesis of 
chronic arthritis in humans are those in which a SCW arthritis is 
flared with the cell walls of a nonrelated endogenous bacterium, E.coli 
(ECW). Table 4 shows that reactivation of a SCW induced arthritis can 
be accomplished by i.V. administration of ECW to the same extent as by 
SCW, indicating that there must be some immunological resemblance 
between the two nonrelated strains. A cell wall component which occurs 
in all bacteria, muramyldipeptide (MDP), might be the critical 
structure. It has been shown in rats (12) that arthritis induced by 
i.a. injection of SCW can be reactivated by i.v. injection of other 
bacteria or MDP, albeit in huge amounts with respect to the latter. It 
has been suggested before (33,34) that different infectious agents 
induce arthritis by a similar mechanism or enhance each other's action 
because of the possession of similar structures (nonbiodegradable 
peptidoglycan moieties). The gastrointestinal tract might then be 
responsible for the continuous supply of antigen (34). In addition, 
we have recently demonstrated that SCW primed murine Τ cells display a 
proliferative réponse upon stimulation with ECW or MDP and vice versa 
(32). This finding together with above the mentioned observations 
(12,13,33,34) might be of utmost importance: Once an arthritis is 
induced by bacterium X (reactive arthritis, septic arthritis and maybe 
all arthritides with unknown etiology), bacterium-primed lymphocytes 
are present in the affected joints. If normally subarthritogenic 
amounts of a nonrelated bacterium Y enter the primed joint, a 
(subclinical) reactivation of the arthritis could occur. Consecutive 
exacerbations could then be the cause of chronicitv. The fact that also 
endogenous bacteria are capable of inducing a flai. i up of SCW induced 
arthritis is very intriguing, because then (unnoticed) irritations, 
inflammations or lesions of the gut or shortlasting infections of the 
urinary tract might provide enough bacterial antigens to reactivate and 
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maintain a foregoing arthritis· This hypothesis not only gives an 
explanation for the relationship between infections of gastrointestinal 
or urinary tract and arthritis, but also between inflammatory bowel 
diseases and arthritis and between food allergy and arthritis. 
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In order to investigate the immunological mechanism of the chronic phase of streptococcal 
cell wall (SCW)-induced arthritis in Lewis rats, we compared the SCW-specific Τ cell response 
in arthritis-susceptible (female Lewis) and resistant (F344) rats. We present evidence that this Τ 
cell response is absent in F344 rats, while it is clearly present in Lewis rats. The Τ cell response 
was analyzed both in the spleen and in lymph nodes. In addition, we show, that injection of 
SCW in the F344 rat induces a general unresponsiveness in this strain: the response to mitogen 
was severely suppressed in SCW-injected F344 rats and, furthermore, when SCW was coinjected 
with ovalbumin, the response to ovalbumin was depressed. The fact that priming with oval­
bumin alone induces a normal response in the F344 rat to both mitogen and ovalbumin implies 
that the observed abnormality after SCW priming is not a general immunological defect in this 
strain. Additionally, we demonstrate that adherent cells of both Lewis and F344 exert negative 
effects on an in vitro Τ cell response after injection with SCW, and that F344-adherent cells are 
more potent in this effect. Removal of OX8-positive cells leads to a restoration of the SCW-
specific Τ cell response in SCW-injected F344 rats, indicating that the expression of this response 
is controlled by (SCW-specific?) suppressor Τ cells. Our results provide suggestive evidence for 
the obligatory role of SCW-specific Τ cells in the expression of chronic joint inflammation after 
systemic injection of SCW. ο |9ββ Academic Pres, loc 
INTRODUCTION 
A single intraperitoneal injection of a sterile, aqueous suspension of cell walls from 
group A streptococci induces a self-limiting, acute polyarthritis and systemic illness 
followed by a chronic erosive polyarthritis. The chronic phase of the disease can only 
be induced in a susceptible rat strain (female Lewis rat), while in most rat strains 
tested in this model the acute disease can be induced (1,2). Joint inflammation devel­
ops coincidently with the deposition of cell wall fragments and the chronic phase is 
dependent upon the continued presence of cell walls in the joint. This does not ex­
plain the localization of the disease, however, because cell walls can be demonstrated 
throughout the body. Despite numerous studies on various features in this model, the 
exact pathogenic mechanism of this chronic joint inflammation is still not completely 
understood. What has become clear, however, is that the distribution and clearance 
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of streptococcal cell walls (SCW)1 in susceptible and resistant (e.g., the F344 rat) rat 
strains is comparable (3,4), just as cutaneous inflammatory reactions to SCW (S, 6) 
and SCW-specific antibody responses (7, 8), implying that none of these parameters 
is of determining importance for development of chronic disease. 
The precise role of Τ cells in this model remains a matter of debate. On one hand, 
doubts have been raised because of the observed abnormalities in interleuldn-2 re· 
sponse (9) and Τ cell anergy in SCW-injected rats ( 10). On the other hand, there are 
several pieces of evidence which point to a direct role for Τ cells in the chronic joint 
inflammation. It has been convincingly demonstrated that the chronic arthritis is 
dependent on major histocompatibility complex Class II expression in the synovium 
(11), that both chronic polyarthritis and Class II expression in the synovium can be 
inhibited by an anti-helper Τ cell drug (cyclosporin A) (12), and that the chronic 
disease is not inducible in nude rats ( 13). So far, surprisingly little attention has been 
paid to a potential role of SCW-specific Τ cells in the chronic inflammatory process 
in the joint. To elucidate the importance of the development of SCW-specific immu­
nity, we analyzed SCW-specific Τ cell responses in arthritis-susceptible (Lewis) and 
resistant (F344) rats after different methods of SCW administration, in different com­
partments of the immune system, and at different times after arthritis expression. 
Our results clearly demonstrate that arthritis-resistant rats are completely unable 
to mount a SCW-specific Τ cell response after different ways of priming with SCW 
and that this inability is present also in lymph nodes and in spleen. Moreover, injec­
tion of SCW induced a state of general Τ cell unresponsiveness in F344 rats, which 
appeared to be controlled by suppressor Τ cells. In the arthritis-susceptible rats we 
always observed a SCW-specific Τ cell response, which was already present at the 
onset of chronic disease. 
Our findings provide suggestive evidence for the involvement of, or even depen­
dence on, SCW-specific Τ cells in the development of SCW-induced chronic polyar­
thritis in rats. Possible pathogenic mechanisms of this disease and regulation of bac­
terium-induced autoimmunity will be presented. 
MATERIALS AND METHODS 
Animals 
Female inbred Lewis and F344 rats were obtained from Olac (UK) and weighed 
130-150 g at the initiation of each experiment. They were fed a standard diet and 
tap water. 
Preparation of Streptococcal Cell Wall Fragments 
Streptococcus pyogenes T12 organisms were cultured in Todd-Hewitt broth and 
after 24 hr the cells were harvested. Cells were disrupted with glass beads and sonica-
tion and the material was subsequently treated with various degrading enzymes as 
1
 Abbreviations used: Con A, concanavalin A; cpm, counts per minute; FACS, fluorescence-activated 
cell sorter, HIHS, heat-inactivated horse serum; IFA, incomplete Freund's adjuvant; LNC, lymph node 
cells; OVA, ovalbumin; PBS. phosphate-buffered saline; PEC, peritoneal exudate cells; PGE2, prostaglan­
din E] ; PHA, phytohaemagglutinin; RC, rabbit complement, SAC, spleen-adherent cells; SC, spleen cells; 
SCW, streptococcal cell wall(s); SNAC, spleen-nonadherent cells; T
s
, suppressor Τ cells. 
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described previously ( 1 ). Further isolation was carried out by differential ultracentifu-
gation steps as has been described (2) and the resulting 100,000,? pellet was used 
throughout the experiments. This preparation contained 12.8% muramicacid. 
Induction and Evaluation of Arthritis 
For induction of arthritis, a sterile suspension of sonicated SCW in phosphate-
buffered saline (PBS), pH 7.4, was injected intraperitoneally into the rats at a dose of 
120 Mg SCW dry wt per gram of body weight ( 120 Mg dry wt = 15 Mg muramic acid). 
In our hands, this dose consistently induces a severe chronic polyarthritis in Lewis 
rats. Extremities distal to the elbow or knee were clinically graded on a scale from 0 
to 4, based on the degree of redness and swelling and the inability to walk. This re­
sulted in a score between 0 and 16 per rat. In addition, the thickness of the four 
extremities was measured with an industrial micrometer and also these values were 
summed per rat. 
Determination of Antibody Levels Directed against SCW 
At various times after SCW injection, blood samples were taken from the rats by 
bleeding from the retroorbital venous plexus. Blood was allowed to clot for 2 hr at 
room temperature and centrifuged for 10 min at a speed of 3500 rpm and the sera 
were stored at -20*C. Anti-SCW antibodies were determined by an enzyme-linked 
immunosorbent assay (ELISA). For this purpose, 96-well flat-bottom microliter 
plates (Costar, Cambridge, MA) were precoated with 150 мі protamine-HCl (0.5 mg/ 
ml, Kabi AB, Stockholm, Sweden) per well for 2 hr. The plates were washed three 
times with wash buffer (PBS + 0.05%, v/v, Tween 20) and subsequently coated with 
150 м1 SCW (50 Mg/ml dry wt) per well overnight. After three washes, the plates were 
postcoated with 150 μΐ gelatin (1%, w/v) in PBS for 2 hr to avoid nonspecific binding. 
The plates were incubated with 100 μΐ/well of twofold dilutions of rat sera (dilu­
tions in 1%, w/v, gelatin in PBS) per well for 1 hr. The plates were washed five times 
and were then incubated with 100 μΐ/well of horseradish peroxidase-conjugated goat 
anti-rat immunoglobulin (Ig) (Nordic, The Netherlands) diluted 500X in 0.5% (w/v) 
gelatin in PBS for 1 hr. After five washes, 100 μΐ of freshly prepared substrate solution 
(0.8 mg/ml of 5-aminosalicylic acid dissolved in 50 mM phosphate buffer, pH 6.0, 
containing 0.8 мі/ml of 30%, ν/ν, H2O2) was added to each well. After 30 min, the 
absorbance at 450 nm was measured in a Titertek Multiskan. All values were cor­
rected for the signal obtained by omitting the antigen coating step. All incubations 
were carried out at room temperature. 
Isolation of Rat Lymph Node Cells or Spleen Cells 
To study the response of lymph node cells, rats were injected with SCW emulsified 
in incomplete Freund's adjuvant (IFA), ovalbumin emulsified in IFA, a combination 
of SCW and OVA emulsified in IFA, or IFA alone. Each rat was injected in four 
footpads with 0.2 ml IFA or PBS containing 50 Mg SCW or ovalbumin. After 9 days 
the draining lymph nodes were removed aseptically. 
To study the response of spleen cells, Lewis and F344 rats were injected with an 
arthritogenic dose of cell walls in PBS intraperitoneally ( 120 Mg SCW dry wt/g rat). 
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At the day of clinical onset of the chronic arthritis in the Lewis rats (e.g.. Days 12-
16), or late in the chronic phase (Day 90), spleens were removed aseptically. 
A single cell suspension of lymph nodes and spleen was made by gently teasing in 
RPMI 1640 dutch modification (dm) (Flow Laboratories) in a sterile infusion admin­
istration system (NPBI BV, EmmerCompascuum, The Netherlands). The cells were 
washed once with RPMI 1640 dm and the erythrocytes were lysed with 0.16 M 
NH4CI, 0.17 M Tris-HCl, pH 7.2, for 2 min at room temperature. The cells 
were washed twice with RPMI 1640 dm and were used in a proliferation assay as 
described below. 
In the case of further purification of adherent and nonadherent cells, the cells (3 
X 106/ml) were incubated for adherence to a culture flask in RPMI 1640 dm + 5% 
heat-inactivated horse serum (HIHS). After 45 min in a COi incubator at 37°C, non­
adherent cells were collected by aspiration and the remaining adherent cells were 
removed using a cell scraper. Cells of both suspensions were centrifuged. The nonad­
herent cells were subsequently suspended in 1 ml RPMI 1640 dm + 20 тЛ/gluta-
mine + 10 тЛ/ pyruvate + 5% HIHS (complete medium) and applied to a nylon 
wool column for further removal of nonadherent cells. After 45 min in a COj incuba­
tor at 374Γ, the nonadherent population was eluted with 25 ml RPMI 1640 dm. 
Adherent cells were suspended in complete medium until use. 
Isolation of Rat Peritoneal Exudate Cells (PEC) 
To study whether antigen-specific cells, with a capacity to migrate to antigenic 
stimuli, were present in arthritic rats, Lewis rats were injected ip with an arthntogenic 
dose of cell walls in PBS. At the onset of chronic arthritis (Days 12-16) or late in the 
chronic phase (Day 90), a challenge of 100 Mg SCW dry wt/g rat was given ip. After 2 
days the peritoneal cavity was washed with 15 ml sterile RPMI 1640 dm and the 
collected cells were washed. After removal of adherent cells (see above), nonadherent 
cells were counted and used in the proliferation assay. 
Proliferative Response of Rat Cells to Streptococcal Antigens or Mitogens 
For use in the proliferation assay, peritoneal cells (PC), lymph node cells (LNC), 
spleen cells (SC), spleen-adherent cells (SAC), or spleen-nonadherent cells (SNAC) 
were suspended in complete medium containing 50 Mg/ml gentamycin with a density 
of 2 X 10' cells/ml. Of the cell suspensions mentioned above, 50 μΐ was placed in the 
well of a sterile 96-well round-bottom microliter plate (Costar). 
In the case of depletion of OX8-positive (suppressor T) cells, LNC were treated as 
follows: 107 LNC were incubated with OX8 (SeraLab, diluted 1/100) and 1/6 diluted 
rabbit serum as a source of complement (RC) in 1 ml RPMI 1640 dm supplemented 
with 0.1% bovine serum albumin (BSA, Sigma Chemicals) for 30 min. at 37°C. Con­
trol LNC were incubated with rabbit serum only. The rabbit serum had been proven 
to display no nonspecific cytotoxicity to rat cells and a good toxicity (100% lysis) in 
combination with an alloantiserum (data not shown). After incubation, the cells were 
washed twice with cold RPMI dm and used in the proliferation assay in the following 
concentration: control cells were adjusted to a concentration of lO'/ml and OX8/ 
RC-treated cells were diluted by the same factor to keep the amount of OX8-negative 
Τ cells similar. 
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FIG. I. Arthritis induced in female Lewis ( · ) and female F344 (O) rats by intraperitoneal injection of 
streptococcal cell walls (IS Mg murarme acid/g body wt). The arthntis was scored by measunng the paw 
thickness with an industrial micrometer. Values represent the mean of a group of five rats. 
To induce antigen-specific proliferation, 100 μΐ SCW or 100 μΐ ovalbumin was 
added to final concentrations as indicated under Results. To study mitogen-induced 
proliferation, ΙΟΟμΙ 1 Mg/ml concanavalin A (Con A)orphytohaemagglutinin(PHA) 
was added. If necessary, SO μΐ of complete medium was added to obtain a final volume 
in all wells of 200 μΐ. 
After 72 hr in a CCh incubator at ЗТ'С, 3.7 X IO4 Bq ( 1 μΟ) [3H]thymidine (Amer-
sham Nederland BV, sp act 0.7-1.1 X 10* MBq/mmol) was added per well. After 24 
hr, the cells were harvested with a cell harvester (Titertek Harvester 550, Flow Labs.) 
onto glass fiber filter papers (Titertek, Flow Labs.). The filter papers were placed in 
Aqualuma (Lumac BV, The Netherlands), and the amount of incorporated [3H]-
thymidine was counted in a liquid scintillation analyzer (LKB Wallac 1214 Rack-
beta). AU values are expressed as the mean of at least triplicate cultures. 
Determination of Τ Cell Subsets in Lymph Nodes, Peritoneum, and Spleens of Lewis 
and F344 Rats after Injection with SCW 
To analyze the different cell suspensions with regard to the responding Τ cell popu­
lation, we used an indirect immunofluorescence assay. For this purpose, 106 cells 
were incubated with each of the following mouse anti-rat monoclonal antibodies: 
W3/13 HLK (pan-T), W3/25 (helper T), or OX 8 (nonhelper T), all diluted 1/50 in 
PBS containing 0.1% (w/v) BSA and 0.1% (w/v) NaNj for 30 min at 0°C. All mono-
clonals were purchased from Seralab. After two washes with PBS/BSA/NaNj, the 
cells were incubated with 1 /50 diluted goat anti-mouse IgG 1 -FITC (Nordic В V, The 
Netherlands) for 30 min at 0*C. The cells were subsequently washed twice and ana­
lyzed with the fluorescence-activated cell sorter (FACS). 
RESULTS 
Evaluation of SC W-Induced Arthritis 
Intraperitoneal injection of 120 μ% SCW (dry wt) into female Lewis rats resulted in 
a chronic arthritis which became clinically visible 10-14 days after injection (Fig. 1). 
With the used SCW preparation, we macroscopically observed only a slight acute 
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TABLE 1 
Proliferative Response [3H]Thyimdine Incorporation in cpm) of Spleen Cells Isolated from Lewis 
and F344 Rats at Clinical Onset of Arthritis in Lewis Rats 
['HJThymidmefx 10'cpm)-incorporated stimulus" 
in vitro (Mg/ml) 
Cells* 
Lewis SC 
F344SC 
LewisSC + F344SC 
Lewis SNAC 
Lewis SNAC + Lewis SAC 
Lewis SNAC + F344 SAC 
F344 SNAC 
F344 SNAC+ F344 SAC 
F344 SNAC + Lewis SAC 
SCW 
100 
48 
IS 
30 
170 
92 
3.6 
42 
22 
29 
Con A 
125 
152 
56 
115 
32 2 
24 2 
17 7 
133 
85 
10 5 
PHA 
125 
132 
56 
88 
216 
178 
100 
130 
46 
128 
None 
10 
12 
14 
18 
19 
2.0 
1.1 
1.4 
0 9 
Note Values represent the mean incorporation of ['HJthymidine. AU cultures were done in triplicate 
and the variation in the mean is within ± 10%. 
" SCW, streptococcal cell walls. Con A, concanavalin A; PHA, phytohaemagglutimn. 
* SC, spleen cells, SNAC, spleen-nonadherent cells; SAC, spleen-adherent cells Per well. Юз SC or, in 
the case of combinations of cells, 5 X 104 cells of each type were used. 
phase, probably due to the fact that our material did not contain large amounts of 
small fragments which are known to be responsible for the acute arthritis (2). In F344 
rats no chronic arthritis was observed (Fig. 1). The clinical evaluation of the arthritis 
in both strains showed a pattern similar to that of the measured limb thicknesses 
(data not shown). 
In Vitro Proliferative Response of Spleen Cells 
To study the cellular anti-SCW response in a situation in which an arthritis occurs, 
Lewis and F344 rats were injected intrapentoneally with an arthritogenic dose of 
SCW and at the day of clinical onset of the chronic arthritis in Lewis rats, the spleens 
were removed from both strains. Spleen cells were used in a proliferation assay as 
total spleen cells, spleen-nonadherent cells, or SNAC to which spleen-adherent cells 
were added. The results of a representative experiment, out of four, are listed in Table 
1. The antigen-specific response was clearly present, as well as the mitogenic response, 
considering SC of Lewis rats. F344 SC did not react to SCW and displayed a low 
response to mitogen. A combination of F344 and Lewis SC led to an intermediate 
antigen and mitogen response. 
Removal of adherent cells led to a higher response in the Lewis rat and also in the 
F344 rat: Adherent cells seem to be at least partly responsible for the suppression 
observed in the spleen. Suggestive evidence for this effect being resident in the adher­
ent population comes from reconstitution experiments. If Lewis or F344 SNAC were 
reconstituted with Lewis SAC, half of the initially observed response remained. Re-
constitution of Lewis SNAC with F344 SAC however inhibited the proliferative re-
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spense to both antigen and mitogen to a much higher extent: only 14% of the SN AC 
response remained. This implies not only that adherent cells with a suppressive ca­
pacity were present in the spleen of both strains, but more important, that in the 
spleen of F344 rats these cells were more active or present to a higher extent. Reconsti­
tution of F344 SNAC with F344 SAC gave the same result as reconstitution with 
Lewis SAC. 
Subsequently we studied PGE2 as a possible mediator involved in this phenome­
non, because adherent cells are known for its production and PGE2 has a recognized 
immunosuppressive capacity. Furthermore, it has been described (3) that SC of F344 
produced more PGE2 than Lewis SC after ip injection of SCW. For this purpose, we 
added 0, 10"', or 10 - ' M indomethacin to the cultures. No effect of indomethacin 
was detected however after addition to any of the cell combinations (data not shown): 
PGE2 does not seem to be responsible for the suppressive effect mediated by adherent 
spleen cells of F344 rats or of Lewis rats after systemic injection of SCW. 
Proliferative Response of Peritoneal Exudate Cells 
There are arguments to suggest that the amply described low responsiveness of 
Lewis SC, isolated after systemic injection of SCW, is due to inhibitory effects of 
adherent cells, albeit that removal of this population did not lead to a complete resto­
ration of the proliferative response. Another possibility for the observed low respon­
siveness in Lewis SC is that, after one systemic injection of SCW, the spleen of the 
arthritic rat is not the main organ in which antigen-specific Τ cells reside. To investi­
gate whether in an arthritic rat SCW-specific cells are present which have the addi­
tional capacity to migrate to antigen, we tested the proliferative response of PEC in 
comparison with SC at the onset of and late in the chronic phase of the disease. 
For the reason that the mononuclear fraction of PEC consisted of more than 70% 
monocytes/macrophages, we removed these cells with mild adherence (only to a plas­
tic surface) from PEC as well as from SC. The remaining PEC population contained 
15% monocytes/macrophages, 5% В cells, 20% granulocytes, and 60% Τ cells of 
which most were of the helper phenotype. The SC population consisted of 17% 
monocytes/macrophages, 35% В cells, and 48% Τ cells (determined by FACS 
analysis). 
The proliferative response of both populations after stimulation with antigen or 
mitogen in vitro is listed in Table 2. The responses of SC isolated 12 or 90 days after 
arthritis induction display a response to antigen which is intermediate to that ob­
tained with unpurified SC and SNAC (Table 1). The response to mitogen is almost 
absent in rats with a 90-day arthritis and present to a low extent in rats with a 12-day 
arthritis. This indicates that with a longer duration of the arthritis less SC can be 
stimulated with mitogen. This finding is in agreement with the described anergy in 
rat spleen cells due to injection of SCW (10). In contrast, the response to antigen of 
PEC is more pronounced than that of SC at both times after arthritis induction, im­
plying that somewhere in the body (and not preferentially in the spleen) of arthritic 
rats SCW-specific Τ cells are present that are able to migrate to locally applied anti­
genic stimuli. In addition, this population of cells reacts to mitogen in an absolutely 
normal way as contrasted with the SC. 
This could mean that the suppressive elements as a result of SCW injection are not 
present throughout the body, but preferentially in the spleen. 
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TABLE 2 
Comparison of the Proliferative Response of Lewis Peritoneal Exudate Cells (PEC) and Spleen Cells (SC) 
12 or 90 Days after Induction ofSCW Arthritis 
Stimulus ш vitro 
(Mg/ml)» 
SCW 100 
30 
10 
Con A3 
1 
None 
PEC-12 
110 
9 0 
52 
27 2 
25 2 
10 
Stimulation index* 
SC-12 
4 4 
3.7 
2.1 
80 
136 
10 
PEC-90 
7 4 
7.7 
39 
23.4 
25 2 
10 
SC-90 
33 
3 1 
29 
3 1 
2 3 
10 
" No cpm with stimulus/No cpm without stimulus. 
' SCW, streptococcal cell walls. Con A, concanavalm A. 
In Vitro Proliferative Response of Lymph Node Cells 
To investigate the possibility that in F344 rats a defect in Τ cell responsiveness 
forms the basis for the observed inability of this strain to build a SCW-specific Τ cell 
response, we tested the proliferation of a more pure Τ cell suspension that was not 
influenced by the possible systemic, nonspecific effects of SCW to SCW. Lymph node 
cells were obtained from the draining lymph nodes of F344 and Lewis rats 9 days 
after priming with SCW, ovalbumin, or a combination of both emulsified in IFA. 
Table 3 shows a representative experiment, out of five, in which the proliferative 
responses of LNC of F344 and Lewis rats to SCW and mitogens are compared to 
each other after priming with SCW/IFA or with IFA alone. From these values it 
TABLE 3 
('HJThymidine Incorporation of F344 and Lewis LNC in Response to SCW or Mitogens 
after m Vivo Priming with SCW/IFA or IFA 
Stimulus* ш vitro 
(Mi/ml) 
SCW 100 
30 
10 
3 
Con Al 
PHAI 
None 
['HJThymidineíNo cpm'X І0Э) incorporated by 
Lewis 
SCW/IFAC 
10 0 
100 
34 
10 
169 
178 
0 6 
IFA 
0 2 
02 
0 2 
02 
16 3 
17 1 
0.3 
F344 
SCW/IFA 
0 3 
0.2 
0 2 
02 
10 
19 
0 3 
IFA 
0.2 
0 3 
0 2 
0 2 
13.9 
17 1 
0 3 
' cpm, counts per minute Mean incorporation of a representative study out of Ave individual rats AH 
cultures were done in quadruplicate and the variation in the mean is within ± 10% 
* SCW, streptococcal cell walls. Con A, concanavalin A, PHA, phytohaemagglutimn 
' IFA, incomplete Freund's adjuvant 
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TABLE 4 
Proliferative Response of Lymph Node Cells Isolated from F344 Rats 9 Days after Priming 
with SCW/IFA, OVA/IFA, or SCW/OVA/IFA 
Stimulus* in vitro 
kg/ml) 
None 
SCW 100 
30 
10 
OVA 1000 
300 
100 
Coo Al 
['HJThymidine incorporation (stimulation index)" 
OVA/IFA 
1.0 
ND' 
ND 
ND 
7.6 
5.9 
3.2 
57.9 
SCW/IFA 
1.0 
2.1 
1.4 
1.6 
ND 
ND 
ND 
3.0 
SCW/OVA/IFA 
1.0 
3.7 
2.9 
2.1 
2.3 
1.4 
1.4 
9.8 
° Values represent the mean incorporation of [3H]thymidine given as a stimulation index (No. cpm with 
stimulus/No. cpm without stimulus). All cultures were done in triplicate and the SD was always within 
10%. 
' SCW, streptococcal cell walls; OVA, ovalbumin; Con A, concanavalin A; IFA, incomplete Freund's 
adjuvant 
' Not done. 
becomes clear that Lewis LNC displayed a dose-dependent proliferative response to 
the priming antigen, SCW. In contrast, LNC of IFA-primed Lewis rats did not prolif-
erate in response to SCW at all, indicating that the used SCW preparation had no 
mitogenic properties. In addition, LNC of both SCW/IFA- and IFA-primed Lewis 
rats showed a good proliferation in response to both mitogens. Con A and PHA. 
LNC derived from SCW/IFA-primed F344 rats, however, did not proliferate after 
stimulation in vitro with SCW, pointing to an inability of F344 rats to display a SCW-
specific proliferation. Also, the mitogenic response in these rats was completely sup-
pressed. LNC of F344 rats primed with IFA alone displayed a normal mitogenic 
response comparable to that of Lewis LNC, indicating that F344 were not defective 
with respect to the ability to react to mitogen. Both F344 and Lewis LNC did not 
proliferate spontaneously. 
To study whether F344 rats were completely unable to mount a cellular immune 
response, we compared the mitogen- and antigen-induced response of LNC of these 
rats after priming with SCW/IFA or ovalbumin/IFA. The results of a representative 
experiment are shown in Table 4. That F344 rats are not completely defective in 
mounting an immune response is obvious: LNC of ovalbumin/IFA-primed F344 rats 
proliferated in a dose-dependent way to the priming antigen, ovalbumin. Ovalbumin 
LNC also responded normally to Con A. Considering the response of SCW/IFA-
primed LNC, again a suppression of the antigen- and mitogen-driven response was 
observed. To investigate whether injection of SCW induced an antigen-specific sup-
pression in F344 rats, we coinjected ovalbumin and SCW in IFA and analyzed the 
response to both antigens. Table 4 shows that in this situation in addition to the 
response against SCW also the response to ovalbumin and mitogen was suppressed. 
These data strongly suggest that SCW induce a general unresponsiveness or anergy 
in the F344 rat. 
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TABLE 5 
Proliferative Response (['H]thymidine Incorporation x 10' cpm) of Lymph Node Cells and OX8(+)* 
Cell-Depleted Lymph Node Cells Isolated from F344 and Lewis Rats after Pnming with SCW/IFA 
F344 Lewis 
imulus in vitro 
fog/ml)* 
None 
SCW 100 
SCW JO 
SCW 10 
Con A 1 25 
LNC 
14 
1.7 
17 
1 1 
32 
LNC-OX8(+) 
depleted 
1 2 
86 
7.9 
1.4 
11.1 
LNC 
15 
16 1 
18.7 
4 4 
26 5 
LNC-OX8(+) 
depleted 
15 
200 
25 5 
5.9 
29 8 
' For depletion of OX8(+) cells, LNC were treated with rabbit serum as a source of complement together 
with anti-OX8, while control cells were incubated with rabbit serum alone. 
* SCW, streptococcal cell walls; Con A, concanavahn A. Values represent the mean incorporation of 
('HJthymidine by IO9 LNC. All cultures were done in triplicate and the variation was always within 10%. 
The features described above were supported by observation of lymph node reac­
tions after pnming with various stimuli. Lymph nodes of Lewis rats pnmed with 
SCW/IFA and of F344 rats primed with ovalbumin/IFA were clearly enlarged, while 
lymph nodes of F344 rats primed with SCW/IFA were comparable to lymph nodes 
of nonpnmed rats with regard to their size. Moreover, when the number of cells 
recovered from the lymph nodes was considered, it was striking that from the lymph 
node of SCW/IFA-pnmed F344 rats even less cells could be isolated compared to 
IFA-stimulated lymph nodes. 
Proliferative Response of LNC or SC after Depletion ofOX8(+) Cells 
A cell subset which is capable of down-regulating the immune response is the sup­
pressor Τ cell (T,) in rats represented by the OX8(+) population. As it has been de­
scribed that BCG can induce T, in mice (14), it seemed reasonable to investigate 
whether the observed unresponsiveness to SCW in F344 LNC and SC and minor 
responsiveness of Lewis SC after priming with SCW were (partly) due to the induction 
of T,. Table 5 shows the proliferative responses of SCW-primed LNC to antigen. 
Depletion of 0X8(4-) cells has only a marginal positive effect on the response of Lewis 
LNC; the same treatment of F344 LNC, however, led to a response which was five 
times higher than in the original population. These data strongly suggest that in 
lymph nodes of F344 rats, T, cells are induced or activated as a response to SCW, 
thus inhibiting a normal antigen-driven proliferative response. In lymph nodes of 
Lewis rats, T, cells are not present in such an amount that proliferation is seriously 
affected. 
If depletion of OX8(+) cells was performed in the spleen of either strain of rats 
after systemic injection of SCW, no effect on the proliferative response worth men­
tioning was observed in the F344 or in the Lewis population (data not shown). An 
explanation for this finding might be that in the spleen the population of adherent 
cells already exerts such inhibitory effects on proliferation (Table 1 ) that the beneficial 
effects of T, depletion are overruled in this system. 
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TABLE 6 
Antibody Response to SCW in F344 and Lewis Rats at Different Times after Arthritis Induction 
Anti-SCWtiter"^-") 
Time after F344 Lewis 
ip injection 
(weeks) SCW» Saline SCW Saline 
11 
13 
6 t 
8 < 
8 4 
8 4 
9 < 
10 4 
10 4 
1 6 
I 8 
I 9 
\ 9 
i io 
l 9 
\ 10 
4 
4 
4 
4 
4 
4 
4 
' Titer = dilution which gives that extinction with half the maximal value. 
* Rau were injected intraperitoneaJly with an arthritogenic dose of SCW (IS Mg muramic acid/g body 
wt) or with saline. A pool of four to five rats was used. 
Antibody Response to SCW in Lewis and F344 Rats after Systemic Injection of an 
Arthritogenic Dose of SCW 
To investigate whether a difference in antibody response existed between F344 and 
Lewis rats, we analyzed the latter response by ELISA at different times after injection 
of an arthritogenic dose of SCW. The results are listed in Table 6. From this table it 
is obvious that, ñrst, control rats of both strains have a small and comparable titer of 
anti-SCW antibodies which does not change during aging and that, second, SCW-
injected rats develop a rising titer of anti-SCW antibodies during time without a sig-
nificant difference between Lewis and F344 rats. These data imply that the presence 
of anti-SCW antibodies alone is not enough for development of arthritis. The ques-
tion arises whether these antibodies somehow contribute to this Τ cell-mediated in­
flammation and remains unanswered. 
DISCUSSION 
This study was designed in order to investigate the pathogenesis of the chronic 
phase of streptococcal cell wall-induced arthritis in rats by comparing the immune 
responses against SCW in arthritis-susceptible (Lewis) and resistant (F344) rats. 
This model for chronic arthritis has been subjected to numerous studies so far, 
but the main explanation for the observed difference between F344 and Lewis rats 
regarding the disease expression remains obscure. Most studies were able to demon­
strate no more than slight differences between the two strains, for instance, concern­
ing the tissue distribution of cell wall fragments (3, 4), mitogen responses of spleen 
cells after SCW injection (10), cutaneous inflammatory reactions to SCW (5,6), anti­
body responses to SCW (7, 8), and IL-2 response and production (9). The thymus-
independent la expression on cells in the synovium during the acute phase of the 
arthritis was also comparable in susceptible and resistant rats; the la expression in the 
chronic phase however was thymus-dependent and occurred only in the synovium 
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of arthritic rats (11). The latter observation together with other studies using nude 
rats (13) or cyclosporin A (12) has convincingly demonstrated that the chronic but 
not the acute phase of the arthritis is dependent on Τ cells. 
The data presented here suggest an absolute dependence of the chronic inflamma­
tion on streptococcal cell wall-specific Τ cells. We show that the arthritis-susceptible 
rat strain (Lewis) develops SCW-specific Τ cells in response to both subcutaneous and 
intraperitoneal administration of SCW. In contrast, the arthritis-resistant rat strain 
(F344) is completely incompetent to mount a cellular anti-SCW response after either 
way of priming with SCW. In addition, the mitogen response is suppressed after prim­
ing with SCW. 
That the unresponsiveness observed in F344 is not a general defect of the immune 
system in this strain becomes clear from Table 4: Immunization with a protein anti­
gen (ovalbumin) induces a normal cellular anti-ovalbumin and a mitogenic response, 
implying that F344 rats are able to respond in a proper way to antigen. Coinjection 
of SCW and ovalbumin, however, results in suppression of both the cellular anti-
SCW and the anti-ovalbumin response. In addition, the response to a mitogen is 
clearly suppressed. These data tempt us to suggest that SCW induce a general unre­
sponsiveness or anergy with respect to Τ cells in the F344 rat, which might explain 
the resistance to SCW-induced chronic joint inflammation in this strain, the latter 
disease being a Τ cell-dependent one (9,11-13). 
A question which might be of great importance for the elucidation of the patho­
genic mechanism of this disease is which cell type and/or factor is responsible for the 
anergy in F344 rats. In an attempt to answer this question, we investigated the influ­
ence of adherent cells and suppressor Τ cells on the cellular immune response against 
SCW in both Lewis and F344 rats. A rationale for the choice of adherent cells as an 
important cell type is the observation that in the Lewis rat spleen cells always respond 
to SCW in a less pronounced way than lymph node cells and the observation that 
adherent cells of F344 produce significantly more PGE2 in response to SCW than 
Lewis rats (3). PGE2 is known to exert a negative effect on the cellular immune re­
sponse. A possible role for suppressor Τ cells is indicated by the observation that 
bacterial components can induce suppressor cells in mice (14) and that a general 
suppression is observed after SCW injection. 
The role of adherent cells in the unresponsiveness in F344 rats and the lower re­
sponse of Lewis spleen cells as compared to that of lymph node cells is investigated 
by in vitro reconstitution experiments (Table 1 ). Removal of the adherent population 
of SC (SAC) led to a much higher response to SCW and mitogen after injection of 
SCW both in F344 and in Lewis rats. Reconstitution of Lewis-nonadherent cells 
(SNAC) with Lewis SAC reduced the response by 45%, whereas reconstitution with 
F344 SAC reduced the response by more than 80%. Vice versa, reconstitution of 
F344 SNAC with either Lewis or F344 SAC reduced the response by 30 and 50%, 
respectively. These experiments give suggestive evidence for the inhibitory effects of 
SAC with respect to the Τ cell response to SCW and, in addition, for the fact that 
SAC obtained from F344 rats are far more potent in this effect. Control SAC (ob­
tained from Lewis or F344 rats that were not injected with SCW) inhibited the re­
sponse of Τ cells by no more than 25% (data not shown). 
To investigate whether the inhibitory effect of SCW-primed SAC on the Τ cell 
response in vitro was mediated by PGE2, we added indomethacin to the cultures. 
Addition of this cyclooxygenase pathway inhibitor did not prevent the inhibitory 
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effect. This makes us conclude that the observed effect of SCW-primed SAC is not 
the result of PGE^ production but must be due to the production of another mediator. 
The identification of this factor is at the moment subjected to further study in our 
laboratory. 
Removal of SAC did not lead to a complete restoration of the defect Τ cell response 
observed in the F344 rat when compared to both the mitogenic and the antigenic 
response in the Lewis rat. This implies that, besides the observed defect in the SAC 
population in the F344 rat, there is an additional defect residing in the F344 SNAC. 
The remaining unresponsiveness in the SCW-primed F344 SNAC population 
could be the result of activation and/or induction of suppressor Τ cells in this rat 
strain. FACS analysis showed no difference in subset distribution between both 
strains (data not shown) after injection of SCW; however, the possibility that SCW-
s peci fie suppressor Τ cells are present or activated to a lesser extent in the Lewis rat 
remains. Table 5 shows that removal of OX8(+) cells (suppressor Τ cells) led to a 
very pronounced restoration of the SCW-specific and mitogenic Τ cell response in 
the SCW-primed F344 LNC. 
Thus, after injection of SCW, SAC of both strains exert some negative effects of 
unknown nature on the SCW-specific and mitogenic Τ cell response in vitro and this 
effect is more obvious in F344 than in Lewis rats. A more important phenomenon, 
in our opinion, is the fact that in F344 far more active (SCW-specific?) suppressor Τ 
cells are present when compared to the Lewis rat after injection of SCW. 
The above-mentioned data tempt us to suggest that SCW-induced arthritis is con­
trolled by suppressor Τ cells, which is in concordance with the evidence amply pres­
ent in the literature, that autoimmune responses are controlled by suppressor Τ cells 
(15-17). Even of greater importance in this context is the observation that HLA-
linked low responsiveness to SCW in man is controlled by suppressor Τ cells ( 18). 
In SCW arthritis the possibility exists that Lewis rats are defective in suppressor Τ 
cell induction and/or activation, even if unwanted; threatening autoimmune re­
sponses are induced as a side effect by certain stimuli. That the Lewis rat indeed 
might have some abnormalities with respect to the development of normal negative 
feedback regulation of immunity is suggested by the notion that the Lewis strain is 
used very frequently as a susceptible strain for various models of autoimmune disease 
(1, 19-21). 
We think there are two possible mechanisms, or a combination of both, underlying 
the pathogenesis of chronic SCW-induced arthritis. First, the presence of SCW-spe­
cific Τ cells together with SCW persisting in the joints can result in chronic disease; 
this does not explain the preferential localization in the joints, however. The second 
possibility is the induction of an autoimmune component which directs the inflam­
matory reaction to the joints. 
That arthritis induced by bacteria might display an autoimmune character has very 
recently been demonstrated by others (22) and by us: bacteria can induce autoim­
mune anti-cartilage responses in mice (23) and rats (manuscript in preparation) 
which can come to full expression in vivo only if the suppressor circuit is weak­
ened (23). 
The development of an anti-cartilage immune response after priming with bacteria 
might explain the localization of the SCW-induced inflammation (the joints) and the 
chronic character of the disease (continuous presence of antigen). 
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In conclusion, here we provide evidence that the development of SCW-specific Τ 
cells after intrapentoneal SCW injection is of utmost importance for development of 
bCW-induced chronic polyarthritis in the Lewis rat. 
Whether the induction of this chronic joint inflammation by bacteria is mediated 
by anti-SCW Τ cell responses only, or if cross-reactive anti-cartilage responses, proba­
bly in combination with persisting bacterial antigen in the joints, are also involved, 
is currently under investigation in our laboratory. 
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CHAPTER 5 
FLARE UP REACTION OF STREPTOCOCCAL CELL WALL INDUCED ARTHRITIS IN LEWIS 
AND F344 RATS. 
Maries F. van den Broek, Mieke C.J. van Bruggen, Wim В. van den Berg. 
submitted. 

SuBoary 
One intraperitoneal injection of a sterile suspension of streptococcal 
cell walls (SCW) induces a chronic erosive polyarthritis in susceptible 
Lewis rats, but not in resistant F344 or nude Lewis rats. 
Because continuous exacerbations might be one possible mechanism 
underlying chronic disease, we studied τ cell dependent flare up 
reactions in Lewis and F344 rats. Injection of SCW into the right knee 
joint of rats induced a transient monoarthritis in both strains. 
Reactivation of the subsided arthritis by intravenous administration of 
the same antigen could be evoked in the Lewis rat only. Even repeated 
intravenous challenges with SCW failed to induce a flare up reaction in 
the F344 rat, while the Lewis rat went through an exacerbation after 
every challenge. 
These results tempt us to speculate that the possible mechanism 
underlying chronic SCW-induced polyarthritis in rats is based upon 
repeated reactivations of a waning arthritis. Very small amounts of SCW 
leak continuously into the hyperreactive joint, where SCW-specific Τ 
cells are activated and thus induce local flare up reactions. 
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Introduction 
Despite a wide array of studies in various animal models, the 
pathogenesis of different forms of chronic joint inflammation still 
remains to be elucidated. Two extensively used models for studying 
arthritis are antigen induced arthritis (AIA) in mice (1-3) and 
streptococcal cell wall (SCW) induced arthritis in rats (4-6). AIA is 
induced by injection of a highly cationic antigen into the knee joint 
of mice after immunization with the same antigen. Due to the 
electrostatic interaction of these cationic antigens with cartilage, 
the retention of antigen in the joint is high and the resulting 
arthritis is of a semi-chronic nature (1,2). Besides antigen retention 
in the joint, a Τ cell response is obligatory for AIA in mice (7,8). In 
this animal model, the subsided arthritis can be reactivated by 
systemic challenge with antigen. These so called flares have been shown 
to be dependent on local hyperreactivity in the arthritic joints which 
is mediated by retained Τ cells (3,9,10), and might contribute to 
chronicity. If, instead of a cationic protein antigen, SCW are injected 
intraarticularly in mice, roughly the same phenomena are observed 
(11). Injection of SCW into the joints of Lewis rats also induces a 
transient monoarthritis, that can be reactivated by systemic challenge 
with homologous or heterologous cell walls or with bacterial 
lipopolysaccharide (LPS) (12-14). 
When a high dose of SCW is injected intraperitoneally as a sterile, 
aqueous suspension, a persisting polyarthritis occurs in susceptible 
rats (4). It has been shown that bacterial fragments disseminate to the 
joint where they persist for prolonged periods of time. An explanation 
for the discrepancy between the intraarticular and intraperitoneal way 
of administration of SCW with respect to arthritis chronicity might be 
the fact that systemic injection leads to the formation of an antigen 
depot throughout the body. From these depots small amounts of SCW can 
continuously leak into the joint, inducing a perpetuous flare of the 
arthritis and chronic disease is a fact. 
Previous studies on this chronic SCW model show a strong genetic 
correlation only for the chronic phase. After systemic administration 
both acute and chronic polyarthritis occurs after systemic 
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administration of cell walls In susceptible rat strains (e.g. Lewis), 
while in resistant rats (e.g. F344) only an acute, complement dependent 
inflammation is observed (4-6,15,16). Despite ample investigations, no 
differences between the two strains could be detected in distribution 
and clearance of cell walls (6,17), cutaneous inflammatory reactions to 
SCW (16) and SCW-specific antibody responses (1Θ). At present, there is 
convincing evidence for a determining role of Τ cells in chronic SCW 
induced arthritis (19-22) and recent studies from our laboratory 
suggest an important role for SCW-specific Τ cells (19). Lewis rats 
mount "normal" anti-SCW Τ cell responses, while F344 rats are 
completely deficient in this. The unresponsiveness in F344 rats is in 
all probability controlled by suppressor Τ cells (19) and dominance of 
suppression may explain the lack of chronic arthritis in this strain. 
To investigate the hypothesis, that in this rat model chronicity is In 
fact a continuous flare, we compared the susceptibility to these Τ cell 
dependent exacerbations of SCW-induced monoarthritis in Lewis and F344 
rats. 
Materials fi Methods 
Rats 
Female Lewis rats were obtained from Zentral Institut Fur 
Versuchtierzucht (Hannover, Federal Republic of Germany) and female 
F344 rats were obtained from Harlan Sprague Dawley (Indianapolis, USA). 
Both strains were housed in our animal laboratory, were fed a standard 
diet and tap water ad lib. 
Rats weighed 100-125 gram at the start of the experiments. 
Streptococcal cell walls (SCW) 
Streptococcus pyogenes Τ12 were cultured in Todd-Hewitt broth and after 
24 hours the cells were harvested. Cells were disrupted with glass 
beads. The material was subsequently treated with various degrading 
enzymes and sonicated as described (4). Further isolation was carried 
out by differential ultracentrifugation steps as has been described (5) 
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and the resulting 100,000 g pellet was used throughout the 
experiments. This preparation contained 12.8 % muramie acid (23). 
The SCW were kindly provided by Drs.A.J.Severijnen, Dept. of 
Immunology, Erasnus University Rotterdam, the Netherlands. 
Arthritis induction by systemic a(Ministxation of SCW 
To induce a chronic polyarthritis, F344 and Lewis rats were injected 
with SCW (15 iig muramic acid per gram rat body weight) 
intraperitoneally. The arthritis was scored macroscopically, by 
measuring paw thickness with an industrial micrometer and by histology. 
Induction of arthritis by intraarticular injection of SCW 
Unilateral inflammation of the knee joint was induced by intraarticular 
(i.a.) injection of 25 pg SCW (dryweight = 3 pg muramic acid) in 10 μΐ 
phosphate buffered saline (PBS) into the right knee joint of F344 and 
Lewis rats. As a control, an equal volume of PBS was injected into the 
left knee joint. 
Induction of flare up reaction 
An exacerbation of the unilateral arthritis was induced in F344 and 
Lewis rats at several times after arthritis induction as indicated in 
results by intravenous injection of 300 pg SCW (dryweight) in PBS. 
Measurement of joint inflammation 
Arthritis and flare up reaction were measured by the ^""Tc uptake 
method (1). Briefly, rats were anaesthesized with pentobarbital (300 
m9/kg) and 0.2 ml (7.4 MBq/ml) ЭЭпкр,,
 w a s
 administered subcutaneously. 
After 30 minutes the 9 9 mTc uptake in the right and the left knee joint 
was measured by external gamma counting. The uptake of this small 
radioisotope is a measure for local blood flow and edema. The severity 
of inflammation is expressed as right over left ratios and all values 
exceeding 1.10 were assigned as inflammation. 
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Joint inflammation was also scored histologically: knee joints were 
removed in toto and processed for histology as described (2). 7 μ 
sections were stained with hematoxilin and eosin (HSE). Scoring of 
inflammation was done by two independent observers on coded slides. 
Depletion of suppressor Τ cells 
Monoclonal antibody ER3 is a mouse IgG2a directed against the rat CD8 
antigen (24) and thus reactive only with cytotoxic and suppressor Τ 
cells. ER3 was kindly provided by Dr. J. Rozing (Dept.of Immunology, 
TNO-IVBG, Rijswijk, the Netherlands). Monoclonal antibody WT32 is a 
mouse IgG2a directed against the human T3 antigen (25) and was kindly 
provided by Dr. W.J.M.Tax (Dept.of Nephrology, University Hospital 
Nijmegen, the Netherlands). WT32 was used as a control monoclonal 
antibody. ER3 and »Γ32 were cytotoxic to target cells in combination 
with rabbit complement and had a cytotoxic titer (dilution at which 50% 
of maximal lysis was observed) of 1/8000. 
Both monoclonal antibodies were administered to rats by intraperitoneal 
injection of 1 ml of crude ascites once every two days, starting at the 
day of i.a. injection of cell walls. 
To check depletion of suppressor Τ cells, spleens were removed from ER3 
and WT32 treated rats. A single cell suspension was made and 
erythrocytes were lysed. Adherent cells were removed by incubation 
during 60 minutes in plastic petridishes. The nonadherent cells were 
collected and adjusted to a number of 107/ml in icecold PBS + 0.5% 
bovine serum albumin (BSA) + 0.05% №N3 (IF buffer). All subsequent 
steps were carried out on ice. 100 μΐ cells was incubated with 100 μΐ 
of a 1/40 dilution of the following murine monoclonal antibodies: W3/25 
(rat helper Τ cells), 0X8 (rat cytotoxic/suppressor Τ cells) (all 
Seralab) and ER3. A bianco suspension was incubated with 100 μΐ IF 
buffer. After 30 minutes the cells were washed twice with IF buffer and 
incubated with 200 μΐ of 1/50 diluted fluorescein isothiocyanate (FITC) 
conjugated goat-anti-mouse IgG (Nordic, Tilburg, the Netherlands) for 
30 minutes. After three washes, the cells were suspended in 100 μΐ PBS 
and 100 μΐ 2% paraformaldehyde was added. Percentages of positive cells 
were scored by two independent observers on coded slides. 
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Statistical analysis 
The R/L ratios of ЭЭпьр,,
 Uptake were compared statistically by the 
two-tailed Mann Whitney U test. 
Results 
Arthritis in F344 and lewis rats after systemic atfeinistration of SCW 
Figure 1 shows the arthritis measured as the sum of the increased paw 
thickness, induced by intraperitoneal injection of 15 pg muramic acid 
per gram rat body weight. This dose has been proven to be arthritogenic 
in female Lewis rats (19). Lewis rats developed an acute as well as a 
chronic joint inflammation after SCW injection, whereas F344 rats only 
developed the acute phase of the disease. These findings are in 
concordance with the results of others (6,15). 
•SUM OF PAW THICKNESS (MM) 
Figure 1: Polyarthritis in F344 (О - O ) and in Lewis ІИ -A) rats 
induced by one intraperitoneal injection of a sterile aqueous 
suspension of streptococcal cell walls (15 ug muramic acid/gram rat). 
The arthritis is scored by measuring the sum of paw thickness with an 
industrial micrometer. The values are the mean from a group of 5 rats. 
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Arthritis in F344 and lewis rats after intra-articular injection of SCW 
As contrasted with systemic administration, intra-articular (i.a.) 
injection of SCW leads to a transient arthritis (11-13) in the injected 
joint only. It is obvious, that the Lewis as well as the P344 rat 
strain develop a monoarthritis, which is comparable in severity during 
the first week (figure 2). After day 7, however, the arthritis in Lewis 
rats is significantly more chronic than that in F344 rats. This 
tendency can already be observed at day 7, although the difference is 
not statistically significant at that moment. 
H/L RATIO OF 9 % , Tc UPTAKE 
I эо 40 ко 
DAYS AFTER I.A. 
Figure 2: Unilateral arthritis and flare up reaction in F344 (a -A) 
and in Lewis (Ш - Ш ) rats induced by intraarticular injection of 
streptococcal cell walls (3 ug muramic acid). The arthritis is scored 
by determining the ratio of Э^льр,,
 Uptake in the right (arthritic) over 
the left (control) knee joint. A flare up reaction is induced by i.v. 
injection of 300 цд SCW at the times indicated by an arrow. The values 
represent the mean . 
I s.d. from groups of 6 rats. 
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Flare up reactions of unilateral SCW-induced arthritis 
Previous studies from our laboratory have demonstrated that flare up 
reactions of antigen-induced and SCW-induced arthritis in mice are 
dependent on helper Τ cells (3,10,11). There is also ample evidence for 
Τ cell dependence of the chronic phase of arthritis induced by i.p. 
injection of SCW (20-22). The knowledge, that F344 rats don't develop 
chronic joint inflammation (6,15) and that this strain mounts 
immunosuppression rather than help (19) upon injection with SCW, 
provided a rationale for studying flare up reactions in Lewis and F344 
rats. 
The flare up reaction induced by i.V. challenge with 300 pg SCW 
(representative experiment out of 4) is shown in figure 2. Lewis rats 
displayed a clear exacerbation of the joint inflammation, while the 
same phenomenon was completely absent in F344 rats. 
To exclude the possibility, that the observed discrepancy between the 
two strains was due to a difference in background arthritis at the day 
of i.V. challenge, we repeated the experiment. In this case, however, 
we induced a flare up reaction no sooner than when the background R/L 
ratio was 1.10 or less (figure 3). This implicated that F344 rats were 
challenged 21 days and Lewis rats 30 days after i.a. injection. The 
results obtained in this experiment (representative out of 3) are 
similar to that shown in figure 2: again no flare up reaction could be 
induced in the F344 rat, while the Lewis rats went through a severe 
exacerbation. 
In figure 2 and 3 also the R/L ratios of °'mTc uptake in F344 and Lewis 
rats are shown resulting from repeated i.V. challenges with SCW 
(representative experiment out of 4). At least once before each 
challenge the inflammation was measured to be sure that the arthritis 
had waned to a sufficient extent. Despite several i.v. challenges, the 
F344 rat remained "resistant" to exacerbations of the arthritis, while 
repeated flare ups could be induced in the Lewis rat. The third 
reactivation in the Lewis rat, however, seemed of a somewhat lower 
severity than the former two. Figure 4 gives a histological view on the 
flare up reaction in Lewis and the absence of it in F344 rats: a flare 
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_R/L RATIO OF Tc UPTAKE. 
^ 
LEWIS 
Figure 3Î Unilateral arthritis and flare up reaction in F344 and Lewis 
rats induced by intraarticular injection of 3 pg muramie acid 
equivalents of SCW. The inflammation is scored by determining the ratio 
of 99mTc uptake in the right (arthritic) over the left (control) knee 
joint. A flare up reaction is induced by l.v. injection of 300 цд SCW 
at the times indicated by an arrow. The values respresent the mean ± 
s.d. from groups of 6 rats. 
up reaction is characterized by an infiltrate, but more importantly, by 
an exudate which consists mainly of granulocytes. These features are 
rarely seen in a waning arthritis (data not shown). 
Because previous in vitro experiments (19) suggested that the Τ cell 
unresponsiveness to SCW in the F344 rat was regulated by OX8+ cells, we 
depleted this subset in vivo before induction of a flare up reaction by 
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administration of monoclonal antibody ER3. However, despite an almost 
complete (more than 98%) depletion of the suppressor/ cytotoxic Τ cell 
subset from F344 rats, no exacerbation of the SCW-induced monoarthritis 
could be induced in this strain (data not shown). 
Figure 4: Histology of flare up reaction and background arthritis in 
rat knee joints. Staining: H&E. ρ = patella,· js = joint space; f = 
femur. 
A - flare up reaction, F344, magnification 25x 
В - flare up reaction, Lewis, magnification lOOx 
С - idem B, magnification 250x 
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Discussion 
This study was designed to shed some light on the pathogenetic 
mechanism of streptococcal cell wall (SCW) induced polyarthritis in 
rats (4), an animal model which is widely used to study chronic joint 
inflammation. Rats suffering from this disease display a biphasic 
polyarthritis. The acute phase (day 1-3 after intraperitoneal injection 
of SCW) is a systemic illness rather than an arthritis and it has been 
shown to be independent of Τ lymphocytes (20-22) and dependent on 
complement (26). The mechanism of the chronic arthritis (starting after 
day 9) still is a matter of debate. It has been convincingly 
demonstrated, however, that the chronic joint inflammation is a Τ cell 
dependent phenomenon (20-22). Chronic arthritis is only inducible in 
susceptible rat strains, of which the female Lewis rat is the 
prototype; F344 rats are resistant to chronic polyarthritis. 
A factor to which a great deal of importance has been contributed is 
the persistence of SCW in the joint (4,6,16,17). This persistence per 
se, however, can not be sufficient for chronic arthritis, because the 
distribution of cell walls in Lewis and F344 rats is similar (6,17). In 
addition, arthritis induced by intraarticular (i.a.) injection of 5 pg 
SCW is of a transient kind (10-14 days) (12-14), while the amount of 
SCW dissiminated to the joint after i.p. injection of 10 mg is even 
less than 5 tig, but still this causes chronic arthritis. 
It might be relevant for the elucidation of the pathogenetic mechanism 
of the chronic arthritis to investigate the difference with respect to 
chronicity between the systemic and the i.a. model. A possible 
explanation for this disparity can be, that locally injected cell walls 
are not accessible for Τ cells anymore after a certain period (due 
toingestion by macrophages f.i.), while a continuous flow of antigen 
can reach the joint from a much larger pool present throughout the body 
as a result of systemic injection. Renewed influx of SCW into the joint 
can induce Τ cell-mediated exacerbations of the waning arthritis. Due 
to locally retained antigen-specific Τ cells, the joint is in a 
hyperreactive state, which implies, that very minute amounts of antigen 
are sufficient to reactivate the waning inflammation. The potential of 
such a mechanism has been extensively proven by former studies from us 
91 
(3,9-11) and others (13,14). Flare up reactions with SCW as an antigen 
could even lead to more severe joint inflammation compared to those 
induced with protein antigens, because in the SCW model two important 
characteristics of SCW, -immunogenicity and nonspecific inflammatory 
capacities-, can work synergistically. 
One way to put the hypothesis that chronic arthritis is a continuous 
flare to the test is to compare exacerbations of locally induced 
arthritis in F344 and Lewis rats. A rationale for this approach is 
given by the knowledge, that exacerbations are Τ cell dependent 
reactions (11), which can be induced with very small amounts of antigen 
in hyperreactive joints and that Lewis rats can mount a SCW-specific Τ 
cell response, while in F344 rats an immunosuppression occurs instead 
(19). 
The results described in this paper provide several pieces of evidence 
for the existence of the abovementioned pathway. Our results obviously 
demonstrate that only Lewis rats suffered from a chronic polyarthritis 
after i.p. injection of cell walls (figure 1), while both in Lewis and 
in F344 rats a monoarthritis could be induced after i.a. injection of 
SCW (figure 2 and 3). Intravenous challenge with SCW evoked a clear 
exacerbation of the waning arthritis in Lewis rats, but failed to have 
any effect in the F344 rat. This striking difference was seen either 
when a similar background arthritis or the same time lapse after i.a. 
was chosen to determine the moment of i.v. challenge. From figure 3 it 
also becomes evident, that even more frequent i.v. challenges with cell 
walls did not lead to exacerbations in the F344 rat, while the Lewis 
rat went through a flare up reaction after each challenge. These 
findings fit perfectly well within our idea, that repeated influxes of 
antigen into the joint can induce repeated exacerbations, and that 
these, -if they occur within a short period of time-, look like a 
chronic inflammation. The fact that F344 rats are resistant to chronic 
arthritis is explained by these results too: this strain is resistant 
to exacerbations. 
A very intriguing question with respect to the knowledge that not every 
individual is susceptible to arthritis is how this resistance to 
exacerbations (and thus to chronic joint inflammation) is controlled. 
It is a well known fact, that flare up reactions of inflammation are 
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initiated by helper Τ cells (3,9-11). A recent in vitro study from our 
laboratory (19) revealed, that in Lewis rats SCW-specific Τ cell 
responses could be demonstrated at different times (10-90 days) after 
different ways of priming (in saline or oil) with various doses (0.1-10 
mg dryweight) of SCW, as contrasted with the F344 rat, in which severe 
immunosuppression was the result. Depletion of the Τ cell population 
from OX8(+) cells (suppressor Τ cells) in vitro partly overcame the 
immunosuppression in the F344 rat and thus led to a restoration of the 
SCW-specific Τ cell response. 
A logical way to investigate the role of this immunoregulatory subset 
in flare up reactions and, indirectly, in chronic arthritis, was to 
deplete F344 rats in vivo from 0X8(+) cells. But, to our surprise, 
depletion of this regulatory subset from F344 rats did not make this 
strain susceptible to exacerbations. This finding implies a discrepancy 
between our in vivo and in vitro data. Also other studies are not 
always in concordance regarding the biological effect of depletion of 
0X8(+) cells on experimental autoimmune diseases: studies in which a 
clear effect of this depletion on the onset, downregulation or severity 
was observed are known (27-30), but also studies in which no effect of 
0X8(+) cell depletion was seen are described (31,32). 
One explanation for the lack of effect of suppressor cell depletion on 
the susceptibility for exacerbations of the F344 rat might be that the 
measured SCW-specific Τ cell response in the F344 rat in vitro after 
removal of 0X8 (+) cells is still too weak to have any biological 
meaning. In addition, a proliferative response is not the same as a 
biological effect. Another explanation might be that, despite removal 
of one regulatory subset, other subsets might still be present in vivo 
to downregulate Τ cell specific reactions, like in adjuvant arthritis 
where a CD4(+) Τ cell clone A2c has been shown to be capable of 
downregulating or preventing arthritis (33,34). A third option could be 
that, unless a SCW-specific Τ cell response is (locally) present in the 
F344 rat after 0X8 (+) cell depletion, other factors in the F344 
"environment" determine the in vivo observed overall response: for 
instance the level of prostaglandin E (6,35), which is a known 
inhibitor of Τ cell responses, is higher in F344 than in Lewis rats 
after injection of SCW. 
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Taken together, we would suggest the following pathogenetic mechanism 
for chronic polyarthritis resulting from one i.p. injection of 
bacterial cell walls in rats: Immediately after injection of SCW a 
massive complement activation takes place, which is responsible for the 
Τ cell independent systemic illness (acute phase). During the following 
week, a SCW-specific Τ cell response is built in susceptible rat 
strains. If, from the depot of badly degradable cell walls in the body, 
small amounts of antigen perpetuously leak into the joints, repeated Τ 
cell dependent exacerbations occur which then result in chronic 
arthritis. This explains the absolute dependence of the systemic model 
on Τ cells and suggests a manner in which these SCW-specific Τ cells 
contribute to the maintenance of arthritis at the same time. 
Something which remains to be elucidated, however, is the reason why 
injection of bacteria and a subsequent immune response leads to an 
inflammation of primarily the joints, while the antigens are present 
throughout the body. One possibility may be that the continuous bending 
and stretching of joints causes microtraumata, which enhance the local 
influx of SCW. Another explanation might be the recent finding (36,37), 
that bacteria can induce crossreactive anti-cartilage responses in mice 
and rats. This crossreactivity can localize the inflammatory response 
in the joints, while a continuous triggering with bacteria can be 
responsible for maintenance of the autoimnune response in a more severe 
way than could be achieved by cartilage as only antigen. The threat of 
a resulting autoimmune response might be the reason why such 
anti-bacterium responses are under stringent regulation in "normal" 
individuals (e.g. F344 rats), thus resulting in a resistance to 
arthritis, while in "arthritis-prone" individuals (e.g. Lewis rats) 
this regulation is defective and chronic arthritis can easily be the 
result of (continuous) bacterial priming. Host factors determining the 
susceptibility to SCW-induced arthritis are currently subjected to 
further study at our laboratory. 
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SUMMARY 
Although different models for rheumatoid arthnlis have been studied, the pathogenesis in humans 
remains unknown A possible mechanism is thecrossreactivily between bacterial components and the 
target-tissue, the cartilage The existence of this crossreactivity is supported by various data from 
clinical and experimental studies Here we provide direct evidence that pnming in vivo with cell wall 
fragments of Streptococcus pyogenes or Escherichia coll can induce a cellular and humoral anti-
cartilage response in Balb/c mice in vitro Τ cells isolated from these mice can be stimulated in vitro to 
proliferate by a vanety of antigens among which are the pnming baclenum, an unrelated bactenum, 
small bactenal components and diverse antigens of cartilagcnous ongin In bactenum-pnmed mice 
antibodies were also detected that displayed a reactivity to cartilage extract besides the reactivity to 
bacteria A crossreactive response occurred m vwo in certain circumstances a delayed type 
hypersensitivity reaction could be elicited in cell-wall-pnmed mice by challenge with cartilage extract 
For the expression of this crossreactive response in vivo however, it was obligatory to attenuate the 
mouse's suppressor-circuit In this paper we would suggest a mechanism for the pathology of chronic 
arthritis, based on repeated challenges with different bactenal stimuli 
Keywords bactena arthntis crossreactivity to cartilage 
INTRODUCTION 
A single injection of streptococcal cell wall fragments into 
susceptible rats results in a chronic polyarthntis (Cromartie et 
al, 1977) which can also be induced with cell wall fragments of 
Lactobacillus casei (Lehman et al, 1983, 1984) The reason for 
the chromcity and the localization in the joints is not completely 
understood It has been suggested that retention of bactenal 
material in the joint (Cromarne etal 1977, Lehman et al, 1983, 
1984) is fully responsible for both features, but the presence of 
cell wall fragments of L casei in the early, but more important 
also in the later, stages of the disease is not restneted to the 
joints The distribution of cell wall material in diverse organs, 
including the joint, is very similar in susceptible (Lew/N) and 
resistant (F334/N) rats (Lehman et at, 1984) Whether rats with 
a different genetic background could mount different immune 
responses to certain bactenal antigens is at present unclear 
Correspondence M F van den Broek, Department of Rheumato­
logy, University Hospital, St Radboud, Geert Grooteplein zuid 8,6525 
GA Nijmegen, The Netherlands 
This study was undertaken to investigate an alternative 
mechanism, which can provide arguments for both the chrom­
city and the localization in the joints The basis of this 
mechanism is the possible crossreactivity of the immune system 
between bactenal cell walls and cartilage components This 
study has been earned out to test the hypothesis that any 
bactenal stimulus from the environment has the capacity to 
induce an anti-cartilage response which may in certain situa­
tions lead to an arthntis Here we present clear evidence for the 
ability of different bactena to induce a cellular and humoral 
anti-cartilage response in Balb/c mice 
MATERIALS AND METHODS 
Priming of mice 
Female Balb/c mice were pnmed by a subcutaneous injection of 
cell wall fragments of Streptococcus pyogenes, Escherichia coll 
RR1 or ovalbumin emulsified in incomplete Freunds adjuvant 
The respective doses of antigen were I 0 mg glucose-equivalents, 
0 2 mg glucose-equivalents or 0 1 mg 
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Preparation of bacterial cell wall tomponents 
Cell wall fragments of S pyogenes were prepared as described 
previously (Lehman et al, 1983) Cell wall fragments of E coli 
RR I were prepared as follows bacteria were grown in I litre 
flasks for 24 h at 37 C, formalin was added to a final 
concentration of 0 6% and the bacteria were fixed for 24 h at 
room temperature Cells were harvested and washed with PBS 
The pellet was transferred to a mortar on ice and Alcoa-powder 
(Alcoa Chemicals, Aluminium Company of America, no A101) 
was added in portions of 0 5 g to a total of twice the weight of the 
bacterial pellet After adding each portion, the mixture was 
thoroughly pounded When all the Alcoa-powder was added, 
twice the volume of PBS was added in portions of I ml The 
Alcoa-powder and the non-disrupted cells were removed by 
ccntnfugation The material was subsequently cenlnfuged for 
15 mm, 25,000 g The pellet was discarded, the supernatant was 
treated with 250 /jg/ml trypsin type III (Sigma Chemical 
Company, St Louis, Missouri, USA) for 4 h at 37 С The 
resulting material was incubated with bovine serum albumin 
(BSA) to check whether there was no proteolytic activity left If 
this was not the case, the preparation was used for stimulation 
The amount of carbohydrate in both cell wall preparations was 
determined as described by Dubois et al (1956), glucose being 
used as a standard 
Τ cell proliferation assay 
Twelve days after priming, spleens of the mice were removed 
ascptically and a single cell suspension was made The erythro­
cytes were lyscd and Τ cells were isolated by adherence to plastic 
andnylonwool Theelutedcellsconsisledof95%thyl 2positive 
cells (NEU. UK) These cells were resuspended in RPMI 1640 
(Dutch modification) supplemented with 5% heat inactivated 
fetal calf scrum, 10 тм pyruvate, 20 тм glulamme and 50 /jg,ml 
gentamycin (all Flow Labs ) Cells (10s) were placed in the wells 
of a 96-well round-bottomed microlitrcplate with variable 
concentrations of different cartilage components, cell walls or 
control stimuli in a final volume of 0 2 ml After 72 h 1 μΟ JH-
thymidine was added per well and 18 h later the incorporated 
Ή-thymidinc was counted All cultures were done in triplicate 
and pools of four spleens were always used The results of a 
representative experiment arc listed in Table I 
Stimuli for Τ cell proliferation in vitro 
The stimuli were prepared as follows dermatansulphatc-pro-
teoglycan (dspg) was prepared as described by van Kuppeveit et 
al (1988) and was kindly provided by Dr A van Kuppevell 
(Department of Chemical Cytology, Faculty of Science, Univer­
sity ofNijmegen, The Netherlands), N-acclylmuramyl-L-alanyl-
D-isoglutamine (muramyldipeptide) was obtained as synthetic 
MDP from Sigma Chemical Company (St Louis, Missouri, 
USA), chondroitin sulphate (CS) was obtained from BDH 
Chemicals Ltd (Poole, UK), heparan sulphate (Heps) was 
obtained from Seikaguku Kogyo Ltd, Tokyo, Japan, bovine 
cartilage extract (ВСЕ) was prepared by incubating cartilage 
slices for 18 h at room temperature with 8 м guanidiniumchlor-
ide and a subsequent dialysis versus PBS of the supernatant The 
material was further isolated by gclfiltration (Sephadex G200, 
Pharmacia Fine Chemicals) Extraction of cartilage according 
to this method results in a preparation containing proteoglycans 
and glycosaminoglycans, but not collagen The amount of 
glycosammoglycans (gags) was determined by measuring the 
metachromatic shift of dimethyl methylene blue (Farndale, 
Saycrs & Barrett, 1982), rheumatoid synovial fluid (SF-RA) was 
obtained by puncture of a knee joint of a patient with definite 
rheumatoid arthritis the amount of gags being determined as 
mentioned above, the culture supernatant of fresh bovine 
chondrocytes (chondrocyte sup) was prepared as follows 
cartilage slices from a fresh bovine knee joint were incubated at 
37 С for 18 h with 3 mg/ml collagcnasc in RPMI 1640 (Dutch 
modification) The washed cells were put into culture for 6 days 
in a CCb-incubator at a density of 5 χ 105,ml in RPMI + 5% fetal 
calf serum+10 тм pyruvate + 20 тм glutamine-l-50 /¿g/ml 
gentamycin (all Flow Labs) The amount of gags was deter-
mined as mentioned above and the hexosamine content was 
measured as described (Lane Smith & Gilkerson, 1979), ovalbu-
min (OA) was obtained from Sigma Chemical Company (St 
Louis, Missouri, USA), collagen type II (CM) was prepared 
from chicken sternum by salt extraction, lipopolysaccande 
(LPS-B) from Δ coli 055 B5 was obtained from Difco Labs 
(Detroit, MI USA), concanavalin A (Con A) was obtained from 
Flow I abs 
bnzyme linked immunosorbent assay 
Polystyrene flatbottom microlilre plates (Costar, Cambridge, 
MA)wcre coaled overnight with per well 150 μΙ ВСЕ or CS (gag 
content =10 /ig/ml) or cell walls of S pyogenes (carbo-
hydratc = 0 4 ¿ig/ml) To avoid nonspecific binding, the plates 
were subsequently coated with 150 μΙ 1/160 elhanolamine per 
well for 2 h After three washes with washbuffer (PBS + 0 05% 
(v/v) Tween-20) the sera were diluted in 1 % (w/v) bovine serum 
albumin (BSA) in PBS in 2-fold dilutions with a final volume of 
100 μΐ per well After I h of incubation the plates were washed 
five times with washbuffer and were incubated with 100 μΙ rabbit 
anti-mouse Ig (Miles, Elkhart, Ind ) diluted I /500 in 0 5% (w/v) 
BSA in PBS for 1 h After five washes with washbuffer 100 μΐ 
pcroxidase-conjugatcd goat anti-rabbit Ig (Miles, Elkhart, Ind ) 
diluted 1/500 was added After 1 h, the plates were washed and 
incubated with 100 μΐ substrate per well 0 8 mg/ml 5-aminosali-
cylic acid, 0 8 μg/ml 30% H2O г in 50 тм sodium phosphate 
buffer, PH 6 0 The extinction at 450 nm was read after 30 mm in 
a Titcrtck Multiskan (Flow Laboratories) All incubations were 
earned out at room temperature 
Delayed type hypersensitivity reaction 
To test the existence of Τ cells crossreactive to ВСЕ m vii 0 due to 
bactenal pnming, we immunized mice with cell walls of 
S pyogenes emulsified in incomplete Freund's adjuvant (IFA) 
The dose of antigen used was 0 2 mg glucose-equivalents As a 
control, mice were primed with 0 2 mg OA in IFA After 14 days 
the mice were boosted with the same material Seven days after 
the booster injection, mice were challenged by injection of ВСЕ 
(5 μg gag-equivalent) in PBS into the right ear The car thickness 
was measured blindly with an industrial micrometer and 
expressed as right over left ratios To weaken the suppressor 
circuit (suppressor Τ cells), mice were treated 1 day before the 
first antigenic stimulus in one of the following ways total body 
irradiation (dosis 250 or 400 rad = 2 5 or 4 gray) or intraperito­
neal injection of cyclophosphamide (2 or 20 mg/kg body weight) 
(Gill&Liew, 1978) 
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Statistics 
DTH reactions were compared statistically by the one tailed 
Mann Whitney IMest. 
RESULTS 
Γ cell response in vitro 
Table I shows the cellular response of Balb/c mice to different 
cartilage components, cell wall preparations or an irrelevant 
antigen (ovalbumin) Mice were pnmed with cell walls of 
Streptococcus pyogenes or Escherichia coli or with ovalbumin. 
In the case of priming with cell walls, the data were the same 
regardless of the used vehicle; this was either incomplete 
Freunds adjuvant (Table 1 ) or PBS (phosphate buffered saline) 
(data not shown). 
Τ cells from mice, primed with cell wall preparations of 5. 
pyogenes or. E.coli displayed a clear response to a variety of 
cartilage components, both to pure and to crude preparations. 
This indicates lhat reaction of a heterogeneous population of 
bacterium-pruned Τ cells with a wide range of cartilage 
components is possible. When these cells were stimulated with 
the priming bactcnum, a clear proliferative response was seen. A 
response of the same magnitude was also seen when the Τ cells 
were stimulated with an unrelated bacterial species. The stimu­
latory properties of both cell wall preparations were similar 
regardless of the priming bactenum. Two very small compo­
nents present in all (MDP) or in Gram-negative (LPS) bacterial 
cell walls induced a response m bacterium-primed Τ cells The 
cartilage components or extracts: dermatansulphale-proteogly-
can, bovine cartilage extract, heparansulphate, chondroitinsul-
phate and supernatant of a bovine chondrocyte culture are all 
clear stimuli for bacterial cell wall primed Τ cells, their 
effectiveness decreasing in the order listed Collagen type II did 
not induce a proliferative response of bactenum-pnmed Τ cells. 
Τ cells from mice primed with ovalbumin showed no distinct 
proliferation in response to any of the used stimuli with the 
exception of ovalbumin itself. A slight, but a significant, 
response occurred to the synovial fluid. This nonspecific 
stimulation might be due to an IL-2 or IL-1 activity. The latter is 
certainly present in the tested fluids (data not shown). LPS also 
induced a response of OA-primed cells, although again signifi­
cantly less than that of bacleria-pnmed cells. The nonspecific 
response might be caused by monokines released upon LPS 
stimulation. Thus it is clear that none of the tested stimuli is 
mitogenic or has other nonspecific effects on the proliferative 
response with the exception of the above mentioned ones. 
Humoral response 
Mice pnmed with cell walls were bled 21 days after priming Sera 
obtained from mice primed with cell walls displayed an antibody 
response to ВСЕ, whereas sera from OA-pnmed mice did not 
(ELISA Fig 1 ). The same results were obtained when CS was the 
coated antigen (data not shown) Streptococcus pyogenes as well 
as E.coli primed mice showed a humoral response to cell walls of 
S.pyogenes, indicating that at the level of antibodies a crossreac-
live response between different, non-related bacteria exists. 
Crossreactive DTH reaction 
A crossreactive response m vwo can also occur as a result of 
priming with bacteria] components in certain circumstances. 
Mice primed with cell walls of S.pyogenes did not display a 
Table Proliferative response of pnmed munne Τ cells lo van« 
bacterial and cartilage denved antigens 
Antigen (pg/ml) 
Streptococcus pyogenes' 
2 
6 
20 
60 
Escherichia coli* 
2 
6 
20 
60 
MDP 
3 
10 
30 
LPS 
0001 
001 
01 
1 
BCEt 
3 
10 
30 
chondrocyte supf 
6 
20 
dspg 
3 
10 
30 
CS 
10 
30 
HepS 
10 
30 
СП 
100 
300 
SF-RA§ 
1/216 
1/72 
1/24 
1/8 
OA 
100 
300 
Medium 
Con A 
H-TdR χ I(H ct/min incorporated by Τ cells 
pnmed with: 
Streptococcus pyogenes fcchenchia colt 
cell wall 
12 
20 
2-6 
5-5 
16 
24 
3 1 
50 
1-5 
19 
30 
14 
19 
34 
55 
17 
2-5 
30 
16 
28 
1-5 
26 
65 
I 7 
30 
1<6 
21 
09 
07 
13 
2-6 
29 
35 
09 
07 
08 
154 
cell wall OA 
12 10 
2-2 0 9 
2-9 0 9 
51 0-9 
1-9 0-6 
3-9 0 8 
4 5 0-8 
6-5 0-6 
12 09 
20 10 
32 12 
12 06 
20 2 1 
2-2 2 1 
50 2 2 
1-2 0-5 
21 0 6 
2-6 0-7 
M 06 
1-9 0-6 
16 0-7 
30 08 
4-9 0 8 
1-7 0-8 
25 08 
1-6 0-8 
1-9 0-7 
0 7 0-4 
0-7 0-5 
10 07 
19 10 
30 10 
41 13 
0-6 2 9 
0 8 6-5 
06 0 6 
150 16 5 
* With respect to total carbohydrate 
t With respect to gag content 
X With respect lo gag content; the amount of hexosamtnc in 
undiluted material was 2 /jmol/ml 
§ Dilution, the amount of gag in undiluted SF was 30 μg/ml 
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Dilution 2 
Hg I (a) Humoral anli BCF response in mice primed 21 days before with cell walls of 5 pyogenes^ · ) and £ coli (* *)orwith 
ovalbumin (O O) (b) Humoral response against cell walls of 5 pyogenes in mice primed 21 days before with cell walls of 
5 pyogenic ( · · ) and E colt (* *) or with ovalbumin (O O) 
crossreacive DTH reaction under normal conditions, but when 
the suppressor cells were attenuated by low doses of cyclophos­
phamide (2 mg/kg) (Gill & Liew, 1978) or total body irradiation 
(250 rad), a crossreactive response occurred in cell wall-pnmcd, 
but not in ovalbumin-pnmcd, mice The blindly measured ratios 
did not show a big difference between the treated group 
(I 11 +0 05 for cyclophosphamide and 1 12 + 0 08 for irradia­
tion) and the control group ( I 04 + 0 04), but the difference was 
statistically significant (P<0 03) A higher dose of cyclophos­
phamide or irradiation suppressed the DTH reaction again, 
probably by an effect on helper circuits 
DISCUSSION 
Here we show that baderai stimuli can induce an unwanted 
crossrective autoimmune response in addition to the normal 
defensive anti-bacterium response This crossreacting anti-
cartilage response occurred both at the cellular and at the 
humoral level as was measured m vitro by an antigen-induced 
proliferative response of isolated Τ cells and an ELISA, 
respectively For expression of the crossrecling response in υκιο 
however, it was obligatory to attenuate the suppressor-circuit of 
the mouse before pnming That attenuation of this circuit is not 
necessary when this Τ cell response in vitro is considered may 
indicate that the system in vitro is more sensitive, or that it lacks 
cells or mediators which are present in vivo For instance 
macrophages, which have been removed before Τ cell stimula­
tion m Miro, are able to mediate suppression of Τ cell responses 
This effect can either be mediated by release of prostaglandins or 
by activation of suppressor cells (Allison, 1978, Ptak et α/, 
1978) Moreover, activation of suppressor cells may display 
other kinetics in vivo and in vitro 
Expression of anti-cartilage response in vivo is not enough to 
induce an arthritis however mice which developed an anli-
carlilage DTH response after bacterial pnming (with foregoing 
attenuation of the suppressor-circuit) did not display any 
abnormality in the joints at all It is possible that, in addition to 
an immunological anti-cartilage response, a sensitization of the 
joints is a prerequisite for arlhntis This is in all probability a 
potentiating factor in one of the animal models for arthritis, the 
streptococcal cell wall induced arthntis In this model, bactenal 
material has been demonstrated in the joints after an intraperi­
toneal injection ofit (Cromarne et al, 1977, Lehman et al, 1983, 
1984) In our study however, the amount of bacterial cell walls 
injected was 10 times less (corrected for the animal weight) than 
in the rat model, so this could be a limiting factor when 
sensitization of the joints is considered Another difference with 
the rat model is the route of administration for the DTH 
reaction, cell wall material was given to mice emulsified in 
incomplete Freund's Adjuvant, so the immune system is 
continuously tnggered by relatively low doses of antigen, while 
in the rat model the immune system is bombarded with 
enormous amounts of antigen at one time The latter causes 
serious systemic effects (Hunter et al, 1980, Ridge et al, 1986), 
probably also affecting the immunoregulatory properties This 
tould then lead lo a more vehement expression ofthe inflamma­
tory reaction 
If mice are more effectively protected against autoreactive 
responses than rats—by a better suppressor-circuit for 
instance— it could be necessary to eliminate suppressor cells by 
stronger means for arthritis to occur due to the presence of anti-
cartilage responses Factors which influence the expression of 
arthritis in this model are currently subjected to further study in 
our laboratory 
In this study we provide direct evidence for the suggestion 
that bactenal stimuli can result in an anti-cartilage response 
Pointers to a role for bacteria in human arthritis can amply be 
found First, streptococcal infections have been shown to give 
nse to acute rheumatic fever (Cantazarro et al, 1954) Second, 
the reported cases of postdysenteric Reiler's syndrome (Calter-
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all, 1976) and arthritis associated with jejunal bypass surgery for 
obesity (Utsinger, 1980) suggest a role for gastroenteric bactcna 
in the induction of arthritis Third, in patients with rheumatoid 
arthntis, Τ cell reactivity to M tuberculosis has been reported 
(Holoshitz el al, 1986) This Τ cell reactivity was specific for 
mycobacteria and was merely found in the synovial fluid during 
the first year of disease, between the second and tenth year 
mainly in the peripheral blood and after ten years of disease not 
in either compartment 
The widely used model for rheumatoid arthritis, the adju­
vant arthritis in rats (Pearson, Waksman & Sharp, 1961), 
provides evidence for the crossreactivity between bacteria and 
cartilage This disease can be transferred with lymphocytes 
(Pearson & Wood, 1964) and even by a Τ cell clone, reactive to 
Mycobacterium tuberculosis (Holoshitz el al, 1983, 1984) The 
clone only induces an arthritis in recipient rats after irradiation 
of the animal, the same condition of the recipient is necessary for 
crossreactivity between the clone and osteoarthntic synovial 
fluid or chondrocyte supcrnatants to occur in ы о (van bden el 
al, I98S) This illustrates the importance of crossreactivity an 
arthritis can only be accomplished if the conditions arc suitable 
for crossreactivity Also in streptococcal cell wall induced 
arthritis, Τ cells are of utmost importance it has been shown 
that only the acute but not the chronic phase of the disease can 
be induced in nude rats (Ridge et al, 1985) The chronic phase of 
the disease is dependent on (crossreacting1) Τ cells, whereas the 
acute response is not and thus is possibly a nonspecific reaction 
These facts may imply that cell-wall-induced arthntis and 
adjuvant arthntis share similar pathogenic pathways, the only 
difference being the bactenum used as a stimulus That different 
bactena can lead to arthntis in expérimental animals has also 
been shown in the rabbit with E coli and Bacillus subnlis 
(Hanglow et al, 1986), and in the mouse with Nocardia ssp , 
Lactobacillus plantarum Staphylococcus epidermis and Strepto-
coccus mutans (Koga et al, 1985) 
Also on the level of antibody responses reactivity to bacterial 
components is demonstrated in patients with vanous rheumatic 
diseases (Pardo et al, 1984, Burgos-Vagas et al, 1986, Johnson 
et α/, 1984) The antibody levels to peptidoglycans were most 
obvious at the time of onset of the disease (Pardo et al, 1984, 
Burgos-Vags, Howard & Ansell 1986), which might be a pointer 
m the direction of bactena or bacterial components as an 
inductory agent in the pathogenesis of rheumatic diseases 
Additional facts of evidence for the existence of crossreact-
ing epitopes on bacteria and proteoglycans or glycosaminogly-
cans are provided by the following observations sera from 
patients with post-strcptococcal glomerulonephritis have been 
shown to contain antibodies reactive with glomerular basement 
membrane heparan sulphate proteoglycan (Mill et α/, 1985) 
Support for the possibility that this could be due to cross 
reactive antibodies is given by the finding that murine hybndo-
mas reactive to streptococcal cell walls crossreact with glomeru­
lar basement membrane (a structure in the kidney, like the joint 
very neh in glycosammoglycans) in vivo and ui vwo (Fritz-
simons, Weber & Lange, 1986) 
Taken together, our data and the studies of others provide 
suggestive evidence for a mechanism for the pathology of 
arthritis If an individual passes through a (subclinical) bacterial 
infection, he will mount an ¿nti-bactenum immune response in 
defence As becomes clear from our data, this anti-baclcnum 
response can display an autoimmune character by reacting with 
vanous cartilage components both at cellular and at humoral 
level This crossreacting response will in all probability need 
some aberrant conditions (defective suppression or feedback 
mechanisms) lo come to full expression and to give nse to joint 
lesions 
We also show that a response induced by one bacterial 
species can be reactivated by another non-related species or even 
by small common baclenal components like LPS (a cell wall 
structure of Gram-negative bactena) and M DP (a cell wall 
structure of almost all bactena) The latter can have important 
consequences for the maintenance of the arthritis once an anti-
bactenum response—and thus an anti-cartilage response—is 
induced by one bactenum, any other invading species or its 
degradation product is able to reactivate not only the anti-
bactenum but also the anti-cartilage response These reactiva-
tions of the anti-cartilage response by (subclinical) infections 
with bactena from the environment or the individual itself 
(gastrointestinal tract) can give rise to (subclinical) exacerba-
tions of the inflammation Exacerbations could also be 
mediated by auto-antigcn, released as a result of cartilage 
damage Repeated flares of the arthntis thus can lead to 
chromcity 
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CHAPTER 7 
CROHN'S DISEASE ASSOCIATED WITH ARTHRITIS: A POSSIBLE ROLE FOR 
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OF ARTHRITIS 
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Introduction 
Several studies have suggested bacterial involvement in both 
experimental and human arthritides (1-8). In addition, the existence of 
epitopes on bacteria which induce immune responses crossreactive with 
cartilage epitopes has been described (9-11). The pathogenetic 
significance of this crossreactivity, however, is at present unclear. 
An important argument for the latter would be preferential presence of 
lymphocytes reactive with both bacterial and cartilage epitopes in 
inflamed joints. Here we present studies on the proliferative responses 
to antigens of bacterial and cartilaginous origin of mononuclear cells 
obtained from synovial fluids (SF) and peripheral blood of a woman with 
enteropathic arthritis. 
Materials and Methods 
The patient involved in this study was a 41-years old woman who was 
diagnosed for Crohn's colitis in 1974. She was treated with prednisone 
and sulphasalazine. From the onset of gastro-intestinal complaints she 
had also arthralgias of knees, elbows, ankles and several finger 
joints. Since 1981 there were episodes of arthritis often synchronous 
with exacerbations of colitis. Bacterial cultures of blood and synovial 
fluid were repeatedly negative as so were serologic tests (Rose-Waaler, 
Latex-fixation and antinuclear antibody). In 1986 a total hip 
prosthesis was placed because of severe dysfunction and destruction. On 
november 5, 1986 the patient was seen because of bilateral knee 
arthritis. Puncture of the right knee yielded 30 ml of yellow fluid 
containing 29,800 leukocytes/mm^, with 91% polymorphs and 9% 
mononuclear cells, λ corticosteroid injection led to amelioration of 
arthritis. On november 28, 1986 the left knee was aspirated yielding 35 
ml yellow fluid with 18,400 leukocytes/nun·', with 90% polymorphs and 10% 
mononuclear cells. 
Mononuclear cells were isolated from synovial fluids obtained at 
november 5 and 28, 1986 as well as from blood taken at the same times 
by centrifugation using a Ficoll-Hypaque density gradient. Control 
mononuclear cells were obtained from the blood of 5 healthy persons. 
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Mononuclear cells were cultured (10° cells/ml) in microtiterwells in 
RPMI 1640 dutch modification supplemented with 5% fetal calf serum, 10 
mM pyruvate, 20 mM glutamine and 50 pg/ml gentamycine (all Flow 
Labs.). To the cells various antigens of bacterial or cartilaginous 
origin were added. As a positive contol the mitogen Concanavalin A was 
used. After 3 days of culture (37<>C, CC^-incubator) , 37 χ IO4 Bq 
(1 μΟϊ) 3H-thymidine was added per well. After 16 hours, the 
incorporated radioactivity was determined as a measure for the 
proliferative response of the cells. All cultures were done in 
triplicate. 
The following antigens were used to stimulate mononuclear 
cells: DSFG (dermatansulfate proteoglycan) (12); MDP (muramyldipeptide) 
a small compound present in cell walls of all bacteria (Sigma 
Chemicals); CS (chondroitin sulfate)(Sigma Chemicals); CII (collagen 
type II) isolated from chicken sternum by salt extraction; 
OVA (ovalbumin)(Sigma Chemicals); ECU and BCW cell walls of Escherichia 
coli and Bacillus megaterium, respectively prepared by disruption of 
the cells with Alcoa powder (Alcoa Chemicals, the Aluminum Company of 
America) in a mortar. The disrupted cells were isolated by 
centrifugation (15 minutes, 25000 χ g): the supernatant was always 
treated with trypsin (250 pg/ml, 4 hours, 370C) before use. The amount 
of carbohydrate was determined as described (13); SCW (Streptococcus 
pyogenes cell walls)were prepared as described (14); ConA (Concanavalin 
A) was used as mitogen. 
Results 
The results of these experiments are listed in table 1. It is shown 
that the proliferative responses of mononuclear cells obtained from the 
left and the right knee joint were similar. There was no significant 
uptake of radioactivity in response to medium, collagen type II or 
ovalbumin, indicating that the cells were not polyclonally activated in 
the joint. There was a definite proliferative response to various 
cartilage antigens and cell walls of both Gram-positive and 
Gram-negative bacteria, the response to the latter group was more 
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Table 1: Proliferative response of mononuclear cells of a patient with 
Crohn's disease associated with arthritis to various stimuli 
of bacterial and cartilaginous origin. 
Ή-thymidine incorporated (cpm) 
stimulus, »g/ml SF l e f t* S F r i g h t PB PBcontrol 
DSPG 
CS 
C U 
ECW 
BCW 
sew 
MDP 
OVA 
ConA 
100 
20 
100 
20 
250 
100*** 
20 
100*** 
20 
100*** 
20 
20 
250 
5 
medium 
5740 
4486 
8970 
5203 
3049 
18474 
6995 
18764 
9011 
11840 
6458 
8791 
2719 
39820 
3229 
ND** 
ND 
8123 
4659 
2656 
18052 
6396 
18799 
11104 
7986 
6520 
9254 
2284 
37950 
2976 
2246 
1309 
1200 
1056 
1074 
2971 
1064 
1760 
1274 
1195 
1094 
993 
1088 
38886 
1203 
1087 
1054 
986 
1039 
1027 
1194 
1038 
997 
1083 
1074 
1038 
1184 
1274 
37626 
1174 
* SF=synovial fluid cells; PB=peripheral blood cells; control=mean of 5 
normal donors. 
** ND=not done 
*** carbohydrate equivalents 
pronounced, however. Peripheral blood mononuclear cells of the patient 
only reacted, albeit to a low extent, to high concentrations of ECW and 
DSPG. Control mononuclear cells did not respond to any of the used 
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Stimuli except for the mitogen (mean values of 5 controls are shown), 
implying that none of the used stimuli was a polyclonal activator. 
That the observed differences between reactivity pattern of SF and PB 
mononuclear cells was due to variations in cell subset composition of 
the populations was excluded by FACS (fluorescence activated cell 
sorter) analysis: all populations tested contained the same amount of 
T4-, T8- and T3-positive cells and the same amount of В cells and 
monocytes (data not shown). 
Discussion 
Crohn's disease is a granulomatous form of enteritis, in which 
increased degradation of the intestinal flora takes place. The degraded 
bacteria will be removed partly in the stool, but probably also a part 
will enter the circulation, thus continuously triggering the inmune 
system. This inflammatory bowel disease is often associated with 
arthritis of varying severity. The reason for this association is not 
known, but our observation that mononuclear cells with a reactivity to 
bacteria are preferentially present in the joint of a patient with 
Crohn's disease associated with arthritis suggests the involvement of 
these cells in the arthritogenic process. An explanation for the 
underlying mechanism could be the crossreactivity of the immune 
response between cartilage and bacteria (9-11): we have described (10) 
that triggering of mice with SCW or ECW induces a humoral and a 
cellular anti-cartilage response. In addition, we showed that a Τ cell 
response against cartilage induced by one bacterium can be reactivated 
by an unrelated one. This might explain the preferential presence of 
bacterium-primed mononuclear cells in the joints of this patient: it is 
the place where crossreactive antigenic material is amply available in 
the form of cartilage or, in later stages, degradation products 
thereof. Bacterium- (and thus cartilage-) reactive Τ cells pass by 
during circulation and may be trapped in the joint in an 
antigen-specific way. 
These data tempt us to suggest the following mechanism as a possible 
way to explain the existence of certain forms of chronic arthritis: An 
individual who expierences a bacterial infection, -which might be an 
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unnoticed one-, will mount an immune response against the infecting 
agent. Due to the similar structure of bacterial cell walls and 
cartilage proteoglycans, this defensive immune response might display 
some unwanted, autoimmune characteristics through a reactivity against 
cartilage components. This crossreactive autoimmune response will need 
some aberrant conditions of the individual to come to full expression, 
such as a certain MHC haplotype, joint trauma or a defective 
suppressor/feedback circuit or a combination thereof. An arthritis 
induced by bacteria can be reactivated by each subsequent triggering by 
another (unrelated) bacterium or by cartilage components released after 
joint damage and thus become chronic. As, to our opinion, Τ cells play 
an important role in this autoimmune response, the same cells might be 
of utmost importance for chronicity of arthritis. 
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FINAL CONSIDERATIONS 

FINAL· CONSIDERATIONS 
Rheumatoid arthritis is the prototype of chronic joint inflammation 
(arthritis) of unknown etiology is a. systemic disease with as most 
eye-catching manifestation a chronic inflammation of the joints. This 
chronic joint inflammation is composed of subsequent remissions and 
exacerbations. Despite a wide array of clinical and experimental 
studies, the explanation why RA is a chronic disease and why it is 
mainly localized in the joints is still a matter of debate. 
Theoretically, chronic inflammation is the result of a continuous 
stimulus, which can be in the form of a perpetuous supply of antigen in 
the circulation or in the form of persisting antigen in the joint. The 
antigen can persist in the joints because of trapping in immune 
complexes or, in the case of a cationic antigen, due to electrostatic 
interactions with the negatively charged cartilage (2-4). Regarding the 
joint as the target for chronic inflammation, it is also possible that 
structures in the joint itself (collagen type II, proteoglycans) behave 
like persisting antigens, the arthritis thus being the result of an 
autoimmune response. This assumption becomes of more physiological 
relevance if immune responses to the joint are initiated by an 
exogenous stimulus, because of the existence of structural mimicry 
between the joint and that stimulus. If autoimmunity as a result from 
crossreactivity is involved, we are walking on the slippery ground of 
the immunological regulation of tolerance. In the course of this 
chapter possible mechanisms for chronicity of joint inflammation will 
be proposed and several pieces of evidence for the involvement of 
crossreactive immune responses and defective tolerance in chronic 
arthritis will be presented. 
The importance of antigen persistence in the joint with respect to 
chronicity is amply shown in a murine model for arthritis, antigen 
induced arthritis (AIA) (1-12). It has been shown in this (7-12) and 
other models (13-16) that the presence of antigen in the circulation 
can lead to an exacerbation of a subsiding arthritis. A continuous 
presence and thus a continuous influx of antigen into the inflamed 
joint might be responsible for chronicity. 
Understanding of the mechanism of flare up reactions thus may 
contribute to the understanding of chronicity and the resulting joint 
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damage. The susceptibility of a joint to flare up reactions depends on 
a hyperreactive state of that joint (7-11,15,16), because nanogreun 
quantities induce a flare up reaction when injected into a previously 
inflamed joint, while the same amount of antigen injected into a naive 
joint of the same animal does not result in an acute inflammation 
(7,8). Because pretreatment of mice with antilymphocyte serum (ALS) 
(9,15) or haplotype-specific monoclonal anti-I-A antibodies (11) 
completely supresses the flare up reaction, it is likely that the 
abovementioned hyperreactivity is caused by antigen-specific Τ cells, 
which are retained in the inflamed joint (9,11,15). Arthus-like 
phenomena don't seem to be of importance, because complement depletion 
has no effect on exacerbations (9). Flare up reactions may contribute 
to pain and joint damage, because exacerbations are in fact acute 
inflammations which are superimposed on the waning chronic one. Acute 
inflammation is characterized by an infiltrate and exudate of 
polymorphonuclear leucocytes (PMNs) and macrophages which are 
disreputable of their capacity to damage a variety of tissues, among 
which cartilage, by the release of lysosomal enzymes (17-19), reactive 
oxygen species (20-22) and other inflammatory mediators like 
interleukin-1 (IL-1) (23,24). 
As stated above, the induction of reactivations of joint inflammation 
has to be a perpetuous process for chronicity. Therefore, the relevant 
stimulus has to be continuously, or at least intermittently present in 
the circulation and/or the joints. A stimulus which meets this 
criterium is a bacterium: it is ubiquitously present exogenously as 
well as endogenously. Moreover, there is ample suggestive evidence from 
clinical observations that bacterial infections and arthritis are 
somehow related: arthritis is associated with streptococcal infections 
of the throat (acute rheumatic fever) (25), frequently associated with 
infections of the gastrointestinal or urinary tract (Reiter's syndrome, 
reactive arthritis) (26,27), jejunal bypass surgery for obesity, -in 
which a blind loop of the jejunum is formed, often resulting in 
bacterial overgrowth (28)-, and inflammatory bowel diseases, like M. 
Crohn (29). In addition, the existence of a variety of animal models in 
which (chronic) arthritis is induced by injection of bacteria (30-36) 
suggests the causal relationship of joint inflammation with bacterial 
infections. 
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Despite intensive research on the mechanisms of the various bacterial 
arthritis models during the last two decades, the pathogenesis of these 
experimental arthritides is not completely understood. Most animal 
models use killed bacteria or cell wall fragments thereof as a stimulus 
(30-33,35,36), but one model has been described so far which uses live 
Yersinia enterocolitica organisms to induce chronic polyarthritis in 
rats (34). In the latter model, the susceptibility for arthritis 
correlates well with the inability of the host to remove the bacteria. 
In this disease, which serves as a model for reactive arthritis, no 
bacteria could be cultured from the joints. The reason for the 
preferential expression of the disease in the joints still has to be 
elucidated. 
The oldest bacterial arthritis model is adjuvant arthritis (30). 
Adjuvant arthritis (AA) is induced by an intradermal injection of 
killed Mycobacterium tuberculosis organisms in oil (0.1 mg/rat). After 
approximately 14 days, a polyarthritis develops in susceptible rat 
strains (e.g. Lewis rat) which subsides after another 3-5 weeks. After 
this period, recovered rats are resistant to another, subsequent 
arthritis induction with M.tuberculosis in oil (37). Later, it was 
shown that other bacteria, like Nocardia asteroides or Corynebacterium 
rubrum, could substitute for M.tuberculosis (38,39). In the early 
ТЭбО'з the general way of thinking was that the bacterial stimulus 
itself was obligatory for the disease to develop (40), but a few years 
later it became obvious that the arthritis was transferrable with 
primed lymphocytes (41), suggesting that responses against 
self-determinants might be involved. Indeed, immune reactivity to joint 
antigens was detected (42). About one decade later, Cohen and 
colleagues isolated a Τ lymphocyte line from an arthritic Lewis rat, 
denoted A2, which could transfer disease into severely irradiated Lewis 
rats (43-47). These experiments provided ultimate proof for the 
involvement of anti-self reactions. The same cell line was also able to 
vaccinate against AA, meaning that rats were resistant to the active 
model after recovery from the passively induced arthritis (44,45). 
Subsequent studies showed that the A2 line consisted of a helper Τ cell 
clone (A2b) which could induce but not vaccinate against AA, and of a 
so-called suppressor/inducer Τ cell clone (A2c) which could vaccinate 
against but not induce AA (44). Besides the known and expected 
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reactivity against M.tuberculosis, the A2b clone displayed a reactivity 
against cartilage proteoglycans in vitro and, if the recipients were 
severely irradiated, also in vivo (46). This implies, that the 
conditions under which A2b induces an arthritis and displays 
crossreactivity with the target-tissue in vivo are similar! Recently, 
the protein (65 kilodaltons) of M.tuberculosis to which A2b and A2c 
respond has been cloned and a relevant nonapeptide has been identified 
(47). It has been demonstrated that vaccination against AA can also be 
carried out by this protein (48, own unpublished results) and that the 
65 kd protein is an ubiquitous protein (present in all bacteria) (49). 
The latter finding might have important consequences when reactivations 
of a bacterial arthritis are considered. 
A third model for bacterial arthritis, streptococcal cell wall (SCW) 
induced arthritis in rats, has been described for the first time in the 
late Ì970's (31). This model is based upon the intraperitoneal 
injection of a sterile, aqueous suspension of cells or cell wall 
fragments from group A streptococci. Injection of the badly 
biodegradable material results in an acute systemic illness together 
with a swelling and redness of the joints. This acute phase occurs 
after 2-4 days and has been shown to be dependent on massive activation 
of complement (50). The acute inflammation wanes after 7-10 days and is 
followed in susceptible rat strains (e.g. female Lewis, Sprague Dawley) 
by a chronic erosive joint inflammation which can last for months, 
while in resistant rats (e.g. Fisher) no chronic arthritis could ever 
be observed (31,50,52-54). The chronic disease manifests itself also by 
granuloma formation in liver and spleen (31,62). 
Despite numerous investigations on the mechanism of this arthritis 
model, the reason why Fisher (F344) rats don't develop a chronic 
arthritis remained obscure until very recent (16,66). Early studies 
were undertaken mainly to investigate, -or better put: to confirm-, the 
role of persisting bacterial antigen in chronicity. Indeed, treatment 
of Lewis rats with an enzyme which degraded the cell wall material, 
mutanolysin, had a beneficial effect on the course of the disease (56) 
and also chemical modification of the cell walls leading to a better 
degradability resulted in a less severe and less chronic disease 
(64,65). But on the other hand, these findings did not explain the 
observed differences in susceptibility to chronic arthritis between 
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Lewis and F344 rats. Comparison of persistence of streptococcal cell 
walls in Lewis and F344 rats (51,57) showed no difference at all. In 
addition, when nonspecific inflammatory reactions to streptococcal cell 
walls were measured in both strains, again no differences were 
detectable (54,55,58). These findings imply that in resistant F344 as 
well as in susceptible Lewis rats antigen persistence and nonspecific 
reactions to that material are comparable and are thus not the 
factor(s) to determine whether an arthritis occurs or not. An important 
step in the elucidation of the pathogenic mechanism was the observation 
that chronic arthritis was not inducible in nude (nu/nu)(athymic) Lewis 
rats (59): a crucial role for Τ lymphocytes was proven. Later studies 
provided more evidence for the involvement of Τ cells in the chronic 
pase of the arthritis: it was shown that cyclosporin A inhibited the 
chronic joint inflammation (61), that the streptococcal cell wall 
induced arthritis and hepatic granuloma formation were dependent on the 
presence of a thymus in recipient Lewis rats (62) and, finally, that 
Major Histocompatibility Complex (MHC) Class II (la) expression in the 
synovia was dependent on the presence of a thymus and coincided with 
joint inflammation (63). In the same study it was also shown that 
treatment with cyclosporin A abrogated the chronic arthritis and, 
simultaneously, the la expression in the joint. Together these studies 
(59-63) suggest a tight relationship between the functionality of 
helper Τ cells and the expression of chronic arthritis in the Lewis 
rat. A puzzling observation in this context is that injection of 
streptococcal cell walls resulted in a deficiency for the autocrine Τ 
cell growth factor interleukin 2 (60). This defect was observed in both 
F344 and Lewis rats, so it is possible that this is a nonspecific 
result from cell walls. 
The difference between Lewis and F344 rats with respect to arthritis 
susceptibility might be explained by our recent observation (66), that 
Lewis rats mount a normal streptococcal cell wall-specific Τ cell 
response after various ways of priming with cell walls, while the same 
treatment results in a situation of complete unresponsiveness in F344 
rats. This unresponsiveness was shown to be a direct result of priming 
with cell walls and not a general defect of the immune system in this 
strain: Immunization with a protein (ovalbumin) induced a cellular 
anti-ovalbumin response in the F344 rat which was comparable to that in 
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the Lewis rat, but co-immunization with ovalbumin and SCW 
induced besides the suppression of the anti-SCW response also a 
suppression of the anti-ovalbumin response in the F344 rat. Adherent 
cells from both SCW-primed Lewis and F344 rats were able to suppress 
the SCW-specific response of Lewis Τ cells and F344 adherent cells were 
more potent in this. This adherent cell-mediated suppression was not 
due to prostaglandin production of this population, -prostaglandin 
being a known inhibitor of Τ cell responses-, because addition of 
indomethacin did not reverse the inhibitory effect. Removal of OX8+ 
cells (suppressor/cytotoxic Τ cells) in vitro led to a partial 
restoration of the SCW-specific Τ cell response in F344 rats after SCW 
priming. These data suggest that in the F344 rat an immunological 
unresponsiveness or tolerance exists which is at least partly mediated 
by suppressor Τ cells. The existence of immunological 
low-responsiveness to this material has been described in humans (67) 
and also in this species the low-responsiveness was dependent on the 
presence of Τ cells with the suppressor phenotype. Another argument 
supporting the determining role of SCW-specific Τ cells in the chronic 
phase of SCW arthritis comes from our recent data on flare up reactions 
of monoarthritis in F344 and Lewis rats (16). In this study we induced 
a monoarthritis by injection of SCW into the right knee joint of naive 
rats. This monoarthritis occurred in Lewis and F344 rats and waned 
within three weeks (13-16). The fact that also in resistent F344 rats 
an arthritis occurred is not surprising, because nonspecific 
inflammatory reactions to SCW have been shown to be comparable in both 
strains (54,55,59). The waning was in agreement with our hypothesis, 
that chronic arthritis is nothing but a continuous exacerbation: 
because no systemic SCW depot is present in the i.a. model from which a 
perpetuous flow of antigen can enter the circulation, no flares occur 
and thus no chronic arthritis is observed. We tried to prolongate the 
arthritis by systemic challenge with SCW after waning (thus inducing 
flares) to provide evidence for the involvement of SCW-specific Τ cells 
in chronic arthritis, because it is an accepted fact that flare up 
reactions are dependent on antigen-specific Τ cells (9,11,15). We 
observed that in Lewis rats a flare up reaction, which lasted 
approximately 7-10 days, occurred after every SCW challenge while in 
F344 rats such reactions were never observed. This fits perfectly well 
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in our earlier observation, that F344 rats are defective in building an 
SCW-specific Τ cell response and that this unresponsiveness is 
regulated by suppressor Τ cells (66). Together, the abovementioned data 
give suggestive evidence for the crucial role of repeated reactivations 
mediated by renewed antigen influx and SCW-specific Τ cells in the 
chronic phase of SCW arthritis in Lewis rats. 
An important question which has remained unanswered until now is why 
the disease resulting from i.p. SCW injection manifests itself mainly 
as an arthritis, while the stimulus is present throughout the body in 
the form of SCW. One explanation might be that bacteria show some 
structural homology with cartilage and that this homology is reponsible 
for an autoimmune anti-cartilage response induced by bacteria besides 
the normal anti-bacterium response, thus directing the disease to the 
joints. There are several observations supporting this: the 
M.tuberculosis-specific Τ cell clones A2b and A2c respond to cartilage 
proteoglycans (47,48), Τ cells isolated from the synovial fluid of a 
patient with M.Crohn associated with severe arthritis react to 
Escherichia coli. Bacillus-species, S.pyogenes and to cartilage 
proteoglycans (29). In addition, our recent studies show that 
inmunization of mice or Lewis rats with S.pyogenes or E.coli results in 
a cellular and humoral immune response against both Grain(+) and Gram(-) 
bacteria and various antigens from cartilaginous origin (68). 
Considering humoral crossreactivity, there is also ample evidence 
supporting its existence: post-streptococcal glomerulonephritis sera 
contain antibodies against glomerular basement membrane (GBM) 
proteoglycans (69) and murine monoclonal anti-streptococcus antibodies 
react with GBM in vivo and in vitro (70,71) and finally, in sera from 
patients with various rheumatic diseases antibodies to bacterial 
peptidoglyeans which presumably crossreact with cartilage have been 
demonstrated (72-74), again suggesting a causal relationship between 
bacteria and arthritis. 
Because reactivity to self-antigens is by definition an unwanted 
phenomenon, it is desirable and expected that the regulation of these 
responses is very stringent. This might explain the absence of 
measurable (crossreactivel) cellular anti-SCW response in the F344 rat 
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(66) and the low-reponsiveness in some humans (67). In this context, 
the F344 rat should be considered as the "normal" individual, while the 
Lewis rat represents the autoimmune-prone individual. That some truth 
might be in this statement comes from the knowledge that almost all 
experimental autoimmune diseases are inducible in the Lewis rat, and 
often in the Lewis rat only (30,31,75-78)1 
One way to prevent the reactivity against self-determinants is 
tolerance to these structures. Tolerance to self-antigens is induced 
immediately after birth and the state of tolerance seems to be 
maintained by suppressor Τ cells (79-Θ1). That immunological tolerance 
might be an explanation for the inability to induce bacterial 
arthritides in most rat strains comes from the following observation 
(82): Conventional F344 rats are known to be resistant to adjuvant 
arthritis in addition to SCW arthritis and, if our hypothesis is true, 
are thus tolerized to certain "dangerous" bacterial epitopes. On behalf 
of this, one would expect F344 rats which never have encountered 
bacteria in their entire life not to be tolerized and thus susceptible 
to bacterial arthritis. Indeed, germfree F344 rats develop adjuvant 
arthritis which is comparable with respect to chronicity and severity 
to that in susceptible Lewis rats. This fascinating observation 
suggests an important role for endogenous (gut flora) bacteria in the 
induction of tolerance and protection against autoimmune arthritis. The 
involvement of gut bacteria in the regulation of autoimmunity is 
further supported by the finding, that repopulation of germfree F344 
rats with E.coli (oral administration) several weeks before arthritis 
induction makes F344 rats resistant to adjuvant arthritis again! 
Whether this tolerance is also of importance in SCW arthritis and by 
which cell subset it is mediated is an intriguing question and this 
will be subjected to further study on our laboratory in the near 
future. 
In other models for autoimmune disease, especially in experimental 
allergic encephalomyelitis (ЕАБ), a lot of work has been done to 
elucidate the regulatory mechanisms involved in the expression of the 
disease. It has been shown for instance, that pretreatment of resistant 
mice with low doses cyclophosphamide or irradiation makes some strains 
susceptible to EAE, suggesting the involvement of suppressor Τ cells in 
the resistance. Other strains, however, remained resistant, which can 
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be explained by a possible inability of their Τ cells to recognize the 
relevant antigenic structures (the famous hole in the repertoire) 
(83). In other words, individuals which are not susceptible to certain 
autoimmune diseases can be divided into two groups: the first has a 
suppressor Τ cell dependent tolerance to certain (self)epitopes, while 
the second group is lacking an appropriate Τ cell receptor/Major 
Histocompatibility Complex (MHO combination for certain antigens. In 
the first group autoinsnunity can be induced by breaking tolerance, 
while the second group form the happy few in which autoimmunity is an 
impossibility. 
The least complicated way of thinking about suppression is as a 
regulatory circuit mediated by CD8+CD4" (ОХ + УЗ/гЗ" in the rat, 
Ьу^2",ЪЗТ4- in the mouse) Τ cells. Indeed, our in vivo and in vitro 
data on the SCW arthritis model in rats support this view (16,66). 
Also in EAE, CD8+ cells have been shown to play a role in dowregulating 
disease (Θ6): In Lewis rats EAE was induced by an encephalitogenic Τ 
cell line (SI), and from the spleens of recovered rats myelin basic 
protein-specific CD8+ Τ cells were isolated, which were able to lyse 
the SI Τ cell line in vitro and to reverse their encephalitogenic 
capacity in vivo. But, on the other hand, in models for adjuvant 
arthritis, collagen type II arthritis and experimental allergic 
encephalomyelitis evidence has arisen that Τ cells with a 
helper-phenotype (CD4+CD8-) are fully responsible for suppression of 
the disease (44,45,84,85). From mice with collagen type II arthritis 
(84) and from mice (85) with EAE, antigen-specific Τ cells have been 
isolated, which display a helper phenotype and which induce resistance 
to subsequent disease induction. The fact that these cells were 
isolated from diseased animals, suggests that these cells have a 
function in vivo, for instance downregulation of autoimmune responses. 
The underlying mechanism could be a simple one (the one mediated by 
CD4+CD8~ suppressor/inducer cells), but also a more sophisticated and 
specific one: One can imagine, that disease inducing Τ cells evoke a 
response against their antigen-specific part and that this response, 
. , ._„„„+ suppressor/cytotoxic Τ cells, downregulates the 
mediated by CD4 CD8  vr ι 
function of the inducing cells. The latter mechanism is supported by 
the observations, that disease-inducing Τ cell lines or clones can 
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induce resistance when they are transferred to recipients in 
"subclinical" doses (87) or when the inducing Τ cells are killed before 
transfer (45,88). 
From all aboveraentioned data and speculations, it will undoubtedly be 
clear that regulation of tolerance and autoimmunity is a complex, 
though very important mechanism, which requires an absolute balance of 
all its constituents. Studies which compare regulatory circuits in 
susceptible to those in resistant individuals with respect to 
autoimmunity are at the moment going on in our laboratory. 
For this purpose we use the SCW arthritis model, susceptible Lewis and 
resistant F344 rats, because we have several pieces of evidence, that 
in this model autoimmunity to cartilage plays a role besides the well 
known reactions to the undegradable and thus persistent cell walls. 
Very recent data from our laboratory showed, that in Lewis rats and in 
various strains of mice cellular anti-bacterium and anti-cartilage 
responses result from subcutaneous immunization with SCW in oil, while 
in F344 rats none of these responses come to expression (16,66). The 
expression of considerable anti-cartilage responses appeared not to be 
sufficient for the initiation of joint inflammation, however, because 
nor in those Lewis rats nor in mice an arthritis was ever observed. 
This might be explained by the fact that crossreactive epitopes are 
hidden in intact cartilage and that autoimmunity becomes important no 
sooner than after the cartilage is damaged resulting in exposition of 
relevant epitopes. As stated before, the SCW arthritis, induced by 
i.p. injection, shows a biphasic pattern: the acute phase is due to a 
massive complement activation inducing a systemic illness which wanes 
after 3-5 days and it is a Τ cell independent reaction. Part of this 
systemic illness is an inflammation of the joints and this inflammation 
might cause enough joint damage to expose certain epitopes. These 
epitopes become important during the second, Τ cell dependent, chronic 
erosive phase of the arthritis (starting at day 14): crossreacting Τ 
cells recognize cartilage epitopes, thus localizing the disease in the 
joints. This would imply that, once autoimmunity is induced, a systemic 
depot of SCW is not necessary for chronic SCW arthritis. But, if we 
immunized Lewis rats or mice with SCW in oil and injected a small 
amount of SCW into the joint, providing a crossreactive immune response 
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and a damaged joint without a systemic depot, only a transient 
arthritis was observed. Our explanation for this apparent discrepancy 
is the following: the control of upcoming autoimmune responses is to 
all probability very stringent, so these responses will be 
downregulated as fast as possible. Possibly, this crossreactive immune 
response is more efficiently stimulated by foreign SCW than by 
self-cartilage components, so downregulation of the immune response 
will be accomplished sooner if a systemic SCW depot is absent. 
Our idea is thus, that autoimmunity and a response against SCW operate 
in concert in the i.p. induced SCW arthritis: circulating Τ cells are 
continuously activated by the omnipresent SCW and the crossreactive 
character of a certain percentage of these Τ cells then directs the 
disease to the joints. 
To test the hypothesis that a damaged joint together with a 
crossreactive anti-SCW response are sufficient for a (transient) 
arthritis, we immunized Lewis and F344 rats with SCW or with an control 
antigen (ovalbumin, OVA) and damaged the cartilage 21 days thereafter 
by i.a. injection of papain. Injection of papain was shown to result in 
a loss of 50% of the proteoglycans within 24 hours. Indeed, preliminary 
data show that in Lewis rats which were immunized with SCW a 
monoarthritis occurred, while in Lewis rats immunized with OVA or in 
both groups of F344 rats no inflammation could be detected. Thus, a 
damaged joint together with a crossreactive anti-bacterium response 
could be sufficient to induce arthritis. 
But, despite we are learning the alphabet of the immunoregulation of 
autoimmune responses, we are far from understanding its language. Thus, 
further experiments will have to be performed to identify the Τ cell 
subsets and their precise specificity involved in the initiation and 
the downregulation of chronic arthritis. With resistant and susceptible 
rat strains and good characterized cell wall and cartilage antigens we 
have valuable tools for unraveling the complex, but intrigiuing 
mechanism of bacterium-induced arthritis. 
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NEDERLANDSE SAMENVATTING 
van het proefschrift, getiteld 
Τ CELL GEMEDIEERDE OPVLAMMINGEN VAN EKSPERÍMENTELE ARTRITIS: EEN 
MOGELIJK MECHANISME VAN CHRONICITEIT 

SAMENVATTING 
Chronische gewrichtsontsteking (artritis) is een frekwent voorkomend 
probleem in de geneeskunde. Het prototype van deze aandoening is 
reumatoïde artritis (chronisch gewrichtsreuma), dat bij ongeveer 2% van 
de volwassen bevolking voorkomt. De ziekte is een zogenaamde 
systeemziekte, hetgeen wil zeggen dat het ontstekingsproces niet alleen 
in de gewrichten, maar ook op allerlei andere plaatsen in het lichaam 
aanwezig is. De oorzaak is vooralsnog onbekend. Eveneens is het 
onduidelijk waarom het ontstekingsproces vooral in de gewrichten tot 
uiting komt en waarom de ontsteking een chronisch karakter heeft. 
Theoretisch is een chronische ontsteking het gevolg van een kontinue 
prikkel. Daarbij kan gedacht worden aan een kontinue aanvoer van de 
ontstekingsprikkel via de bloedstroom of aan een prikkel die langdurig 
in het lichaam aanwezig blijft (persisteert). Wanneer het gewricht als 
doelwitorgaan wordt beschouwd, is het ook nog mogelijk dat strukturen 
in het gewricht zelf (zoals Proteoglykanen of kollageen) fungeren als 
prikkel, zodat de ontstekingsreaktie in feite gericht is tegen 
lichaamseigen strukturen: dit wordt dan een autoimmuunrespons genoemd 
(auto = zelf, immuunrespons = afweerreaktie). 
Studies, die beschreven zijn in dit proefschrift, hebben aangetoond dat 
injektie van een bepaalde prikkel (antigeen) in het kniegewricht van 
muizen leidt tot een gewrichtsontsteking, mits dezelfde muizen een 
goede immuunrespons vertonen tegen dat antigeen. Dit geeft aan, dat de 
aanwezigheid van een antigeen op een bepaalde plaats in het lichaam 
leidt tot een ontsteking op die plaats als het individu overgevoelig 
(immuun) is voor dat antigeen. Deze vorm van artritis is van aflopende 
aard, maar de ontsteking kan gereaktiveerd worden door een injektie van 
hetzelfde antigeen in de bloedstroom: hernieuwd kontakt met hetzelfde 
antigeen leidt dus tot een opvlamming van de artritis en een kontinu 
kontakt zou op deze manier inderdaad een chronische ontsteking kunnen 
veroorzaken. Deze opvlammingsreakties bleken afhankelijk te zijn van 
antigeen specifieke Τ cellen die zijn achtergebleven in het ontstoken 
gewricht. Een Τ cel of Τ lymfocyt is een bepaald soort witte bloedcel 
die betrokken is bij de regulatie en uitvoering van afweerreakties en 
zonder deze Τ cellen zijn opvlammingen, en misschien ook chronische 
ontstekingen, dus onmogelijk. 
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Een voorbeeld van een prikkel die kontinu in de bloedstroom aanwezig 
zou kunnen zijn is een bakterie: deze mikroorganismen komen in grote 
getale voor in onze omgeving en in ons lichaam (darm). Decennia geleden 
is de relatie tussen bakteriële infekties van het maagdarmkanaal of het 
urogenitale stelsel en gewrichtsontsteking (artritis) al opgemerkt. 
Naar een verklaring voor deze relatie is men nog steeds zoekende. Een 
veel gehoorde veronderstelling voor het mechanisme van de artritis is 
de volgende: bakteriën of bakteriële antigenen zouden zich vanuit de 
infektiehaard (maagdarmkanaal, urogenitale stelsel) verspreiden door 
het lichaam en zich onder andere ophouden in de gewrichten. Het lichaam 
bouwt een afweerreaktie op tegen de bakteriën, en die afweerreaktie zal 
zich met name afspelen op die plaatsen in het lichaam, waar de 
bakteriën zich bevinden, zodat op deze manier de gewrichtsontsteking 
inderdaad verklaard zou kunnen worden. 
Er zijn echter verschillende feiten die deze veronderstelling niet 
volledig ondersteunen. Het argument dat het preferentieel verblijf van 
bakteriën in het gewricht verantwoordelijk is voor de plaats van de 
ontsteking in de gewrichten gaat mank: er is geen steekhoudende reden 
te bedenken voor deze voorkeurslokalisering van bakteriën. Bovendien 
was het tot nu toe onmogelijk bakteriën te isoleren of te kweken uit de 
ontstoken gewrichten of hun aanwezigheid zelfs maar aan te tonen. Als 
bakteriën niet (in verhoogde mate) in het gewricht zitten maar 
gelijkmatig over het lichaam zijn verdeeld, is het niet goed te 
begrijpen waarom de iramuunrespons tegen de bakteriën tot een ontsteking 
van met name de gewrichten leidt. 
In dit proefschrift staan eksperimenten beschreven die een mogelijke 
verklaring geven voor het feit dat de aanwezigheid van een 
afweerreaktie tegen bakteriën kan leiden tot een gewrichtsontsteking. 
Er wordt getoond dat injektie van bakteriën een immuunrespons induceert 
in proefdieren (muis, rat) die, geheel volgens verwachting, specifiek 
is voor die bakteriën. Naast deze gewenste en in feite beschermende 
afweerreaktie bleek echter ook een meer bedreigende immuunrespons 
aantoonbaar te zijn die specifiek was voor kraakbeen-Proteoglykanen: 
een zogenaamde autoimmuunrespons. Deze autoimmuunrespons bleek niet in 
alle rattestammen meetbaar te zijn en de aanwezigheid van de 
immuunrespons tegen bakteriën en kraakbeen korreleerde met de 
ontvankelijkheid voor artritis na injektie met bakteriën in de 
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bloedbaan. Deze observatie zou dus mogelijk verklaren hoe prikkels 
waarmee iedereen in aanraking komt (bakteriën) slechts in bepaalde 
mensen verantwoordelijk kunnen zijn voor een ontsteking op een 
specifieke plaats in het lichaam, de gewrichten, zonder dat de prikkel 
zelf ter plekke hoeft te zijn. Verder is aangetoond dat in de ratten 
die niet ontvankelijk zijn voor artritis bepaalde "regulator Τ cellen" 
verhinderen dat de Τ cel reaktie tegen bakteriën en kraakbeen goed op 
gang komt: in ontvankelijke ratten leken deze regulator cellen niet of 
minder goed te funktioneren. 
Samengevat denken we dat het volgende mechanisme een rol kan spelen bij 
bepaalde vormen van chronische artritis: als een bakterie in grotere 
hoeveelheden dan normaal het lichaam van een individu binnenkomt (door 
een infektie bijvoorbeeld) dan kunnen er twee dingen gebeuren. In de 
meeste mensen zal een afweerreaktie opgebouwd worden die specifiek is 
voor die bakterie en die als doel heeft de indringer uit het lichaam te 
verwijderen. In sommige mensen echter kan een "bijwerking" van deze 
afweerreaktie een reaktiviteit tegen het lichaamseigen kraakbeen zijn, 
omdat kraakbeen en bakteriën struktureel wel wat op elkaar lijken. Deze 
ongewenste en bedreigende autoimmuunrespons zal in de eerste groep 
mensen onderdrukt worden door goed funktionerende regulator cellen, die 
afwezig zijn in de tweede groep. In de tweede groep zal door de 
autoimmuunrespons een gewrichtsontsteking ontstaan die door ( een 
samenwerking van) de volgende mechanismen onderhouden kan worden: ten 
eerste leidt gewrichtsontsteking tot kraakbeenafbraak en dus tot de 
aanwezigheid van kraakbeenbestanddelen in de bloedstroom. Deze 
bestanddelen zouden, net zoals boven is beschreven voor muizen, kunnen 
zorgen voor opvlammmingen en, bij een kontinue aanwezigheid in de 
bloedstroom, voor chronische ontsteking. Een tweede, en volgens ons 
belangrijkere mogelijkheid is, dat iedere keer, wanneer een kleine 
hoeveelheid bakteriën van welk soort dan ook in de bloedstroom komt, 
bijvoorbeeld via de darm, een opvlamming van de artritis kan ontstaan. 
Dit tweede mechanisme loopt waarschijnlijk via een aktivering van 
cirkulerende bakterie-specifieke Τ cellen die door hun autoimmuun 
karakter de ontsteking met name in het gewricht reaktiveren. Maar welke 
faktoren nu precies bepalen waarom bepaalde individuen ontvankelijk 
zijn voor bakteriële artritis en hoe deze ontvankelijkheid is te 
verminderen of te voorkomen is op dit moment het onderwerp van verdere 
studie op ons laboratorium. 
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CURRICULUM VITAE 
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karakterisering van antigene determinanten van de malaria-parasiet 
Plasmodium falciparum op de afdeling Molekulaire Biologie o.l.v. Prof. 
dr. J.J.G. Schoenmakers. 
Vanaf 1985 is zij werkzaam op de afdeling Reumatische Ziekten van het 
Akademisch Ziekenhuis Nijmegen (hoofd: Prof. dr. L.B.A. van de Putte) 
waar zij, gesubsidieerd door de Nederlandse Vereniging voor 
Reumabestrijding, het in dit proefschrift beschreven onderzoek 
verrichtte in het kader van haar promotie. Vanaf maart 1988 is zij aan 
dezelfde afdeling verbonden als wetenschappelijk medewerkster. 
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1. Antigeen-specifleke, МНС Klasse II gerestrikteerde Τ lymfocyten 
spelen een bepalende rol in de initiëring van opvlammingen van 
ontstekingen en dragen derhalve bij tot chroniciteit. 
Dit proefschrift. 
2. Induktie van autoimmuniteit tegen kraakbeen door bakteriën kan de 
lokalisering van het ontstekingsproces, zoals die gezien wordt bij 
verschillende eksperimentele en reaktieve artritiden, verklaren. 
Dit proefschrift. 
3. De ekspressie van autoimmuniteit in de rat wordt mogelijk 
gereguleerd door НТб"1" Τ lymfocyten. 
Greiner et al., J.exp.Med.166: 461-475, 1985 en dit proefschrift. 
4. De relatie tussen chronische darmlesies en artritis in 
seronegatieve spondylartropatie'ên en het gunstige effekt van 
salazopyrine op beide fenomenen suggereert een betrokkenheid van 
endogene bakteriën in de patogenese van artritis. 
Mielants et al., J.Rheumatol.14: 456-471, 1987 en dit proefschrift. 
5. Het is niet onwaarschijnlijk, dat de darmflora al in een vroeg 
levensstadium van de gastheer een toleriserende werking heeft 
m.b.t. bepaalde bakteriële epitopen en derhalve beschermt tegen 
autoimmuniteit ten gevolge van bakteriële infekties. 
Kohashi et al., Arthr.Rheum.29: 547-553, 1986. 
6. De veelvuldig veronderstelde strukturele overeenkomst tussen 
HLA-B27 en bepaalde bakteriën verklaart de klinisch ekspressie van 
reaktieve artritis of M. Bechterew op geen enkele wijze. 
7. De observatie van J. Allen et al. (ARA 1988), dat behandeling met 
interferon-gamma een gunstig effekt heeft op het verloop van 
Streptokokken celwand artritis in ratten, berust waarschijnlijk op 
een artefakt. 
8. Produktie van reumafaktor kan een neveneffekt zijn van bakteri'éle 
infekties. De overmatige produktie ervan in bepaalde ziekten duidt 
mogelijk eerder op polyklonale aktivering van В lymfocyten in die 
ziekte dan op een kausaal verband tussen reumafaktor en die ziekte. 
Mannik et al., J.exp.Med.166: 702-715, 1987. 
9. Reumatoïde artritis is geen erfelijke ziekte sensu stricto. 
Het karakteriseren van RFLP's (restriction fragment length 
polymorphisms) bij deze patiënten en hun familieleden zal daarom 
niet wezenlijk bijdragen tot kennis omtrent de patogenese van 
reumatoïde artritis. 
10. Het ontkennen van het bestaan van suppressor Τ lymfocyten is een 
modeverschijnsel. 
11. Membramen bestaan niet. 
12. Het gebruik van anabole Steroiden in de topsport zou gelegaliseerd 
moeten worden. 
13. Onderzoekers op het gebied van de eksakte wetenschappen vervuilen 
in ernstige mate de Nederlandse taal. 
14. Het beperken van de oppositie tijdens een promotie tot opmerkingen 
over tik- en zetfouten of het uiterlijk van boekje of 
promovendus getuigt van een gebrek aan kreativiteit. 
15. Als twee personen van verschillend geslacht een werkkamer delen, is 
het allerminst vanzelfsprekend, dat zij zijn sekretaresse is. 
Stellingen bij het proefschrift, getiteld "T cell mediated 
exacerbations of experimental arthritis: a possible mechanism for 
chronicity", van Maries van den Broek. 
